BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos. 1995;16:351-380. [PMID: 8527686 DOI: 10.1002/bdd.2510160502] [Cited by in Crossref: 883] [Cited by in F6Publishing: 775] [Article Influence: 35.3] [Reference Citation Analysis]
Number Citing Articles
1 Kirman C, Aylward L, Suh M, Harris M, Thompson C, Haws L, Proctor D, Lin S, Parker W, Hays S. Physiologically based pharmacokinetic model for humans orally exposed to chromium. Chemico-Biological Interactions 2013;204:13-27. [DOI: 10.1016/j.cbi.2013.04.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
2 Yang CL, Chao YJ, Wang HC, Hou YC, Chen CG, Chang CC, Shan YS. Local ablation of gastric cancer by reconstituted apolipoprotein B lipoparticles carrying epigenetic drugs. Nanomedicine 2021;37:102450. [PMID: 34332115 DOI: 10.1016/j.nano.2021.102450] [Reference Citation Analysis]
3 Pridgen EM, Alexis F, Farokhzad OC. Polymeric nanoparticle technologies for oral drug delivery. Clin Gastroenterol Hepatol 2014;12:1605-10. [PMID: 24981782 DOI: 10.1016/j.cgh.2014.06.018] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 10.4] [Reference Citation Analysis]
4 Ganesh AN, Heusser C, Garad S, Sánchez-félix MV. Patient-centric design for peptide delivery: Trends in routes of administration and advancement in drug delivery technologies. Medicine in Drug Discovery 2021;9:100079. [DOI: 10.1016/j.medidd.2020.100079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Harding SV, Fraser KG, Wykes LJ. Probiotics stimulate liver and plasma protein synthesis in piglets with dextran sulfate-induced colitis and macronutrient restriction. J Nutr 2008;138:2129-35. [PMID: 18936209 DOI: 10.3945/jn.108.090019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
6 Li Y, Jiang C, Jiang X, Sun Z, Cona MM, Liu W, Zhang J, Ni Y. Biliary and duodenal drainage for reducing the radiotoxic risk of antineoplastic 131I-hypericin in rat models. Exp Biol Med (Maywood) 2015;240:1764-73. [PMID: 25956680 DOI: 10.1177/1535370215584891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Holm R, Müllertz A, Mu H. Bile salts and their importance for drug absorption. Int J Pharm 2013;453:44-55. [PMID: 23598075 DOI: 10.1016/j.ijpharm.2013.04.003] [Cited by in Crossref: 120] [Cited by in F6Publishing: 106] [Article Influence: 15.0] [Reference Citation Analysis]
8 Hong S, Shen S, Tan DC, Ng WK, Liu X, Chia LS, Irwan AW, Tan R, Nowak SA, Marsh K, Gokhale R. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods. Drug Deliv 2016;23:316-27. [PMID: 24853963 DOI: 10.3109/10717544.2014.913323] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
9 Machado JG, Hyland KA, Dvorak CM, Murtaugh MP. Gene expression profiling of jejunal Peyer’s patches in juvenile and adult pigs. Mamm Genome 2005;16:599-612. [DOI: 10.1007/s00335-005-0008-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
10 Goode GA, Wagh SJ, Irby DJ, Ma D, Jacobs RF, Kearns GL, Almoazen H. Bioavailability testing of a newly developed clindamycin oral suspension in a pediatric porcine model. Pharm Dev Technol 2019;24:1038-43. [PMID: 31134840 DOI: 10.1080/10837450.2019.1624771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Enomoto H, Yeatts J, Carbajal L, Krishnan BR, Madan JP, Laumas S, Blikslager AT, Messenger KM. In vivo assessment of a delayed release formulation of larazotide acetate indicated for celiac disease using a porcine model. PLoS One 2021;16:e0249179. [PMID: 33844694 DOI: 10.1371/journal.pone.0249179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chiou WL, Jeong HY, Chung SM, Wu TC. Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans. Pharm Res 2000;17:135-40. [PMID: 10751026 DOI: 10.1023/a:1007552927404] [Cited by in Crossref: 138] [Cited by in F6Publishing: 22] [Article Influence: 6.6] [Reference Citation Analysis]
13 Labelle MA, Ispas-Szabo P, Masseau I, Chorfi Y, Mateescu MA. In vivo evaluation of targeted delivery of biological agents using barium sulfate. Int J Pharm 2019;572:118801. [PMID: 31678529 DOI: 10.1016/j.ijpharm.2019.118801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Gonzalez LM, Moeser AJ, Blikslager AT. Porcine models of digestive disease: the future of large animal translational research. Transl Res 2015;166:12-27. [PMID: 25655839 DOI: 10.1016/j.trsl.2015.01.004] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 13.7] [Reference Citation Analysis]
15 Vertzoni M, Augustijns P, Grimm M, Koziolek M, Lemmens G, Parrott N, Pentafragka C, Reppas C, Rubbens J, Van Den Αbeele J, Vanuytsel T, Weitschies W, Wilson CG. Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: An UNGAP review. European Journal of Pharmaceutical Sciences 2019;134:153-75. [DOI: 10.1016/j.ejps.2019.04.013] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 27.5] [Reference Citation Analysis]
16 Jatho A, Cambia JM, Myung SK. Consumption of artificially sweetened soft drinks and risk of gastrointestinal cancer: a meta-analysis of observational studies. Public Health Nutr 2021;:1-15. [PMID: 33691824 DOI: 10.1017/S136898002100104X] [Reference Citation Analysis]
17 Connelly S, Fanelli B, Hasan NA, Colwell RR, Kaleko M. Oral Metallo-Beta-Lactamase Protects the Gut Microbiome From Carbapenem-Mediated Damage and Reduces Propagation of Antibiotic Resistance in Pigs. Front Microbiol 2019;10:101. [PMID: 30804903 DOI: 10.3389/fmicb.2019.00101] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
18 DeSesso JM, Lavin AL, Hsia SM, Mavis RD. Assessment of the carcinogenicity associated with oral exposures to hydrogen peroxide. Food Chem Toxicol 2000;38:1021-41. [PMID: 11038240 DOI: 10.1016/s0278-6915(00)00098-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ganderup NC, Harvey W, Mortensen JT, Harrouk W. The minipig as nonrodent species in toxicology--where are we now? Int J Toxicol 2012;31:507-28. [PMID: 23134714 DOI: 10.1177/1091581812462039] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
20 Adhikari C, Das A, Chakraborty A. Zeolitic Imidazole Framework (ZIF) Nanospheres for Easy Encapsulation and Controlled Release of an Anticancer Drug Doxorubicin under Different External Stimuli: A Way toward Smart Drug Delivery System. Mol Pharmaceutics 2015;12:3158-66. [DOI: 10.1021/acs.molpharmaceut.5b00043] [Cited by in Crossref: 81] [Cited by in F6Publishing: 58] [Article Influence: 13.5] [Reference Citation Analysis]
21 McCartney F, Rosa M, Brayden DJ. Evaluation of Sucrose Laurate as an Intestinal Permeation Enhancer for Macromolecules: Ex Vivo and In Vivo Studies. Pharmaceutics 2019;11:E565. [PMID: 31683652 DOI: 10.3390/pharmaceutics11110565] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
22 de Jong P, Vissers MM, van der Meer R, Bovee-Oudenhoven IM. In silico model as a tool for interpretation of intestinal infection studies. Appl Environ Microbiol 2007;73:508-15. [PMID: 17122404 DOI: 10.1128/AEM.01299-06] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
23 Stern AH. A quantitative assessment of the carcinogenicity of hexavalent chromium by the oral route and its relevance to human exposure. Environmental Research 2010;110:798-807. [DOI: 10.1016/j.envres.2010.08.002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 5.7] [Reference Citation Analysis]
24 Tokunaga S, Kawata T. The effect of evocalcet on vagus nerve activity of the gastrointestinal tract in miniature pigs. PLoS One 2021;16:e0245785. [PMID: 33481922 DOI: 10.1371/journal.pone.0245785] [Reference Citation Analysis]
25 Connelly S, Subramanian P, Hasan NA, Colwell RR, Kaleko M. Distinct consequences of amoxicillin and ertapenem exposure in the porcine gut microbiome. Anaerobe 2018;53:82-93. [DOI: 10.1016/j.anaerobe.2018.04.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
26 Fugono J, Yasui H, Sakurai H. Pharmacokinetic study on gastrointestinal absorption of insulinomimetic vanadyl complexes in rats by ESR spectroscopy. J Pharm Pharmacol 2001;53:1247-55. [PMID: 11578107 DOI: 10.1211/0022357011776531] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
27 Kim TH, Paik SH, Chi YH, Bulitta JB, Lee DY, Lim JY, Chung SE, Song CH, Jeong HM, Shin S, Shin BS. Regional Absorption of Fimasartan in the Gastrointestinal Tract by an Improved in situ Absorption Method in Rats. Pharmaceutics 2018;10:E174. [PMID: 30282950 DOI: 10.3390/pharmaceutics10040174] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
28 Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 2007;24:2198-206. [PMID: 17577641 DOI: 10.1007/s11095-007-9367-4] [Cited by in Crossref: 387] [Cited by in F6Publishing: 323] [Article Influence: 27.6] [Reference Citation Analysis]
29 Hanh ND, Sinchaipanid N, Mitrevej A. Physicochemical characterization of phyllanthin from Phyllanthus amarus Schum. et Thonn. Drug Dev Ind Pharm 2014;40:793-802. [PMID: 23594304 DOI: 10.3109/03639045.2013.788010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
30 Hubbard TD, Murray IA, Nichols RG, Cassel K, Podolsky M, Kuzu G, Tian Y, Smith P, Kennett MJ, Patterson AD, Perdew GH. Dietary Broccoli Impacts Microbial Community Structure and Attenuates Chemically Induced Colitis in Mice in an Ah receptor dependent manner. J Funct Foods 2017;37:685-98. [PMID: 29242716 DOI: 10.1016/j.jff.2017.08.038] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
31 Zhou H, Seitz K. In Vivo Evaluation of Oral Dosage Form Performance. Developing Solid Oral Dosage Forms. Elsevier; 2009. pp. 365-78. [DOI: 10.1016/b978-0-444-53242-8.00016-3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
32 Kolf-Clauw M, Castellote J, Joly B, Bourges-Abella N, Raymond-Letron I, Pinton P, Oswald IP. Development of a pig jejunal explant culture for studying the gastrointestinal toxicity of the mycotoxin deoxynivalenol: histopathological analysis. Toxicol In Vitro 2009;23:1580-4. [PMID: 19607908 DOI: 10.1016/j.tiv.2009.07.015] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 5.9] [Reference Citation Analysis]
33 Bush J, van den Boom R, Franklin S. Comparison of aloe vera and omeprazole in the treatment of equine gastric ulcer syndrome. Equine Vet J 2018;50:34-40. [DOI: 10.1111/evj.12706] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
34 Thomas S. Physiologically-based Simulation Modelling for the Reduction of Animal Use in the Discovery of Novel Pharmaceuticals. Altern Lab Anim 2009;37:497-511. [DOI: 10.1177/026119290903700507] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
35 Perng C, Kearney AS, Palepu NR, Smith BR, Azzarano LM. Assessment of oral bioavailability enhancing approaches for SB-247083 using flow-through cell dissolution testing as one of the screens. International Journal of Pharmaceutics 2003;250:147-56. [DOI: 10.1016/s0378-5173(02)00521-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
36 Li N, Taylor LS, Ferruzzi MG, Mauer LJ. Kinetic study of catechin stability: effects of pH, concentration, and temperature. J Agric Food Chem 2012;60:12531-9. [PMID: 23205662 DOI: 10.1021/jf304116s] [Cited by in Crossref: 121] [Cited by in F6Publishing: 102] [Article Influence: 13.4] [Reference Citation Analysis]
37 Stolaki M, Minekus M, Venema K, Lahti L, Smid EJ, Kleerebezem M, Zoetendal EG. Microbial communities in a dynamic in vitro model for the human ileum resemble the human ileal microbiota. FEMS Microbiol Ecol 2019;95:fiz096. [PMID: 31295351 DOI: 10.1093/femsec/fiz096] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
38 Yeo S, Lee S, Park H, Shin H, Holzapfel W, Huh CS. Development of putative probiotics as feed additives: validation in a porcine-specific gastrointestinal tract model. Appl Microbiol Biotechnol 2016;100:10043-54. [PMID: 27633101 DOI: 10.1007/s00253-016-7812-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
39 Miyake M, Minami T, Hirota M, Toguchi H, Odomi M, Ogawara K, Higaki K, Kimura T. Novel oral formulation safely improving intestinal absorption of poorly absorbable drugs: Utilization of polyamines and bile acids. Journal of Controlled Release 2006;111:27-34. [DOI: 10.1016/j.jconrel.2005.11.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
40 Tachecí I, Kvetina J, Bures J, Osterreicher J, Kunes M, Pejchal J, Rejchrt S, Spelda S, Kopácová M. Wireless capsule endoscopy in enteropathy induced by nonsteroidal anti-inflammatory drugs in pigs. Dig Dis Sci. 2010;55:2471-2477. [PMID: 20013311 DOI: 10.1007/s10620-009-1066-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
41 Rai J, Kaushik K. Reduction of Animal Sacrifice in Biomedical Science & Research through Alternative Design of Animal Experiments. Saudi Pharm J 2018;26:896-902. [PMID: 30202234 DOI: 10.1016/j.jsps.2018.03.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
42 Wang C, Kang C, Xian Y, Zhang M, Chen X, Pei M, Zhu W, Hang S. Sensing of L-Arginine by Gut-Expressed Calcium Sensing Receptor Stimulates Gut Satiety Hormones Cholecystokinin and Glucose-Dependent Insulinotropic Peptide Secretion in Pig Model. J Food Sci 2018;83:2394-401. [PMID: 30088839 DOI: 10.1111/1750-3841.14297] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
43 Masson CJ, Plat J, Mensink RP, Namiot A, Kisielewski W, Namiot Z, Füllekrug J, Ehehalt R, Glatz JF, Pelsers MM. Fatty acid- and cholesterol transporter protein expression along the human intestinal tract. PLoS One 2010;5:e10380. [PMID: 20454462 DOI: 10.1371/journal.pone.0010380] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
44 Cheng J, Teply BA, Jeong SY, Yim CH, Ho D, Sherifi I, Jon S, Farokhzad OC, Khademhosseini A, Langer RS. Magnetically Responsive Polymeric Microparticles for Oral Delivery of Protein Drugs. Pharm Res 2006;23:557-64. [DOI: 10.1007/s11095-005-9444-5] [Cited by in Crossref: 105] [Cited by in F6Publishing: 92] [Article Influence: 7.0] [Reference Citation Analysis]
45 Peters CM, Green RJ, Janle EM, Ferruzzi MG. Formulation with ascorbic acid and sucrose modulates catechin bioavailability from green tea. Food Res Int. 2010;43:95-102. [PMID: 20161530 DOI: 10.1016/j.foodres.2009.08.016] [Cited by in Crossref: 110] [Cited by in F6Publishing: 105] [Article Influence: 10.0] [Reference Citation Analysis]
46 Dressman JB, Thelen K, Willmann S. An update on computational oral absorption simulation. Expert Opinion on Drug Metabolism & Toxicology 2011;7:1345-64. [DOI: 10.1517/17425255.2011.617743] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
47 Prescher M, Kroll T, Schmitt L. ABCB4/MDR3 in health and disease – at the crossroads of biochemistry and medicine. Biological Chemistry 2019;400:1245-59. [DOI: 10.1515/hsz-2018-0441] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
48 Lozoya-Agullo I, González-Álvarez I, Merino-Sanjuán M, Bermejo M, González-Álvarez M. Preclinical models for colonic absorption, application to controlled release formulation development. Eur J Pharm Biopharm 2018;130:247-59. [PMID: 30064699 DOI: 10.1016/j.ejpb.2018.07.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
49 Dąbrowska K. Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review. Med Res Rev 2019;39:2000-25. [PMID: 30887551 DOI: 10.1002/med.21572] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 35.5] [Reference Citation Analysis]
50 Wasan KM. The Role of Lymphatic Transport in Enhancing Oral Protein and Peptide Drug Delivery. Drug Development and Industrial Pharmacy 2002;28:1047-58. [DOI: 10.1081/ddc-120014573] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
51 Jaiswal JV, Wadegaonkar PA, Hajare SW. The Bioflavonoid Galangin Suppresses the Growth of Ehrlich Ascites Carcinoma in Swiss Albino Mice: A Molecular Insight. Appl Biochem Biotechnol 2012;167:1325-39. [DOI: 10.1007/s12010-012-9646-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
52 Kambayashi A, Dressman JB. A novel in vivo predictive dissolution testing coupled with a modeling and simulation for hydrogel matrix monolithic extended release oral dosage forms. European Journal of Pharmaceutical Sciences 2019;138:105044. [DOI: 10.1016/j.ejps.2019.105044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Kalepu S, Manthina M, Padavala V. Oral lipid-based drug delivery systems – an overview. Acta Pharmaceutica Sinica B 2013;3:361-72. [DOI: 10.1016/j.apsb.2013.10.001] [Cited by in Crossref: 224] [Cited by in F6Publishing: 141] [Article Influence: 28.0] [Reference Citation Analysis]
54 Schneider F, Hoppe M, Koziolek M, Weitschies W. Influence of Postprandial Intragastric Pressures on Drug Release from Gastroretentive Dosage Forms. AAPS PharmSciTech 2018;19:2843-50. [DOI: 10.1208/s12249-018-1022-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
55 Abdallah A, Elemba E, Zhong Q, Sun Z. Gastrointestinal Interaction between Dietary Amino Acids and Gut Microbiota: With Special Emphasis on Host Nutrition. Curr Protein Pept Sci 2020;21:785-98. [PMID: 32048965 DOI: 10.2174/1389203721666200212095503] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
56 El-sherbiny I, Khalil I, Ali I, Yacoub M. Updates on smart polymeric carrier systems for protein delivery. Drug Development and Industrial Pharmacy 2017;43:1567-83. [DOI: 10.1080/03639045.2017.1338723] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
57 Påhlman I, Wilén M, Bowald S. Efficient Biliary Excretion of Susalimod, Probably via the Bromosulphthalein Carrier, Studied in a Chronic Bile Fistula Model in Dogs. Journal of Pharmacy and Pharmacology 1999;51:61-6. [DOI: 10.1211/0022357991771962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
58 Martinez MN, Mochel JP, Neuhoff S, Pade D. Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics. AAPS J 2021;23:59. [PMID: 33907906 DOI: 10.1208/s12248-021-00590-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Townsend D 4th, Casey MA, Brown DR. Mediation of neurogenic ion transport by acetylcholine, prostanoids and 5-hydroxytryptamine in porcine ileum. Eur J Pharmacol 2005;519:285-9. [PMID: 16135363 DOI: 10.1016/j.ejphar.2005.07.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
60 Wang J, Li W, Wang B, Zhou Z. Influence of clamping parameters on the trauma of rabbit small intestine tissue. Clin Biomech (Bristol, Avon) 2019;70:31-9. [PMID: 31386974 DOI: 10.1016/j.clinbiomech.2019.07.011] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Mochel JP, Jergens AE, Kingsbury D, Kim HJ, Martín MG, Allenspach K. Intestinal Stem Cells to Advance Drug Development, Precision, and Regenerative Medicine: A Paradigm Shift in Translational Research. AAPS J 2017;20:17. [PMID: 29234895 DOI: 10.1208/s12248-017-0178-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
62 Eckernäs E, Tannergren C. Physiologically Based Biopharmaceutics Modeling of Regional and Colon Absorption in Dogs. Mol Pharm 2021;18:1699-710. [PMID: 33720733 DOI: 10.1021/acs.molpharmaceut.0c01201] [Reference Citation Analysis]
63 Higashiyama H, Uemura M, Igarashi H, Kurohmaru M, Kanai-Azuma M, Kanai Y. Anatomy and development of the extrahepatic biliary system in mouse and rat: a perspective on the evolutionary loss of the gallbladder. J Anat 2018;232:134-45. [PMID: 29023691 DOI: 10.1111/joa.12707] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
64 Maisel K, Ensign L, Reddy M, Cone R, Hanes J. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. J Control Release. 2015;197:48-57. [PMID: 25449804 DOI: 10.1016/j.jconrel.2014.10.026] [Cited by in Crossref: 193] [Cited by in F6Publishing: 178] [Article Influence: 27.6] [Reference Citation Analysis]
65 Koleva PT, Bridgman SL, Kozyrskyj AL. The infant gut microbiome: evidence for obesity risk and dietary intervention. Nutrients 2015;7:2237-60. [PMID: 25835047 DOI: 10.3390/nu7042237] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 12.7] [Reference Citation Analysis]
66 Chandra L, Borcherding DC, Kingsbury D, Atherly T, Ambrosini YM, Bourgois-Mochel A, Yuan W, Kimber M, Qi Y, Wang Q, Wannemuehler M, Ellinwood NM, Snella E, Martin M, Skala M, Meyerholz D, Estes M, Fernandez-Zapico ME, Jergens AE, Mochel JP, Allenspach K. Derivation of adult canine intestinal organoids for translational research in gastroenterology. BMC Biol 2019;17:33. [PMID: 30975131 DOI: 10.1186/s12915-019-0652-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
67 Fox CB, Chirra HD, Desai TA. Planar bioadhesive microdevices: a new technology for oral drug delivery. Curr Pharm Biotechnol 2014;15:673-83. [PMID: 25219863 DOI: 10.2174/1389201015666140915152706] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
68 Casteleyn C, Rekecki A, Van Der Aa A, Simoens P, Van Den Broeck W. Surface area assessment of the murine intestinal tract as a prerequisite for oral dose translation from mouse to man. Lab Anim 2010;44:176-83. [DOI: 10.1258/la.2009.009112] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
69 Sugano K. Introduction to computational oral absorption simulation. Expert Opinion on Drug Metabolism & Toxicology 2009;5:259-93. [DOI: 10.1517/17425250902835506] [Cited by in Crossref: 87] [Cited by in F6Publishing: 70] [Article Influence: 7.3] [Reference Citation Analysis]
70 Suenderhauf C, Parrott N. A Physiologically Based Pharmacokinetic Model of the Minipig: Data Compilation and Model Implementation. Pharm Res 2013;30:1-15. [DOI: 10.1007/s11095-012-0911-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
71 Perleberg C, Kind A, Schnieke A. Genetically engineered pigs as models for human disease. Dis Model Mech. 2018;11. [PMID: 29419487 DOI: 10.1242/dmm.030783] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 25.0] [Reference Citation Analysis]
72 Brunner K, Samassa F, Sansonetti PJ, Phalipon A. Shigella-mediated immunosuppression in the human gut: subversion extends from innate to adaptive immune responses. Hum Vaccin Immunother 2019;15:1317-25. [PMID: 30964713 DOI: 10.1080/21645515.2019.1594132] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
73 Jin RU, Mills JC. Are Gastric and Esophageal Metaplasia Relatives? The Case for Barrett's Stemming from SPEM. Dig Dis Sci 2018;63:2028-41. [PMID: 29948563 DOI: 10.1007/s10620-018-5150-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
74 Giuliano C, Fiore F, Di Marco A, Padron Velazquez J, Bishop A, Bonelli F, Gonzalez-paz O, Marcucci I, Harper S, Narjes F, Pacini B, Monteagudo E, Migliaccio G, Rowley M, Laufer R. Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase. Xenobiotica 2008;35:1035-54. [DOI: 10.1080/00498250500356548] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
75 Yang L, Watanabe S, Li J, Chu JS, Katsuma M, Yokohama S, Fix JA. Effect of colonic lactulose availability on the timing of drug release onset in vivo from a unique colon-specific drug delivery system (CODES). Pharm Res 2003;20:429-34. [PMID: 12669964 DOI: 10.1023/a:1022660305931] [Cited by in Crossref: 29] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
76 Pezzali JG, Shoveller AK, Ellis J. Examining the Effects of Diet Composition, Soluble Fiber, and Species on Total Fecal Excretion of Bile Acids: A Meta-Analysis. Front Vet Sci 2021;8:748803. [PMID: 34692814 DOI: 10.3389/fvets.2021.748803] [Reference Citation Analysis]
77 Shelat KJ, Nicholson T, Flanagan BM, Zhang D, Williams BA, Gidley MJ. Rheology and microstructure characterisation of small intestinal digesta from pigs fed a red meat-containing Western-style diet. Food Hydrocolloids 2015;44:300-8. [DOI: 10.1016/j.foodhyd.2014.09.036] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
78 Zou D, Arora M, Ganugula R, Kumar M, Scott EM, Shah D, Kumar MNVR. Nanoparticles that do not compete with endogenous ligands - Molecular characterization in vitro, acute safety in canine, and interspecies pharmacokinetics modeling to humans. J Control Release 2021;332:64-73. [PMID: 33600881 DOI: 10.1016/j.jconrel.2021.02.009] [Reference Citation Analysis]
79 Pechenkin MA, Balabushevich NG, Zorov IN, Izumrudov VA, Klyachko NL, Kabanov AV, Larionova NI. Use of Protease Inhibitors in Composite Polyelectrolyte Microparticles in Order to Increase the Bioavailability of Perorally Administered Encapsulated Proteins. Pharm Chem J 2013;47:62-9. [DOI: 10.1007/s11094-013-0898-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
80 Hunter AC, Elsom J, Wibroe PP, Moghimi SM. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. Nanomedicine 2012;8 Suppl 1:S5-20. [PMID: 22846372 DOI: 10.1016/j.nano.2012.07.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 6.6] [Reference Citation Analysis]
81 Arnold YE, Kalia YN. Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early-Stage Drug Development. Biomedicines 2020;8:E340. [PMID: 32927779 DOI: 10.3390/biomedicines8090340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
82 Augustijns P, Annaert P, Heylen P, Van den Mooter G, Kinget R. Drug absorption studies of prodrug esters using the Caco-2 model: evaluation of ester hydrolysis and transepithelial transport. International Journal of Pharmaceutics 1998;166:45-53. [DOI: 10.1016/s0378-5173(98)00013-1] [Cited by in Crossref: 36] [Article Influence: 1.6] [Reference Citation Analysis]
83 Eberle JA, Widmayer P, Breer H. Receptors for short-chain fatty acids in brush cells at the "gastric groove". Front Physiol 2014;5:152. [PMID: 24795647 DOI: 10.3389/fphys.2014.00152] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
84 Risovic V, Sachs-Barrable K, Boyd M, Wasan KM. Potential mechanisms by which Peceol increases the gastrointestinal absorption of amphotericin B. Drug Dev Ind Pharm 2004;30:767-74. [PMID: 15491054 DOI: 10.1081/ddc-120039793] [Cited by in Crossref: 33] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
85 Patel GB, Sprott GD. Archaeobacterial Ether Lipid Liposomes (Archaeosomes) as Novel Vaccine and Drug Delivery Systems. Critical Reviews in Biotechnology 2008;19:317-57. [DOI: 10.1080/0738-859991229170] [Cited by in Crossref: 127] [Cited by in F6Publishing: 106] [Article Influence: 9.8] [Reference Citation Analysis]
86 Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64:557-570. [PMID: 22212900 DOI: 10.1016/j.addr.2011.12.009] [Cited by in Crossref: 835] [Cited by in F6Publishing: 730] [Article Influence: 83.5] [Reference Citation Analysis]
87 Fotaki N. Pros and cons of methods used for the prediction of oral drug absorption. Expert Review of Clinical Pharmacology 2014;2:195-208. [DOI: 10.1586/17512433.2.2.195] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
88 Schultz HB, Wignall AD, Thomas N, Prestidge CA. Enhancement of abiraterone acetate oral bioavailability by supersaturated-silica lipid hybrids. Int J Pharm 2020;582:119264. [PMID: 32278053 DOI: 10.1016/j.ijpharm.2020.119264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
89 Hayward A, Bensel T, Mazdiyasni H, Rogner J, Kirtane AR, Lee YL, Hua T, Bajpayee A, Collins J, McDonnell S, Cleveland C, Lopes A, Wahane A, Langer R, Traverso G. Scalable Gastric Resident Systems for Veterinary Application. Sci Rep 2018;8:11816. [PMID: 30087406 DOI: 10.1038/s41598-018-30212-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
90 Pereira DL, Walters J, Bennett NC, Alagaili AN, Mohammed OB, Kotzé SH. The comparative gastrointestinal morphology of Jaculus jaculus (Rodentia) and Paraechinus aethiopicus (Erinaceomorpha): GASTROINTESTINAL MORPHOLOGY OF MAMMALS. Journal of Morphology 2016;277:671-9. [DOI: 10.1002/jmor.20526] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
91 Faith NG, Peterson LD, Luchansky JB, Czuprynski CJ. Intragastric inoculation with a cocktail of Listeria monocytogenes strains does not potentiate the severity of infection in A/J mice compared to inoculation with the individual strains comprising the cocktail. J Food Prot 2006;69:2664-70. [PMID: 17133809 DOI: 10.4315/0362-028x-69.11.2664] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
92 Guo Z, Martucci NJ, Moreno-Olivas F, Tako E, Mahler GJ. Titanium Dioxide Nanoparticle Ingestion Alters Nutrient Absorption in an In Vitro Model of the Small Intestine. NanoImpact 2017;5:70-82. [PMID: 28944308 DOI: 10.1016/j.impact.2017.01.002] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 21.3] [Reference Citation Analysis]
93 Bures J, Tacheci I, Kvetina J, Radochova V, Prchal L, Kohoutova D, Valis M, Novak M, Dolezal R, Kopacova M, Rejchrt S, Sestak V, Knoblochova V, Peterova E, Zdarova Karasova J. The Impact of Dextran Sodium Sulfate-Induced Gastrointestinal Injury on the Pharmacokinetic Parameters of Donepezil and Its Active Metabolite 6-O-desmethyldonepezil, and Gastric Myoelectric Activity in Experimental Pigs. Molecules 2021;26:2160. [PMID: 33918638 DOI: 10.3390/molecules26082160] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
94 Ehrhart NP, Kaminskaya K, Miller JA, Zaruby JF. In Vivo Assessment of Absorbable Knotless Barbed Suture for Single Layer Gastrotomy and Enterotomy Closure: In Vivo Knotless Barbed Suture. Veterinary Surgery 2013;42:210-6. [DOI: 10.1111/j.1532-950x.2013.01090.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 5] [Article Influence: 4.6] [Reference Citation Analysis]
95 Hillman ET, Lu H, Yao T, Nakatsu CH. Microbial Ecology along the Gastrointestinal Tract. Microbes Environ 2017;32:300-13. [PMID: 29129876 DOI: 10.1264/jsme2.ME17017] [Cited by in Crossref: 184] [Cited by in F6Publishing: 100] [Article Influence: 46.0] [Reference Citation Analysis]
96 Fotaki N, Symillides M, Reppas C. In vitro versus canine data for predicting input profiles of isosorbide-5-mononitrate from oral extended release products on a confidence interval basis. Eur J Pharm Sci 2005;24:115-22. [PMID: 15626585 DOI: 10.1016/j.ejps.2004.10.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
97 Zhang Q, Guan J, Sacci J, Ager A, Ellis W, Milhous W, Kyle D, Lin AJ. Unambiguous synthesis and prophylactic antimalarial activities of imidazolidinedione derivatives. J Med Chem 2005;48:6472-81. [PMID: 16190773 DOI: 10.1021/jm0504252] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
98 EFSA Panel on Contaminants in the Food Chain (CONTAM). Scientific Opinion on the risks to public health related to the presence of chromium in food and drinking water. EFS2 2014;12. [DOI: 10.2903/j.efsa.2014.3595] [Cited by in Crossref: 41] [Cited by in F6Publishing: 17] [Article Influence: 5.9] [Reference Citation Analysis]
99 Baumann J, Kouassi NM, Foni E, Klenk HD, Matrosovich M. H1N1 Swine Influenza Viruses Differ from Avian Precursors by a Higher pH Optimum of Membrane Fusion. J Virol 2016;90:1569-77. [PMID: 26608319 DOI: 10.1128/JVI.02332-15] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
100 Singh AV, Romeo A, Scott K, Wagener S, Leibrock L, Laux P, Luch A, Kerkar P, Balakrishnan S, Dakua SP, Park BW. Emerging Technologies for In Vitro Inhalation Toxicology. Adv Healthc Mater 2021;:e2100633. [PMID: 34292676 DOI: 10.1002/adhm.202100633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
101 Willmann S, Edginton AN, Dressman JB. Development and Validation of a Physiology-based Model for the Prediction of Oral Absorption in Monkeys. Pharm Res 2007;24:1275-82. [DOI: 10.1007/s11095-007-9247-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
102 Gu C, Rao D, Gandhi RB, Hilden J, Raghavan K. Using a Novel Multicompartment Dissolution System to Predict the Effect of Gastric pH on the Oral Absorption of Weak Bases with Poor Intrinsic Solubility. Journal of Pharmaceutical Sciences 2005;94:199-208. [DOI: 10.1002/jps.20242] [Cited by in Crossref: 97] [Cited by in F6Publishing: 85] [Article Influence: 6.1] [Reference Citation Analysis]
103 Al-Saffar A, Nogueira da Costa A, Delaunois A, Leishman DJ, Marks L, Rosseels ML, Valentin JP. Gastrointestinal Safety Pharmacology in Drug Discovery and Development. Handb Exp Pharmacol 2015;229:291-321. [PMID: 26091645 DOI: 10.1007/978-3-662-46943-9_12] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
104 Udwadia TE. Training for laparoscopic colorectal surgery creating an appropriate porcine model and curriculum for training. J Minim Access Surg 2021;17:180-7. [PMID: 33723182 DOI: 10.4103/jmas.JMAS_86_20] [Reference Citation Analysis]
105 Song Y, Peressin K, Wong PY, Page SW, Garg S. Key Considerations in Designing Oral Drug Delivery Systems for Dogs. J Pharm Sci 2016;105:1576-85. [PMID: 27056627 DOI: 10.1016/j.xphs.2016.03.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
106 Agarwal T, Narayana SGH, Pal K, Pramanik K, Giri S, Banerjee I. Calcium alginate-carboxymethyl cellulose beads for colon-targeted drug delivery. International Journal of Biological Macromolecules 2015;75:409-17. [DOI: 10.1016/j.ijbiomac.2014.12.052] [Cited by in Crossref: 109] [Cited by in F6Publishing: 86] [Article Influence: 18.2] [Reference Citation Analysis]
107 Cheng X, Ming X, Croyle MA. PEGylated adenoviruses for gene delivery to the intestinal epithelium by the oral route. Pharm Res 2003;20:1444-51. [PMID: 14567640 DOI: 10.1023/a:1025714412337] [Cited by in Crossref: 36] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
108 Buzoianu SG, Walsh MC, Rea MC, O'Donovan O, Gelencsér E, Ujhelyi G, Szabó E, Nagy A, Ross RP, Gardiner GE, Lawlor PG. Effects of feeding Bt maize to sows during gestation and lactation on maternal and offspring immunity and fate of transgenic material. PLoS One 2012;7:e47851. [PMID: 23091650 DOI: 10.1371/journal.pone.0047851] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
109 Schoellhammer CM, Chen Y, Cleveland C, Minahan D, Bensel T, Park JY, Saxton S, Lee YL, Booth L, Langer R, Traverso G. Defining optimal permeant characteristics for ultrasound-mediated gastrointestinal delivery. J Control Release 2017;268:113-9. [PMID: 29051063 DOI: 10.1016/j.jconrel.2017.10.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
110 Matoori S, Bao Y, Schmidt A, Fischer EJ, Ochoa-Sanchez R, Tremblay M, Oliveira MM, Rose CF, Leroux JC. An Investigation of PS-b-PEO Polymersomes for the Oral Treatment and Diagnosis of Hyperammonemia. Small 2019;15:e1902347. [PMID: 31721441 DOI: 10.1002/smll.201902347] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
111 Raoof A, Moriarty D, Brayden D, Corrigan OI, Cumming I, Butler J, Devane J. Comparison of Methodologies for Evaluating Regional Intestinal Permeability. In: Young D, Devane JG, Butler J, editors. In Vitro-in Vivo Correlations. Boston: Springer US; 1997. pp. 181-9. [DOI: 10.1007/978-1-4684-6036-0_16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
112 Doihara H, Nozawa K, Kawabata-shoda E, Kojima R, Yokoyama T, Ito H. Molecular cloning and characterization of dog TRPA1 and AITC stimulate the gastrointestinal motility through TRPA1 in conscious dogs. European Journal of Pharmacology 2009;617:124-9. [DOI: 10.1016/j.ejphar.2009.06.038] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
113 Arumugasaamy N, Navarro J, Kent Leach J, Kim PCW, Fisher JP. In Vitro Models for Studying Transport Across Epithelial Tissue Barriers. Ann Biomed Eng 2019;47:1-21. [DOI: 10.1007/s10439-018-02124-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
114 Guo F, Ouyang T, Peng T, Zhang X, Xie B, Yang X, Liang D, Zhong H. Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides. Biomater Sci 2019;7:1493-506. [PMID: 30672923 DOI: 10.1039/c8bm01485j] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 10.5] [Reference Citation Analysis]
115 Li Z, He X, Tian S, Feng G, Huang C, Xun M, Wu Z, Wang Y. Simultaneous Evaluation of Dissolution and Permeation of Oral Drug Solid Formulations for Predicting Absorption Rate-Limiting Factors and In Vitro-In Vivo Correlations: Case Study Using a Poorly Soluble Weakly Basic Drug. AAPS PharmSciTech 2019;20:321. [PMID: 31650430 DOI: 10.1208/s12249-019-1544-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
116 Smrdel P, Grabnar I, Locatelli I, Cerne M, Andrensek S, Kovacic N, Kristl A, Bogataj M, Urleb U, Mrhar A. Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423--a new phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity. Drug Dev Ind Pharm 2009;35:1293-304. [PMID: 19832629 DOI: 10.3109/03639040902889814] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
117 Hwang SU, Eun K, Kim M, Yoon JD, Cai L, Choi H, Oh D, Lee G, Kim H, Kim E, Hyun SH. Establishment of 3D Neuro-Organoids Derived from Pig Embryonic Stem-Like Cells. Int J Mol Sci 2021;22:2600. [PMID: 33807555 DOI: 10.3390/ijms22052600] [Reference Citation Analysis]
118 Brown TD, Whitehead KA, Mitragotri S. Materials for oral delivery of proteins and peptides. Nat Rev Mater 2020;5:127-48. [DOI: 10.1038/s41578-019-0156-6] [Cited by in Crossref: 74] [Cited by in F6Publishing: 39] [Article Influence: 37.0] [Reference Citation Analysis]
119 Van Gelder J, Shafiee M, De Clercq E, Penninckx F, Van den Mooter G, Kinget R, Augustijns P. Species-dependent and site-specific intestinal metabolism of ester prodrugs. Int J Pharm. 2000;205:93-100. [PMID: 11000545 DOI: 10.1016/S0378-5173(00)00507-X] [Cited by in Crossref: 42] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
120 Lundquist P, Artursson P. Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues. Advanced Drug Delivery Reviews 2016;106:256-76. [DOI: 10.1016/j.addr.2016.07.007] [Cited by in Crossref: 218] [Cited by in F6Publishing: 182] [Article Influence: 43.6] [Reference Citation Analysis]
121 Widmayer P, Breer H, Hass N. Candidate chemosensory cells in the porcine stomach. Histochem Cell Biol 2011;136:37-45. [DOI: 10.1007/s00418-011-0824-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
122 Zaefarian F, Cowieson AJ, Pontoppidan K, Abdollahi MR, Ravindran V. Trends in feed evaluation for poultry with emphasis on in vitro techniques. Anim Nutr 2021;7:268-81. [PMID: 34258415 DOI: 10.1016/j.aninu.2020.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Schnurr TM, Reynolds AJ, Duffy LK, Dunlap KL. Glucose transporter-4 in white blood cells of young and old sled dogs: a model for human biomarker development. Polar Rec (Gr Brit) 2015;51:160-4. [PMID: 28713178 DOI: 10.1017/S0032247413000831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
124 . Appendices. Physiologically-Based Pharmacokinetic (PBPK) Modeling and Simulations. Hoboken: John Wiley & Sons, Inc.; 2012. pp. 407-21. [DOI: 10.1002/9781118140291.app1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
125 Christensen MB, Oberg K, Wolchok JC. Tensile properties of the rectal and sigmoid colon: a comparative analysis of human and porcine tissue. Springerplus 2015;4:142. [PMID: 25977885 DOI: 10.1186/s40064-015-0922-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
126 Cheng K, Li C, Uss AS. Prediction of oral drug absorption in humans – from cultured cell lines and experimental animals. Expert Opinion on Drug Metabolism & Toxicology 2008;4:581-90. [DOI: 10.1517/17425255.4.5.581] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
127 Sigfridsson K, Nordmark A, Theilig S, Lindahl A. A formulation comparison between micro- and nanosuspensions: the importance of particle size for absorption of a model compound, following repeated oral administration to rats during early development. Drug Dev Ind Pharm 2011;37:185-92. [PMID: 20653464 DOI: 10.3109/03639045.2010.504209] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
128 Li L, Lietz G, Seal C. Buckwheat and CVD Risk Markers: A Systematic Review and Meta-Analysis. Nutrients 2018;10:E619. [PMID: 29762481 DOI: 10.3390/nu10050619] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
129 Mcentee C, Lavelle E, O’hagan D. Antigen Delivery Systems I. Mucosal Immunology. Elsevier; 2015. pp. 1211-31. [DOI: 10.1016/b978-0-12-415847-4.00063-x] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
130 Valic MS, Halim M, Schimmer P, Zheng G. Guidelines for the experimental design of pharmacokinetic studies with nanomaterials in preclinical animal models. J Control Release 2020;323:83-101. [PMID: 32278829 DOI: 10.1016/j.jconrel.2020.04.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
131 Ferraris D, Duvall B, Delahanty G, Mistry B, Alt J, Rojas C, Rowbottom C, Sanders K, Schuck E, Huang K, Redkar S, Slusher BB, Tsukamoto T. Design, Synthesis, and Pharmacological Evaluation of Fluorinated Tetrahydrouridine Derivatives as Inhibitors of Cytidine Deaminase. J Med Chem 2014;57:2582-8. [DOI: 10.1021/jm401856k] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
132 Liao D, Gregersen H, Agger P, Laustsen C, Ringgaard S, Stødkilde-jørgensen H, Zhao J. 3D reconstruction and fiber quantification in the pig lower esophageal sphincter region using in vitro diffusion tensor imaging. Biomed Phys Eng Express 2018;4:025002. [DOI: 10.1088/2057-1976/aa976e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
133 Carlert S, Lennernäs H, Abrahamsson B. Evaluation of the use of Classical Nucleation Theory for predicting intestinal crystalline precipitation of two weakly basic BSC class II drugs. European Journal of Pharmaceutical Sciences 2014;53:17-27. [DOI: 10.1016/j.ejps.2013.12.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
134 Connelly S, Bristol JA, Hubert S, Subramanian P, Hasan NA, Colwell RR, Kaleko M. SYN-004 (ribaxamase), an oral beta-lactamase, mitigates antibiotic-mediated dysbiosis in a porcine gut microbiome model. J Appl Microbiol 2017;123:66-79. [PMID: 28245091 DOI: 10.1111/jam.13432] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
135 Suenderhauf C, Tuffin G, Lorentsen H, Grimm H, Flament C, Parrott N. Pharmacokinetics of Paracetamol in Göttingen Minipigs: In Vivo Studies and Modeling to Elucidate Physiological Determinants of Absorption. Pharm Res 2014;31:2696-707. [DOI: 10.1007/s11095-014-1367-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
136 Stewart BH, Helen Chan O. Use of immobilized artificial membrane chromatography for drug transport applications††Abbreviations: blood-brain barrier, BBB; bovine brain microvessel endothelial cells, BBMEC; calculated log distribution coefficient (Pallas, CompuDrug, Budapest, Hungary), ClogD; calculated log partition coefficient, ClogP; capacity factor on an IAM column, k¢IAM; capacity factor on a reversed-phase column, k¢w; log distribution coefficient, log D; immobilized artificial membrane, IAM; nonsteroidal antiinflammatory, NSAID; octadecylsilicate, ODS; log octanol:water intrinsic partition coefficient, log P; phosphate-buffered saline, PBS; phosphatidylcholine, PC. Journal of Pharmaceutical Sciences 1998;87:1471-8. [DOI: 10.1021/js980262n] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 2.6] [Reference Citation Analysis]
137 Papich MG. Drug compounding for veterinary patients. AAPS J 2005;7:E281-7. [PMID: 16353910 DOI: 10.1208/aapsj070229] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
138 Grove M, Müllertz A, Pedersen GP, Nielsen JL. Bioavailability of seocalcitol III. Administration of lipid-based formulations to minipigs in the fasted and fed state. Eur J Pharm Sci 2007;31:8-15. [PMID: 17383165 DOI: 10.1016/j.ejps.2007.01.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
139 Boyd M, Risovic V, Jull P, Choo E, Wasan KM. A stepwise surgical procedure to investigate the lymphatic transport of lipid-based oral drug formulations: Cannulation of the mesenteric and thoracic lymph ducts within the rat. Journal of Pharmacological and Toxicological Methods 2004;49:115-20. [DOI: 10.1016/j.vascn.2003.11.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
140 Furuhashi T, Sugitate K, Nakai T, Jikumaru Y, Ishihara G. Rapid profiling method for mammalian feces short chain fatty acids by GC-MS. Analytical Biochemistry 2018;543:51-4. [DOI: 10.1016/j.ab.2017.12.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
141 Leadley RJ, Chi L, Rebello SS, Gagnon A. Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents. Journal of Pharmacological and Toxicological Methods 2000;43:101-16. [DOI: 10.1016/s1056-8719(00)00095-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
142 Pang J, Dalziel G, Dean B, Ware JA, Salphati L. Pharmacokinetics and Absorption of the Anticancer Agents Dasatinib and GDC-0941 under Various Gastric Conditions in Dogs – Reversing the Effect of Elevated Gastric pH with Betaine HCl. Mol Pharmaceutics 2013;10:4024-31. [DOI: 10.1021/mp400356m] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
143 Skibinski CG, Das A, Chen K, Liao J, Manni A, Kester M, El-bayoumy K. A novel biologically active acid stable liposomal formulation of docosahexaenoic acid in human breast cancer cell lines. Chemico-Biological Interactions 2016;252:1-8. [DOI: 10.1016/j.cbi.2016.03.035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
144 Miller J, Zaruby J, Kaminskaya K. Evaluation of a Barbed Suture Device versus Conventional Suture in a Canine Enterotomy Model. Journal of Investigative Surgery 2012;25:107-11. [DOI: 10.3109/08941939.2011.603818] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
145 Parvaneh K, Jamaluddin R, Karimi G, Erfani R. Effect of probiotics supplementation on bone mineral content and bone mass density. ScientificWorldJournal 2014;2014:595962. [PMID: 24587733 DOI: 10.1155/2014/595962] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 7.4] [Reference Citation Analysis]
146 Abid Z, Dalskov Mosgaard M, Manfroni G, Singh Petersen R, Hagner Nielsen L, Müllertz A, Boisen A, Sylvest Keller S. Investigation of Mucoadhesion and Degradation of PCL and PLGA Microcontainers for Oral Drug Delivery. Polymers (Basel) 2019;11:E1828. [PMID: 31703261 DOI: 10.3390/polym11111828] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
147 Gagner M. Safety and efficacy of a side-to-side duodeno-ileal anastomosis for weight loss and type-2 diabetes: duodenal bipartition, a novel metabolic surgery procedure. Ann Surg Innov Res 2015;9:6. [PMID: 26473004 DOI: 10.1186/s13022-015-0015-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
148 Rezhdo O, Speciner L, Carrier R. Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement. J Control Release 2016;240:544-60. [PMID: 27520734 DOI: 10.1016/j.jconrel.2016.07.050] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
149 Warnken Z, Puppolo M, Hughey J, Duarte I, Jansen-varnum S. In Vitro–In Vivo Correlations of Carbamazepine Nanodispersions for Application in Formulation Development. Journal of Pharmaceutical Sciences 2018;107:453-65. [DOI: 10.1016/j.xphs.2017.10.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
150 Sri Paran T, Rolle U, Puri P. Postnatal changes in enteric plexus axonal thickness. Pediatr Surg Int 2008;24:1365-7. [PMID: 18956200 DOI: 10.1007/s00383-008-2265-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
151 Bergman E, Lundahl A, Fridblom P, Hedeland M, Bondesson U, Knutson L, Lennernäs H. Enterohepatic Disposition of Rosuvastatin in Pigs and the Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil. Drug Metab Dispos 2009;37:2349-58. [DOI: 10.1124/dmd.109.029363] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
152 Coles LT, Moughan PJ, Awati A, Darragh AJ, Zou ML. Predicted Apparent Digestion of Energy-Yielding Nutrients Differs between the Upper and Lower Digestive Tracts in Rats and Humans. The Journal of Nutrition 2010;140:469-76. [DOI: 10.3945/jn.109.116293] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
153 Christiansen ML, Holm R, Kristensen J, Kreilgaard M, Jacobsen J, Abrahamsson B, Müllertz A. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS). European Journal of Pharmaceutical Sciences 2014;57:164-72. [DOI: 10.1016/j.ejps.2013.11.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
154 Adhikari C, Das A, Chakraborty A. Controlled release of a sparingly water-soluble anticancer drug through pH-responsive functionalized gold-nanoparticle-decorated liposomes. Chemphyschem 2015;16:866-71. [PMID: 25586408 DOI: 10.1002/cphc.201402748] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
155 Klausner EA, Lavy E, Friedman M, Hoffman A. Expandable gastroretentive dosage forms. J Control Release. 2003;90:143-162. [PMID: 12810298 DOI: 10.1016/s0168-3659(03)00203-7] [Cited by in Crossref: 170] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
156 Kavanagh N, Corrigan OI. Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices—influence of agitation rate and dissolution medium composition. International Journal of Pharmaceutics 2004;279:141-52. [DOI: 10.1016/j.ijpharm.2004.04.016] [Cited by in Crossref: 113] [Cited by in F6Publishing: 98] [Article Influence: 6.6] [Reference Citation Analysis]
157 Hunter AC, Elsom J, Wibroe PP, Moghimi SM. Polymeric particulate technologies for oral drug delivery and targeting: A pathophysiological perspective. Maturitas 2012;73:5-18. [DOI: 10.1016/j.maturitas.2012.05.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
158 Stroh M, Addy C, Wu Y, Stoch SA, Pourkavoos N, Groff M, Xu Y, Wagner J, Gottesdiener K, Shadle C, Wang H, Manser K, Winchell GA, Stone JA. Model-based decision making in early clinical development: minimizing the impact of a blood pressure adverse event. AAPS J 2009;11:99-108. [PMID: 19199043 DOI: 10.1208/s12248-009-9083-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
159 Hua S. Physiological and Pharmaceutical Considerations for Rectal Drug Formulations. Front Pharmacol 2019;10:1196. [PMID: 31680970 DOI: 10.3389/fphar.2019.01196] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
160 Shishoo C, Shah S, Rathod I, Savale S, Kotecha J, Shah P. Stability of rifampicin in dissolution medium in presence of isoniazid. International Journal of Pharmaceutics 1999;190:109-23. [DOI: 10.1016/s0378-5173(99)00286-0] [Cited by in Crossref: 54] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
161 Maher S, Brayden DJ, Casettari L, Illum L. Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update. Pharmaceutics 2019;11:E41. [PMID: 30669434 DOI: 10.3390/pharmaceutics11010041] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 26.5] [Reference Citation Analysis]
162 Wang Z, Zhao J, Song L, Mashayekhi H, Chefetz B, Xing B. Adsorption and desorption of phenanthrene on carbon nanotubes in simulated gastrointestinal fluids. Environ Sci Technol 2011;45:6018-24. [PMID: 21662386 DOI: 10.1021/es200790x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 9.9] [Reference Citation Analysis]
163 Stresser DM, Sun J, Wilson SS. Evaluation of Tissue Stem Cell-Derived Human Intestinal Organoids, a Physiologically Relevant Model to Evaluate Cytochrome P450 Induction in Gut. Drug Metab Dispos 2021;49:245-53. [PMID: 33355212 DOI: 10.1124/dmd.120.000281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Wang JL, Zhao L, Zhu J, Wang DK, Ren MJ, Wang M, Liu Y, Boron WF, Chen LM. Expression, Localization, and Effect of High Salt Intake on Electroneutral Na+/HCO3 - Cotransporter NBCn2 in Rat Small Intestine: Implication in Intestinal NaCl Absorption. Front Physiol 2019;10:1334. [PMID: 31736772 DOI: 10.3389/fphys.2019.01334] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
165 Li Y, Kim J, Park Y, Mcclements DJ. Modulation of lipid digestibility using structured emulsion-based delivery systems: Comparison of in vivo and in vitro measurements. Food Funct 2012;3:528. [DOI: 10.1039/c2fo10273k] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
166 Singh P, Kaur M. CN− scavenger: a leap towards development of a CN− antidote. Chem Commun 2011;47:9122. [DOI: 10.1039/c1cc12668g] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
167 Khoo S, Edwards GA, Porter CJ, Charman WN. A Conscious Dog Model for Assessing the Absorption, Enterocyte‐Based Metabolism, and Intestinal Lymphatic Transport of Halofantrine. Journal of Pharmaceutical Sciences 2001;90:1599-607. [DOI: 10.1002/jps.1110] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 3.9] [Reference Citation Analysis]
168 Alvarez R, Lewis AG, Toure MH, Seeley RJ. A comparison of rodent models of vertical sleeve gastrectomy. Surg Obes Relat Dis 2018;14:1471-9. [PMID: 30093310 DOI: 10.1016/j.soard.2018.06.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
169 Chiang P, Nagapudi K, Dolton MJ, Liu J. Exploring Multicompartment Plug Flow–Based Model Approach in Biopharmaceutics: Impact of Stomach Setting and the Estimation of the Fraction Absorbed of Orally Administered Basic Drugs. Journal of Pharmaceutical Sciences 2020;109:1261-9. [DOI: 10.1016/j.xphs.2019.11.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Tu Y, Peng F, Wilson DA. Motion Manipulation of Micro‐ and Nanomotors. Adv Mater 2017;29:1701970. [DOI: 10.1002/adma.201701970] [Cited by in Crossref: 101] [Cited by in F6Publishing: 88] [Article Influence: 25.3] [Reference Citation Analysis]
171 Ziegler A, Gonzalez L, Blikslager A. Large Animal Models: The Key to Translational Discovery in Digestive Disease Research. Cell Mol Gastroenterol Hepatol 2016;2:716-24. [PMID: 28090566 DOI: 10.1016/j.jcmgh.2016.09.003] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 12.0] [Reference Citation Analysis]
172 Groo A, Lagarce F. Mucus models to evaluate nanomedicines for diffusion. Drug Discovery Today 2014;19:1097-108. [DOI: 10.1016/j.drudis.2014.01.011] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 7.4] [Reference Citation Analysis]
173 Ikegami K, Tagawa K, Osawa T. Bioavailability and in Vivo Release Behavior of Controlled-Release Multiple-Unit Theophylline Dosage Forms in Beagle Dogs, Cynomolgus Monkeys, and Göttingen Minipigs. Journal of Pharmaceutical Sciences 2006;95:1888-95. [DOI: 10.1002/jps.20537] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
174 Drozdowski L, Thomson AB. Intestinal mucosal adaptation. World J Gastroenterol 2006; 12(29): 4614-4627 [PMID: 16937429 DOI: 10.3748/wjg.v12.i29.4614] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
175 Vdoviaková K, Petrovová E, Maloveská M, Krešáková L, Teleky J, Elias MZ, Petrášová D. Surgical Anatomy of the Gastrointestinal Tract and Its Vasculature in the Laboratory Rat. Gastroenterol Res Pract 2016;2016:2632368. [PMID: 26819602 DOI: 10.1155/2016/2632368] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
176 Preuss H, Ghorai P, Kraus A, Dove S, Buschauer A, Seifert R. Constitutive activity and ligand selectivity of human, guinea pig, rat, and canine histamine H2 receptors. J Pharmacol Exp Ther 2007;321:983-95. [PMID: 17332265 DOI: 10.1124/jpet.107.120014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
177 Thörn HA, Hedeland M, Bondesson U, Knutson L, Yasin M, Dickinson P, Lennernäs H. Different Effects of Ketoconazole on the Stereoselective First-Pass Metabolism of R / S -Verapamil in the Intestine and the Liver: Important for the Mechanistic Understanding of First-Pass Drug-Drug Interactions. Drug Metab Dispos 2009;37:2186-96. [DOI: 10.1124/dmd.109.028027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
178 Dalskov Mosgaard M, Strindberg S, Abid Z, Singh Petersen R, Højlund Eklund Thamdrup L, Joukainen Andersen A, Sylvest Keller S, Müllertz A, Hagner Nielsen L, Boisen A. Ex vivo intestinal perfusion model for investigating mucoadhesion of microcontainers. Int J Pharm 2019;570:118658. [PMID: 31491485 DOI: 10.1016/j.ijpharm.2019.118658] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
179 Bibi S, Kang Y, Yang G, Zhu M. Grape seed extract improves small intestinal health through suppressing inflammation and regulating alkaline phosphatase in IL-10-deficient mice. Journal of Functional Foods 2016;20:245-52. [DOI: 10.1016/j.jff.2015.10.021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
180 Lai X, Zhao H, Zhang Y, Guo K, Xu Y, Chen S, Zhang J. Intranasal Delivery of Copper Oxide Nanoparticles Induces Pulmonary Toxicity and Fibrosis in C57BL/6 mice. Sci Rep 2018;8:4499. [PMID: 29540716 DOI: 10.1038/s41598-018-22556-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 14.7] [Reference Citation Analysis]
181 Cao Y, Zhang Y, Li J, Ge G, Hu D, Liu H, Huang T, Wang Y, Fang Z, Sun D, Huo H, Yin J, Yang L. CYP3A catalyses schizandrin biotransformation in human, minipig and rat liver microsomes. Xenobiotica 2009;40:38-47. [DOI: 10.3109/00498250903366052] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
182 Ungell A. In Vitro Absorption Studies and Their Relevance to Absorption from the GI Tract. Drug Development and Industrial Pharmacy 2008;23:879-92. [DOI: 10.3109/03639049709148694] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
183 Gregory PC, Hoffmann K, Kamphues J, Möeler A. The Pancreatic Duct Ligated (Mini)pig as a Model for Pancreatic Exocrine Insufficiency in Man. Pancreas 2016;45:1213-26. [PMID: 27623555 DOI: 10.1097/MPA.0000000000000674] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
184 Strobel S, Encarnação JA, Becker NI, Trenczek TE. Histological and histochemical analysis of the gastrointestinal tract of the common pipistrelle bat (Pipistrellus pipistrellus). Eur J Histochem 2015;59:2477. [PMID: 26150154 DOI: 10.4081/ejh.2015.2477] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
185 Gonzalez LM, Kinnin LA, Blikslager AT. Characterization of discrete equine intestinal epithelial cell lineages. Am J Vet Res 2015;76:358-66. [PMID: 25815577 DOI: 10.2460/ajvr.76.4.358] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
186 Henze LJ, Griffin BT, Christiansen M, Bundgaard C, Langguth P, Holm R. Exploring gastric emptying rate in minipigs: Effect of food type and pre-dosing of metoclopramide. European Journal of Pharmaceutical Sciences 2018;118:183-90. [DOI: 10.1016/j.ejps.2018.03.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
187 Kotla NG, Rana S, Sivaraman G, Sunnapu O, Vemula PK, Pandit A, Rochev Y. Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives. Adv Drug Deliv Rev 2019;146:248-66. [PMID: 29966684 DOI: 10.1016/j.addr.2018.06.021] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 16.3] [Reference Citation Analysis]
188 Rassnick KM, Muindi JR, Johnson CS, Bailey DB, Trump DL. Oral bioavailability of DN101, a concentrated formulation of calcitriol, in tumor-bearing dogs. Cancer Chemother Pharmacol 2011;67:165-71. [PMID: 20306264 DOI: 10.1007/s00280-010-1304-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
189 Brown DR, Poonyachoti S, Osinski MA, Kowalski TR, Pampusch MS, Elde RP, Murtaugh MP. Delta-opioid receptor mRNA expression and immunohistochemical localization in porcine ileum. Dig Dis Sci 1998;43:1402-10. [PMID: 9690372 DOI: 10.1023/a:1018877823534] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
190 van der Pijl PC, Kies AK, Ten Have GA, Duchateau GS, Deutz NE. Pharmacokinetics of proline-rich tripeptides in the pig. Peptides 2008;29:2196-202. [PMID: 18789987 DOI: 10.1016/j.peptides.2008.08.011] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
191 Vogt G. Synthesis of digestive enzymes, food processing, and nutrient absorption in decapod crustaceans: a comparison to the mammalian model of digestion. Zoology (Jena) 2021;147:125945. [PMID: 34217027 DOI: 10.1016/j.zool.2021.125945] [Reference Citation Analysis]
192 Tippin TK, Thakker DR. Biorelevant Refinement of the Caco-2 Cell Culture Model to Assess Efficacy of Paracellular Permeability Enhancers. Journal of Pharmaceutical Sciences 2008;97:1977-92. [DOI: 10.1002/jps.21118] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
193 Yan Y, Kim H, Seo K, Lee WS, Lee G, Woo J, Yong C, Choi H. The Physicochemical Properties, in Vitro Metabolism and Pharmacokinetics of a Novel Ester Prodrug of EXP3174. Mol Pharmaceutics 2010;7:2132-40. [DOI: 10.1021/mp100166c] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
194 Cotter PD, Gahan CGM, Hill C. A glutamate decarboxylase system protects Listeria monocytogenes in gastric fluid. Mol Microbiol 2001;40:465-75. [DOI: 10.1046/j.1365-2958.2001.02398.x] [Cited by in Crossref: 266] [Cited by in F6Publishing: 241] [Article Influence: 13.3] [Reference Citation Analysis]
195 Groo A, Mircheva K, Bejaud J, Ailhas C, Panaiotov I, Saulnier P, Ivanova T, Lagarce F. Development of 2D and 3D Mucus Models and Their Interactions with Mucus-Penetrating Paclitaxel-Loaded Lipid Nanocapsules. Pharm Res 2014;31:1753-65. [DOI: 10.1007/s11095-013-1280-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
196 Hurst S, Loi C, Brodfuehrer J, El-kattan A. Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans. Expert Opinion on Drug Metabolism & Toxicology 2007;3:469-89. [DOI: 10.1517/17425255.3.4.469] [Cited by in Crossref: 86] [Cited by in F6Publishing: 54] [Article Influence: 6.1] [Reference Citation Analysis]
197 Dunlap KL, Reynolds AJ, Duffy LK. Total antioxidant power in sled dogs supplemented with blueberries and the comparison of blood parameters associated with exercise. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 2006;143:429-34. [DOI: 10.1016/j.cbpa.2005.09.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
198 Barth BB, Huang HI, Hammer GE, Shen X. Opportunities and Challenges for Single-Unit Recordings from Enteric Neurons in Awake Animals. Micromachines (Basel) 2018;9:E428. [PMID: 30424361 DOI: 10.3390/mi9090428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
199 Thomas N, Rades T, Müllertz A. Recent developments in oral lipid-based drug delivery. Journal of Drug Delivery Science and Technology 2013;23:375-82. [DOI: 10.1016/s1773-2247(13)50054-2] [Cited by in Crossref: 16] [Article Influence: 2.0] [Reference Citation Analysis]
200 Zhang D, Wei C, Hop CECA, Wright MR, Hu M, Lai Y, Khojasteh SC, Humphreys WG. Intestinal Excretion, Intestinal Recirculation, and Renal Tubule Reabsorption Are Underappreciated Mechanisms That Drive the Distribution and Pharmacokinetic Behavior of Small Molecule Drugs. J Med Chem 2021;64:7045-59. [PMID: 34010555 DOI: 10.1021/acs.jmedchem.0c01720] [Reference Citation Analysis]
201 Fancher RM, Zhang H, Sleczka B, Derbin G, Rockar R, Marathe P. Development of a Canine Model to Enable the Preclinical Assessment of Ph-dependent Absorption of Test Compounds. Journal of Pharmaceutical Sciences 2011;100:2979-88. [DOI: 10.1002/jps.22486] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
202 Imai T, Sakai M, Ohtake H, Azuma H, Otagiri M. Absorption-enhancing effect of glycyrrhizin induced in the presence of capric acid. International Journal of Pharmaceutics 2005;294:11-21. [DOI: 10.1016/j.ijpharm.2004.12.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
203 Montedonico S, Sri Paran T, Pirker M, Rolle U, Puri P. Developmental changes in submucosal nitrergic neurons in the porcine distal colon. J Pediatr Surg 2006;41:1029-35. [PMID: 16677906 DOI: 10.1016/j.jpedsurg.2005.12.063] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
204 Wolk O, Epstein S, Ioffe-Dahan V, Ben-Shabat S, Dahan A. New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities. Expert Opin Drug Deliv 2013;10:1275-86. [PMID: 23721560 DOI: 10.1517/17425247.2013.800480] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
205 Fagerholm U, Sjöström B, Sroka-markovic J, Wijk A, Svensson M, Lennernäs H. The Effect of a Drug-delivery System Consisting of Soybean Phosphatidyl Choline and Medium-chain Monoacylglycerol on the Intestinal Permeability of Hexarelin in the Rat. Journal of Pharmacy and Pharmacology 1998;50:467-73. [DOI: 10.1111/j.2042-7158.1998.tb06187.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
206 Behrens W, Schweinitzer T, Bal J, Dorsch M, Bleich A, Kops F, Brenneke B, Didelot X, Suerbaum S, Josenhans C. Role of energy sensor TlpD of Helicobacter pylori in gerbil colonization and genome analyses after adaptation in the gerbil. Infect Immun 2013;81:3534-51. [PMID: 23836820 DOI: 10.1128/IAI.00750-13] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
207 Wang Y, Li Y, He L, Mao B, Chen S, Martinez V, Guo X, Shen X, Liu B, Li C. Commensal flora triggered target anti-inflammation of alginate-curcumin micelle for ulcerative colitis treatment. Colloids Surf B Biointerfaces 2021;203:111756. [PMID: 33865087 DOI: 10.1016/j.colsurfb.2021.111756] [Reference Citation Analysis]
208 Fagerholm U. Prediction of human pharmacokinetics--gastrointestinal absorption. J Pharm Pharmacol 2007;59:905-16. [PMID: 17637184 DOI: 10.1211/jpp.59.7.0001] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
209 Papich MG, Martinez MN. Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls. AAPS J 2015;17:948-64. [PMID: 25916691 DOI: 10.1208/s12248-015-9743-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
210 Arnold YE, Thorens J, Bernard S, Kalia YN. Drug Transport across Porcine Intestine Using an Ussing Chamber System: Regional Differences and the Effect of P-Glycoprotein and CYP3A4 Activity on Drug Absorption. Pharmaceutics 2019;11:E139. [PMID: 30901927 DOI: 10.3390/pharmaceutics11030139] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
211 Ozaki S, Kushida I, Yamashita T, Hasebe T, Shirai O, Kano K. Evaluation of Drug Supersaturation by Thermodynamic and Kinetic Approaches for the Prediction of Oral Absorbability in Amorphous Pharmaceuticals. Journal of Pharmaceutical Sciences 2012;101:4220-30. [DOI: 10.1002/jps.23306] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
212 Craven LJ, Silverman M, Burton JP. Transfer of altered behaviour and irritable bowel syndrome with diarrhea (IBS-D) through fecal microbiota transplant in mouse model indicates need for stricter donor screening criteria. Ann Transl Med 2017;5:490. [PMID: 29299452 DOI: 10.21037/atm.2017.10.03] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
213 Humberstone AJ, Porter CJ, Charman WN. A physicochemical Basis for the Effect of Food on the Absolute Oral Bioavailability of Halofantrine. Journal of Pharmaceutical Sciences 1996;85:525-9. [DOI: 10.1021/js950472p] [Cited by in Crossref: 97] [Cited by in F6Publishing: 90] [Article Influence: 3.9] [Reference Citation Analysis]
214 Sequeira IR, Lentle RG, Kruger MC, Hurst RD. Assessment of the Effect of Intestinal Permeability Probes (Lactulose And Mannitol) and Other Liquids on Digesta Residence Times in Various Segments of the Gut Determined by Wireless Motility Capsule: A Randomised Controlled Trial. PLoS One 2015;10:e0143690. [PMID: 26629926 DOI: 10.1371/journal.pone.0143690] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
215 Szutowski MM, Łukasik M, Wawer ZT, Chrobak K, Michalska M, Borzecka K, Brzeziński J. In vivo effect of 5- and 8-methoxypsoralens and cimetidine on R,S-warfarin metabolism in rat. J Appl Toxicol 2002;22:327-32. [PMID: 12355562 DOI: 10.1002/jat.867] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
216 Cherkas Y, McMillian MK, Amaratunga D, Raghavan N, Sasaki JC. ABC gene-ranking for prediction of drug-induced cholestasis in rats. Toxicol Rep 2016;3:252-61. [PMID: 28959545 DOI: 10.1016/j.toxrep.2016.01.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
217 Alsenz J. The Impact of Solubility and Dissolution Assessment on Formulation Strategy and Implications for Oral Drug Disposition. Encyclopedia of Drug Metabolism and Interactions. Hoboken: John Wiley & Sons, Inc.; 2011. [DOI: 10.1002/9780470921920.edm066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
218 Sciascia Q, Daş G, Metges CC. REVIEW: The pig as a model for humans: Effects of nutritional factors on intestinal function and health1. Journal of Animal Science 2016;94:441-52. [DOI: 10.2527/jas.2015-9788] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 5.2] [Reference Citation Analysis]
219 Redan BW, Chegeni M, Ferruzzi MG. Differentiated Caco-2 cell monolayers exhibit adaptation in the transport and metabolism of flavan-3-ols with chronic exposure to both isolated flavan-3-ols and enriched extracts. Food Funct 2017;8:111-21. [DOI: 10.1039/c6fo01289b] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
220 ILSI Research Foundation., Risk Science Institute. Achieving continuous improvement in reductions in foodborne listeriosis--a risk-based approach. J Food Prot 2005;68:1932-94. [PMID: 16161698 DOI: 10.4315/0362-028x-68.9.1932] [Cited by in Crossref: 116] [Cited by in F6Publishing: 12] [Article Influence: 7.3] [Reference Citation Analysis]
221 Olsen L, Ingvast-larsson C, Larsson P, Brostrom H, Bondesson U, Sundqvist M, Tjalve H. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment. J Vet Pharmacol Ther 2006;29:129-35. [DOI: 10.1111/j.1365-2885.2006.00724.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
222 Afonso-pereira F, Dou L, Trenfield SJ, Madla CM, Murdan S, Sousa J, Veiga F, Basit AW. Sex differences in the gastrointestinal tract of rats and the implications for oral drug delivery. European Journal of Pharmaceutical Sciences 2018;115:339-44. [DOI: 10.1016/j.ejps.2018.01.043] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
223 Petrovic AA, Petricevic SM, Ristic SM, Ibric SR, Simic SS, Djuric ZR, Popovic RB. Preliminary evaluation of the in vitro release and in vivo absorption in rabbits of the modified-release dosage forms. Drug Development and Industrial Pharmacy 2013;39:889-900. [DOI: 10.3109/03639045.2012.713364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
224 Kanerva H, Klebovich I, Drabant S, Urtti A, Nevalainen T. Different Absorption Profiles of Deramciclane in Man and in Dog. Journal of Pharmacy and Pharmacology 1998;50:1087-93. [DOI: 10.1111/j.2042-7158.1998.tb03317.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
225 Mclean CC, Teft WA, Morse BL, Gryn SE, Hegele RA, Kim RB. Food Effect on Rosuvastatin Disposition and Low-Density Lipoprotein Cholesterol. Clin Pharmacol Ther 2018;104:525-33. [DOI: 10.1002/cpt.973] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
226 Park JH, Robinson JR. Effect of a Hydrophobic Phospholipid Lining of the Gastric Mucosa in Bioadhesion. Pharm Res 2008;25:16-24. [DOI: 10.1007/s11095-007-9353-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
227 Lim YF, Lentle RG, Janssen PW, Williams MA, de Loubens C, Mansel BW, Chambers P. Determination of villous rigidity in the distal ileum of the possum (Trichosurus vulpecula). PLoS One 2014;9:e100140. [PMID: 24956476 DOI: 10.1371/journal.pone.0100140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
228 Dupont D, Le Feunteun S, Marze S, Souchon I. Structuring food to control its disintegration in the gastrointestinal tract and optimize nutrient bioavailability. Innovative Food Science & Emerging Technologies 2018;46:83-90. [DOI: 10.1016/j.ifset.2017.10.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
229 Radloff J, Falchuk EL, Markov AG, Amasheh S. Molecular Characterization of Barrier Properties in Follicle-Associated Epithelium of Porcine Peyer's Patches Reveals Major Sealing Function of Claudin-4. Front Physiol 2017;8:579. [PMID: 28855873 DOI: 10.3389/fphys.2017.00579] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
230 Nielsen TS, Fredborg M, Theil PK, Yue Y, Bruhn LV, Andersen V, Purup S. Dietary Red Meat Adversely Affects Disease Severity in a Pig Model of DSS-Induced Colitis Despite Reduction in Colonic Pro-Inflammatory Gene Expression. Nutrients 2020;12:E1728. [PMID: 32526985 DOI: 10.3390/nu12061728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
231 Thanou M, Verhoef JC, Verheijden JH, Junginger HE. Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs. Pharm Res 2001;18:823-8. [PMID: 11474787 DOI: 10.1023/a:1011092613951] [Cited by in Crossref: 61] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
232 Lacombe O, Woodley J, Solleux C, Delbos J, Boursier-neyret C, Houin G. Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes. European Journal of Pharmaceutical Sciences 2004;23:385-91. [DOI: 10.1016/j.ejps.2004.09.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
233 Patel GB, Agnew BJ, Deschatelets L, Fleming L, Sprott G. In vitro assessment of archaeosome stability for developing oral delivery systems. International Journal of Pharmaceutics 2000;194:39-49. [DOI: 10.1016/s0378-5173(99)00331-2] [Cited by in Crossref: 69] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
234 Bures J, Kopácová M, Kvetina J, Osterreicher J, Sinkorová Z, Svoboda Z, Tachecí I, Filip S, Spelda S, Kunes M, Rejchrt S. Different solutions used for submucosal injection influenced early healing of gastric endoscopic mucosal resection in a preclinical study in experimental pigs. Surg Endosc 2009;23:2094-101. [PMID: 19057952 DOI: 10.1007/s00464-008-0207-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
235 Kong L, Harrington L, Li Q, Cheley S, Davis BG, Bayley H. Single-molecule interrogation of a bacterial sugar transporter allows the discovery of an extracellular inhibitor. Nature Chem 2013;5:651-9. [DOI: 10.1038/nchem.1695] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
236 Fröhlich E, Roblegg E. Oral uptake of nanoparticles: human relevance and the role of in vitro systems. Arch Toxicol 2016;90:2297-314. [PMID: 27342244 DOI: 10.1007/s00204-016-1765-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 8.2] [Reference Citation Analysis]
237 Souza da Silva C, Bolhuis JE, Gerrits WJ, Kemp B, van den Borne JJ. Effects of dietary fibers with different fermentation characteristics on feeding motivation in adult female pigs. Physiol Behav 2013;110-111:148-57. [PMID: 23313406 DOI: 10.1016/j.physbeh.2013.01.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
238 Merchant HA, Afonso-Pereira F, Rabbie SC, Youssef SA, Basit AW. Gastrointestinal characterisation and drug solubility determination in animals. J Pharm Pharmacol 2015;67:630-9. [PMID: 25560785 DOI: 10.1111/jphp.12361] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
239 Jantscher-krenn E, Marx C, Bode L. Human milk oligosaccharides are differentially metabolised in neonatal rats. Br J Nutr 2013;110:640-50. [DOI: 10.1017/s0007114512005727] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 4.6] [Reference Citation Analysis]
240 Brown CS, Rabinstein AA, Nystrom EM, Britton JW, Singh TD. Antiseizure Medication use in Gastric Bypass Patients and Other Post-Surgical Malabsorptive States. Epilepsy Behav Rep 2021;16:100439. [PMID: 33997757 DOI: 10.1016/j.ebr.2021.100439] [Reference Citation Analysis]
241 Petnehazy O, Donko T, Ellis R, Csoka A, Czeibert K, Baksa G, Zucker E, Repa K, Takacs A, Repa I, Moizs M. Creating a cross-sectional, CT and MR atlas of the Pannon minipig. Anat Histol Embryol 2021;50:562-71. [PMID: 33529429 DOI: 10.1111/ahe.12657] [Reference Citation Analysis]
242 Lozoya-agullo I, Araújo F, González-álvarez I, Merino-sanjuán M, González-álvarez M, Bermejo M, Sarmento B. PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen. European Journal of Pharmaceutical Sciences 2018;115:119-25. [DOI: 10.1016/j.ejps.2017.12.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
243 Proctor DM, Suh M, Chappell G, Borghoff SJ, Thompson CM, Wiench K, Finch L, Ellis-Hutchings R. An Adverse Outcome Pathway (AOP) for forestomach tumors induced by non-genotoxic initiating events. Regul Toxicol Pharmacol 2018;96:30-40. [PMID: 29684431 DOI: 10.1016/j.yrtph.2018.04.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
244 Lotfipour F, Shahi S, Farjami A, Salatin S, Mahmoudian M, Dizaj SM. Safety and Toxicity Issues of Therapeutically Used Nanoparticles from the Oral Route. Biomed Res Int 2021;2021:9322282. [PMID: 34746313 DOI: 10.1155/2021/9322282] [Reference Citation Analysis]
245 Sehgal I, Winters WD, Scott M, David A, Gillis G, Stoufflet T, Nair A, Kousoulas K. Toxicologic assessment of a commercial decolorized whole leaf aloe vera juice, lily of the desert filtered whole leaf juice with aloesorb. J Toxicol 2013;2013:802453. [PMID: 23554812 DOI: 10.1155/2013/802453] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
246 Drozdowski LA, Clandinin MT, Thomson AB. Morphological, kinetic, membrane biochemical and genetic aspects of intestinal enteroplasticity. World J Gastroenterol 2009; 15(7): 774-787 [PMID: 19230039 DOI: 10.3748/wjg.15.774] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
247 Lu Y, Sun W, Gu Z. Stimuli-responsive nanomaterials for therapeutic protein delivery. J Control Release 2014;194:1-19. [PMID: 25151983 DOI: 10.1016/j.jconrel.2014.08.015] [Cited by in Crossref: 282] [Cited by in F6Publishing: 239] [Article Influence: 40.3] [Reference Citation Analysis]
248 Qiu Y, Huang Y, Zhang Z, Cox BF, Liu R, Hong J, Mu P, Lay HS, Cummins G, Desmulliez MPY, Clutton E, Zheng H, Qiu W, Cochran S. Ultrasound Capsule Endoscopy With a Mechanically Scanning Micro-ultrasound: A Porcine Study. Ultrasound Med Biol 2020;46:796-804. [PMID: 31902446 DOI: 10.1016/j.ultrasmedbio.2019.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
249 Chiou WL, Buehler PW. Comparison of oral absorption and bioavailablity of drugs between monkey and human. Pharm Res 2002;19:868-74. [PMID: 12134959 DOI: 10.1023/a:1016169202830] [Cited by in Crossref: 95] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
250 Ten Bruggencate SJ, Bovee-Oudenhoven IM, Lettink-Wissink ML, Van der Meer R. Dietary fructooligosaccharides increase intestinal permeability in rats. J Nutr 2005;135:837-42. [PMID: 15795444 DOI: 10.1093/jn/135.4.837] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 5.6] [Reference Citation Analysis]
251 Musther H, Harwood MD, Yang J, Turner DB, Rostami-Hodjegan A, Jamei M. The Constraints, Construction, and Verification of a Strain-Specific Physiologically Based Pharmacokinetic Rat Model. J Pharm Sci 2017;106:2826-38. [PMID: 28495566 DOI: 10.1016/j.xphs.2017.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
252 Martinez MN, Papich MG. Factors influencing the gastric residence of dosage forms in dogs. J Pharm Sci 2009;98:844-60. [PMID: 18661535 DOI: 10.1002/jps.21499] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
253 Zietek T, Boomgaarden WAD, Rath E. Drug Screening, Oral Bioavailability and Regulatory Aspects: A Need for Human Organoids. Pharmaceutics 2021;13:1280. [PMID: 34452240 DOI: 10.3390/pharmaceutics13081280] [Reference Citation Analysis]
254 Shin SK, Kaiser EE, West FD. Alcohol Induced Brain and Liver Damage: Advantages of a Porcine Alcohol Use Disorder Model. Front Physiol 2020;11:592950. [PMID: 33488396 DOI: 10.3389/fphys.2020.592950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
255 Vieira AC, Murdan S, Serra AC, Veiga FJ, Gonsalves AMDR, Basit AW. Influence of feeding regimens on rat gut fluids and colonic metabolism of diclofenac-β-cyclodextrin. Carbohydrate Polymers 2014;112:758-64. [DOI: 10.1016/j.carbpol.2014.06.064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
256 Gore AV, Liang AC, Chien YW. Comparative Biomembrane Permeation of Tacrine Using Yucatan Minipigs and Domestic Pigs as the Animal Model. Journal of Pharmaceutical Sciences 1998;87:441-7. [DOI: 10.1021/js970359u] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
257 Maher S, Brayden DJ. Formulation strategies to improve the efficacy of intestinal permeation enhancers. Adv Drug Deliv Rev 2021;177:113925. [PMID: 34418495 DOI: 10.1016/j.addr.2021.113925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Norinder U, Bergström C. Prediction of ADMET Properties. ChemMedChem 2006;1:920-37. [DOI: 10.1002/cmdc.200600155] [Cited by in Crossref: 108] [Cited by in F6Publishing: 81] [Article Influence: 7.2] [Reference Citation Analysis]
259 Lentz KA, Quitko M, Morgan DG, Grace JE Jr, Gleason C, Marathe PH. Development and validation of a preclinical food effect model. J Pharm Sci 2007;96:459-72. [PMID: 17075867 DOI: 10.1002/jps.20767] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
260 Collnot EM, Ali H, Lehr CM. Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. J Control Release. 2012;161:235-246. [PMID: 22306429 DOI: 10.1016/j.jconrel.2012.01.028] [Cited by in Crossref: 141] [Cited by in F6Publishing: 128] [Article Influence: 15.7] [Reference Citation Analysis]
261 Kazmierczak MJ, Wiedmann M, Boor KJ. Alternative sigma factors and their roles in bacterial virulence. Microbiol Mol Biol Rev 2005;69:527-43. [PMID: 16339734 DOI: 10.1128/MMBR.69.4.527-543.2005] [Cited by in Crossref: 242] [Cited by in F6Publishing: 139] [Article Influence: 16.1] [Reference Citation Analysis]
262 Tønsberg H, Holm R, Bisgaard J, Jacobsen J, Müllertz A. Effects of polysorbate 80 on the in-vitro precipitation and oral bioavailability of halofantrine from polyethylene glycol 400 formulations in rats. Journal of Pharmacy and Pharmacology 2010;62:63-70. [DOI: 10.1211/jpp.62.01.0006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
263 Saengkerdsub S, Ricke SC. Ecology and characteristics of methanogenic archaea in animals and humans. Crit Rev Microbiol. 2014;40:97-116. [PMID: 23425063 DOI: 10.3109/1040841x.2013.763220] [Cited by in Crossref: 36] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
264 Thomas S, Brightman F, Gill H, Lee S, Pufong B. Simulation modelling of human intestinal absorption using Caco-2 permeability and kinetic solubility data for early drug discovery. J Pharm Sci 2008;97:4557-74. [PMID: 18300298 DOI: 10.1002/jps.21305] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
265 Balimane PV, Chong S, Morrison RA. Current methodologies used for evaluation of intestinal permeability and absorption. Journal of Pharmacological and Toxicological Methods 2000;44:301-12. [DOI: 10.1016/s1056-8719(00)00113-1] [Cited by in Crossref: 177] [Cited by in F6Publishing: 25] [Article Influence: 8.4] [Reference Citation Analysis]
266 Salmaso C, Toniolo I, Fontanella CG, Da Roit P, Albanese A, Polese L, Stefanini C, Foletto M, Carniel EL. Computational Tools for the Reliability Assessment and the Engineering Design of Procedures and Devices in Bariatric Surgery. Ann Biomed Eng 2020;48:2466-83. [PMID: 32472365 DOI: 10.1007/s10439-020-02542-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
267 Kiebooms JAL, Vanden Bussche J, Hemeryck LY, Fievez V, Vanhaecke L. Intestinal Microbiota Contribute to the Endogenous Formation of Thiouracil in Livestock. J Agric Food Chem 2012;60:7769-76. [DOI: 10.1021/jf3017145] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
268 Gilmore MS, Coburn PS, Nallapareddy SR, Murray BE. Enterococcal Virulence. In: Gilmore MS, Clewell DB, Courvalin P, Dunny GM, Murray BE, Rice LB, editors. The Enterococci. Washington: ASM Press; 2002. pp. 301-54. [DOI: 10.1128/9781555817923.ch8] [Cited by in Crossref: 53] [Cited by in F6Publishing: 26] [Article Influence: 7.6] [Reference Citation Analysis]
269 Kirman CR, Hays SM, Aylward LL, Suh M, Harris MA, Thompson CM, Haws LC, Proctor DM. Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium. Chem Biol Interact 2012;200:45-64. [PMID: 22981460 DOI: 10.1016/j.cbi.2012.08.016] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
270 Sri Paran T, Rolle U, Puri P. Age-related changes in the myenteric plexus of the porcine bowel. J Pediatr Surg 2009;44:1771-7. [PMID: 19735824 DOI: 10.1016/j.jpedsurg.2008.12.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
271 Fagerholm U, Breuer O, Swedmark S, Hoogstraate J. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582. Journal of Pharmacy and Pharmacology 2005;57:587-97. [DOI: 10.1211/0022357056028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
272 Mazzoni C, Tentor F, Strindberg SA, Nielsen LH, Keller SS, Alstrøm TS, Gundlach C, Müllertz A, Marizza P, Boisen A. From concept to in vivo testing: Microcontainers for oral drug delivery. Journal of Controlled Release 2017;268:343-51. [DOI: 10.1016/j.jconrel.2017.10.013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
273 Shono Y, Jantratid E, Dressman JB. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: Case example nelfinavir. European Journal of Pharmaceutics and Biopharmaceutics 2011;79:349-56. [DOI: 10.1016/j.ejpb.2011.04.005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 6.4] [Reference Citation Analysis]
274 Bélteky P, Rónavári A, Zakupszky D, Boka E, Igaz N, Szerencsés B, Pfeiffer I, Vágvölgyi C, Kiricsi M, Kónya Z. Are Smaller Nanoparticles Always Better? Understanding the Biological Effect of Size-Dependent Silver Nanoparticle Aggregation Under Biorelevant Conditions. Int J Nanomedicine 2021;16:3021-40. [PMID: 33935497 DOI: 10.2147/IJN.S304138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
275 P. Nejdfors, M. Ekelund, B. Jeppsso. Mucosal in Vitro Permeability in the Intestinal Tract of the Pig, the Rat, and Man: Species- and Region-Related Differences. Scandinavian Journal of Gastroenterology 2009;35:501-7. [DOI: 10.1080/003655200750023769] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
276 Kouti V, Papazoglou L, Flaskos J, Angelopoulou K, Karkavelas G, Rallis T. Ursodeoxycholic acid promotes intestinal adaptation in a cat model of short bowel syndrome. Fundam Clin Pharmacol 2011;25:734-42. [PMID: 21210842 DOI: 10.1111/j.1472-8206.2010.00901.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
277 Randall KJ, Turton J, Foster JR. Explant culture of gastrointestinal tissue: a review of methods and applications. Cell Biol Toxicol. 2011;27:267-284. [PMID: 21384137 DOI: 10.1007/s10565-011-9187-5] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]
278 Nickerson KP, Chanin RB, Sistrunk JR, Rasko DA, Fink PJ, Barry EM, Nataro JP, Faherty CS. Analysis of Shigella flexneri Resistance, Biofilm Formation, and Transcriptional Profile in Response to Bile Salts. Infect Immun 2017;85:e01067-16. [PMID: 28348056 DOI: 10.1128/IAI.01067-16] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
279 Quinten T, De Beer T, Onofre F, Mendez-montealvo G, Wang Y, Remon J, Vervaet C. Sustained-Release and Swelling Characteristics of Xanthan Gum/Ethylcellulose-Based Injection Moulded Matrix Tablets: in Vitro and in Vivo Evaluation. Journal of Pharmaceutical Sciences 2011;100:2858-70. [DOI: 10.1002/jps.22480] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
280 Scheubel E, Adamy L, Hoffart V, Cardot JM. Selection of the most suitable dissolution method for an extended release formulation based on IVIVC level A obtained on cynomolgus monkey. Drug Dev Ind Pharm 2010;36:1320-9. [PMID: 20849348 DOI: 10.3109/03639041003801877] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
281 Seal CJ, Brownlee IA. Whole-grain foods and chronic disease: evidence from epidemiological and intervention studies. Proc Nutr Soc 2015;74:313-9. [PMID: 26062574 DOI: 10.1017/S0029665115002104] [Cited by in Crossref: 70] [Cited by in F6Publishing: 38] [Article Influence: 11.7] [Reference Citation Analysis]
282 Orlandin JR, Machado LC, Ambrósio CE, Travagli V. Ozone and its derivatives in veterinary medicine: A careful appraisal. Vet Anim Sci 2021;13:100191. [PMID: 34401601 DOI: 10.1016/j.vas.2021.100191] [Reference Citation Analysis]
283 Lock JY, Carlson TL, Carrier RL. Mucus models to evaluate the diffusion of drugs and particles. Adv Drug Deliv Rev 2018;124:34-49. [PMID: 29117512 DOI: 10.1016/j.addr.2017.11.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 16.0] [Reference Citation Analysis]
284 Roberts MS, Magnusson BM, Burczynski FJ, Weiss M. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet. 2002;41:751-790. [PMID: 12162761 DOI: 10.2165/00003088-200241100-00005] [Cited by in Crossref: 391] [Cited by in F6Publishing: 343] [Article Influence: 20.6] [Reference Citation Analysis]
285 Berg N, De Wever B, Fuchs HW, Gaca M, Krul C, Roggen EL. Toxicology in the 21st century – Working our way towards a visionary reality. Toxicology in Vitro 2011;25:874-81. [DOI: 10.1016/j.tiv.2011.02.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
286 Jena A, Montoya CA, Mullaney JA, Dilger RN, Young W, McNabb WC, Roy NC. Gut-Brain Axis in the Early Postnatal Years of Life: A Developmental Perspective. Front Integr Neurosci 2020;14:44. [PMID: 32848651 DOI: 10.3389/fnint.2020.00044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
287 Rónavári A, Bélteky P, Boka E, Zakupszky D, Igaz N, Szerencsés B, Pfeiffer I, Kónya Z, Kiricsi M. Polyvinyl-Pyrrolidone-Coated Silver Nanoparticles-The Colloidal, Chemical, and Biological Consequences of Steric Stabilization under Biorelevant Conditions. Int J Mol Sci 2021;22:8673. [PMID: 34445378 DOI: 10.3390/ijms22168673] [Reference Citation Analysis]
288 Ungell AL, Nylander S, Bergstrand S, Sjöberg A, Lennernäs H. Membrane transport of drugs in different regions of the intestinal tract of the rat. J Pharm Sci. 1998;87:360-366. [PMID: 9523990 DOI: 10.1021/js970218s] [Cited by in Crossref: 193] [Cited by in F6Publishing: 169] [Article Influence: 8.4] [Reference Citation Analysis]
289 Enlo-scott Z, Swedrowska M, Forbes B. Epithelial permeability and drug absorption in the lungs. Inhaled Medicines. Elsevier; 2021. pp. 267-99. [DOI: 10.1016/b978-0-12-814974-4.00004-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
290 Tajiri S, Kanamaru T, Yoshida K, Hosoi Y, Fukui S, Konno T, Yada S, Nakagami H. Colonoscopic method for estimating the colonic absorption of extended-release dosage forms in dogs. European Journal of Pharmaceutics and Biopharmaceutics 2010;75:238-44. [DOI: 10.1016/j.ejpb.2010.03.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
291 Steger U, Sawitzki B, Gassel AM, Gassel HJ, Wood KJ. Impact of hepatic rearterialization on reperfusion injury and outcome after mouse liver transplantation. Transplantation. 2003;76:327-332. [PMID: 12883187 DOI: 10.1097/01.tp.0000071521.36828.f7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
292 Schilrreff P, Simioni YR, Jerez HE, Caimi AT, de Farias MA, Villares Portugal R, Romero EL, Morilla MJ. Superoxide dismutase in nanoarchaeosomes for targeted delivery to inflammatory macrophages. Colloids and Surfaces B: Biointerfaces 2019;179:479-87. [DOI: 10.1016/j.colsurfb.2019.03.061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
293 Jin SY, Liu YL, Xu LN, Jiang Y, Wang Y, Yang BX, Yang H, Ma TH. Cloning and characterization of porcine aquaporin 1 water channel expressed extensively in gastrointestinal system. World J Gastroenterol 2006; 12(7): 1092-1097 [PMID: 16534851 DOI: 10.3748/wjg.v12.i7.1092] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
294 Sokolis DP. Variation of Passive Biomechanical Properties of the Small Intestine along Its Length: Microstructure-Based Characterization. Bioengineering (Basel) 2021;8:32. [PMID: 33652760 DOI: 10.3390/bioengineering8030032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Deluco B, Fourie KR, Simko OM, Wilson HL. Localization of Claudin-3 and Claudin-4 within the Small Intestine of newborn piglets. Physiol Rep 2021;9:e14717. [PMID: 33523589 DOI: 10.14814/phy2.14717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
296 Schipper NG, Vårum KM, Stenberg P, Ocklind G, Lennernäs H, Artursson P. Chitosans as absorption enhancers of poorly absorbable drugs. European Journal of Pharmaceutical Sciences 1999;8:335-43. [DOI: 10.1016/s0928-0987(99)00032-9] [Cited by in Crossref: 150] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
297 Yáñez JA, Wang SW, Knemeyer IW, Wirth MA, Alton KB. Intestinal lymphatic transport for drug delivery. Adv Drug Deliv Rev 2011;63:923-42. [PMID: 21689702 DOI: 10.1016/j.addr.2011.05.019] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 11.9] [Reference Citation Analysis]
298 Martinez MN, El-Kattan A, Awji E, Papich M. Reconciling Human-Canine Differences in Oral Bioavailability: Looking beyond the Biopharmaceutics Classification System. AAPS J 2019;21:99. [PMID: 31396733 DOI: 10.1208/s12248-019-0364-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
299 Lim YF, Williams MA, Lentle RG, Janssen PW, Mansel BW, Keen SA, Chambers P. An exploration of the microrheological environment around the distal ileal villi and proximal colonic mucosa of the possum (Trichosurus vulpecula). J R Soc Interface 2013;10:20121008. [PMID: 23389898 DOI: 10.1098/rsif.2012.1008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
300 Yao HT, Huang SY, Chiang MT. A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats. Food Chem Toxicol 2008;46:1525-34. [PMID: 18255211 DOI: 10.1016/j.fct.2007.12.012] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
301 Stewart AS, Freund JM, Gonzalez LM. Advanced three-dimensional culture of equine intestinal epithelial stem cells. Equine Vet J 2018;50:241-8. [PMID: 28792626 DOI: 10.1111/evj.12734] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
302 Parenti M, McClorry S, Maga EA, Slupsky CM. Metabolomic changes in severe acute malnutrition suggest hepatic oxidative stress: a secondary analysis. Nutr Res 2021;91:44-56. [PMID: 34134040 DOI: 10.1016/j.nutres.2021.05.005] [Reference Citation Analysis]
303 Keemink J, Sjögren E, Holm R, Bergström CAS. Does the Intake of Ethanol Affect Oral Absorption of Poorly Soluble Drugs? J Pharm Sci 2019;108:1765-71. [PMID: 30562491 DOI: 10.1016/j.xphs.2018.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
304 Nielsen P, Müllertz A, Norling T, Kristensen H. The effect of α-tocopherol on the in vitro solubilisation of lipophilic drugs. International Journal of Pharmaceutics 2001;222:217-24. [DOI: 10.1016/s0378-5173(01)00701-3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
305 Shaikh M, Rajan K, Forsyth CB, Voigt RM, Keshavarzian A. Simultaneous gas-chromatographic urinary measurement of sugar probes to assess intestinal permeability: use of time course analysis to optimize its use to assess regional gut permeability. Clin Chim Acta 2015;442:24-32. [PMID: 25591964 DOI: 10.1016/j.cca.2014.12.040] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
306 Tu Y, Peng F, Adawy A, Men Y, Abdelmohsen LKEA, Wilson DA. Mimicking the Cell: Bio-Inspired Functions of Supramolecular Assemblies. Chem Rev 2016;116:2023-78. [DOI: 10.1021/acs.chemrev.5b00344] [Cited by in Crossref: 177] [Cited by in F6Publishing: 152] [Article Influence: 29.5] [Reference Citation Analysis]
307 Davis M, Pineda Munoz S. The temporal scale of diet and dietary proxies. Ecol Evol 2016;6:1883-97. [PMID: 27087936 DOI: 10.1002/ece3.2054] [Cited by in Crossref: 69] [Cited by in F6Publishing: 39] [Article Influence: 13.8] [Reference Citation Analysis]
308 Venkatesan N, Yoshimitsu J, Ito Y, Shibata N, Takada K. Liquid filled nanoparticles as a drug delivery tool for protein therapeutics. Biomaterials 2005;26:7154-63. [PMID: 15967493 DOI: 10.1016/j.biomaterials.2005.05.012] [Cited by in Crossref: 136] [Cited by in F6Publishing: 106] [Article Influence: 8.5] [Reference Citation Analysis]
309 Claeys B, Vervaeck A, Hillewaere XK, Possemiers S, Hansen L, De Beer T, Remon JP, Vervaet C. Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding. European Journal of Pharmaceutics and Biopharmaceutics 2015;90:44-52. [DOI: 10.1016/j.ejpb.2014.11.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
310 Kimble B, Black LA, Li KM, Valtchev P, Gilchrist S, Gillett A, Higgins DP, Krockenberger MB, Govendir M. Pharmacokinetics of meloxicam in koalas ( Phascolarctos cinereus ) after intravenous, subcutaneous and oral administration. J Vet Pharmacol Ther 2013;36:486-93. [DOI: 10.1111/jvp.12038] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
311 das Neves J, Sverdlov Arzi R, Sosnik A. Molecular and cellular cues governing nanomaterial-mucosae interactions: from nanomedicine to nanotoxicology. Chem Soc Rev 2020;49:5058-100. [PMID: 32538405 DOI: 10.1039/c8cs00948a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
312 Suzuki S, Shirasaka Y, Okada R, Eguchi A, Kishimoto H, Langguth P, Inoue K. Quantitative analysis of the effect of controlled-release formulation on nonlinear gastrointestinal absorption of P-glycoprotein substrate talinolol using physiologically based pharmacokinetic absorption model. Journal of Drug Delivery Science and Technology 2020;56:101057. [DOI: 10.1016/j.jddst.2019.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
313 Olayanju A, Jones L, Greco K, Goldring CE, Ansari T. Application of porcine gastrointestinal organoid units as a potential in vitro tool for drug discovery and development: Porcine GI organoids as a potential in vitro tool for drug development. J Appl Toxicol 2019;39:4-15. [DOI: 10.1002/jat.3641] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
314 Tang H, Mayersohn M. Porcine Prediction of Pharmacokinetic Parameters in People: A Pig in a Poke? Drug Metab Dispos 2018;46:1712-24. [PMID: 30171162 DOI: 10.1124/dmd.118.083311] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
315 Sardelli L, Pacheco DP, Ziccarelli A, Tunesi M, Caspani O, Fusari A, Briatico Vangosa F, Giordano C, Petrini P. Towards bioinspired in vitro models of intestinal mucus. RSC Adv 2019;9:15887-99. [DOI: 10.1039/c9ra02368b] [Cited by in Crossref: 9] [Article Influence: 4.5] [Reference Citation Analysis]
316 Yeap YY, Lock J, Lerkvikarn S, Semin T, Nguyen N, Carrier RL. Intestinal mucus is capable of stabilizing supersaturation of poorly water-soluble drugs. J Control Release 2019;296:107-13. [PMID: 30527813 DOI: 10.1016/j.jconrel.2018.11.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
317 Huckaby JT, Lai SK. PEGylation for enhancing nanoparticle diffusion in mucus. Advanced Drug Delivery Reviews 2018;124:125-39. [DOI: 10.1016/j.addr.2017.08.010] [Cited by in Crossref: 120] [Cited by in F6Publishing: 101] [Article Influence: 40.0] [Reference Citation Analysis]
318 Květina J, Tachecí I, Pavlík M, Kopáčová M, Rejchrt S, Douda T, Kuneš M, Bureš J. Use of electrogastrography in preclinical studies of cholinergic and anticholinergic agents in experimental pigs. Physiol Res 2015;64:S647-52. [PMID: 26674291 DOI: 10.33549/physiolres.933227] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
319 Jewell A, Williams H, Hoad CL, Gellert PR, Ashford MB, Butler J, Stolnik S, Scurr D, Stocks MJ, Marciani L, Gowland PA, Gershkovich P. Assessing Lymphatic Uptake of Lipids Using Magnetic Resonance Imaging: A Feasibility Study in Healthy Human Volunteers with Potential Application for Tracking Lymph Node Delivery of Drugs and Formulation Excipients. Pharmaceutics 2021;13:1343. [PMID: 34575420 DOI: 10.3390/pharmaceutics13091343] [Reference Citation Analysis]
320 Reese AT, Pereira FC, Schintlmeister A, Berry D, Wagner M, Hale LP, Wu A, Jiang S, Durand HK, Zhou X, Premont RT, Diehl AM, O'Connell TM, Alberts SC, Kartzinel TR, Pringle RM, Dunn RR, Wright JP, David LA. Microbial nitrogen limitation in the mammalian large intestine. Nat Microbiol 2018;3:1441-50. [PMID: 30374168 DOI: 10.1038/s41564-018-0267-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 14.0] [Reference Citation Analysis]
321 Hironaka T, Itokawa S, Ogawara K, Higaki K, Kimura T. Quantitative evaluation of PEPT1 contribution to oral absorption of cephalexin in rats. Pharm Res 2009;26:40-50. [PMID: 18784906 DOI: 10.1007/s11095-008-9703-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
322 Maga EA, Weimer BC, Murray JD. Dissecting the role of milk components on gut microbiota composition. Gut Microbes 2013;4:136-9. [PMID: 23235404 DOI: 10.4161/gmic.23188] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
323 Tran T, Bønløkke P, Rodríguez-rodríguez C, Nosrati Z, Esquinas PL, Borkar N, Plum J, Strindberg S, Karagiozov S, Rades T, Müllertz A, Saatchi K, Häfeli UO. Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems. Journal of Controlled Release 2020;317:375-84. [DOI: 10.1016/j.jconrel.2019.11.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
324 Jia J, Dong C, Zhang W, Cui Y, Liu J. Evaluation of pharmacokinetic and pharmacodynamic relationship for oral sustained-release atenolol pellets in rats. Journal of Pharmaceutical and Biomedical Analysis 2011;55:342-8. [DOI: 10.1016/j.jpba.2011.01.044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
325 Lindahl A, Sjöberg A, Bredberg U, Toreson H, Ungell AL, Lennernäs H. Regional intestinal absorption and biliary excretion of fluvastatin in the rat: possible involvement of mrp2. Mol Pharm 2004;1:347-56. [PMID: 16026004 DOI: 10.1021/mp0499297] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
326 Larauche M, Wang Y, Wang PM, Dubrovsky G, Lo YK, Hsiang EL, Dunn JCY, Taché Y, Liu W, Million M. The effect of colonic tissue electrical stimulation and celiac branch of the abdominal vagus nerve neuromodulation on colonic motility in anesthetized pigs. Neurogastroenterol Motil 2020;32:e13925. [PMID: 32578346 DOI: 10.1111/nmo.13925] [Reference Citation Analysis]
327 Morrison JS, Nophsker MJ, Haskell RJ. A Combination Turbidity and Supernatant Microplate Assay to Rank‐Order the Supersaturation Limits of Early Drug Candidates. Journal of Pharmaceutical Sciences 2014;103:3022-32. [DOI: 10.1002/jps.24090] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
328 Van den Mooter G. The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate. Drug Discovery Today: Technologies 2012;9:e79-85. [DOI: 10.1016/j.ddtec.2011.10.002] [Cited by in Crossref: 297] [Cited by in F6Publishing: 262] [Article Influence: 33.0] [Reference Citation Analysis]
329 Al-Saffar A, Takemi S, Saaed HK, Sakata I, Sakai T. Utility of animal gastrointestinal motility and transit models in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2019;40-41:101633. [PMID: 31594654 DOI: 10.1016/j.bpg.2019.101633] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
330 Barone F, Laghi L, Gianotti A, Ventrella D, Saa DLT, Bordoni A, Forni M, Brigidi P, Bacci ML, Turroni S. In Vivo Effects of Einkorn Wheat (Triticum monococcum) Bread on the Intestinal Microbiota, Metabolome, and on the Glycemic and Insulinemic Response in the Pig Model. Nutrients 2018;11:E16. [PMID: 30577558 DOI: 10.3390/nu11010016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
331 Gravesen C, Judy JD. Effect of biosolids characteristics on retention and release behavior of azithromycin and ciprofloxacin. Environmental Research 2020;184:109333. [DOI: 10.1016/j.envres.2020.109333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
332 Auer T, Wiederstein-Grasser I, Sauseng S, Delcev P, Preisegger KH. The Effect of Negative Pressure in the Abdominal Cavity With Suprasorb CNP on Abdominal Organs-An Experimental Study. Front Surg 2020;7:584926. [PMID: 33644109 DOI: 10.3389/fsurg.2020.584926] [Reference Citation Analysis]
333 Fu DJ, Wang L, Chouairi FK, Rose IM, Abetov DA, Miller AD, Yamulla RJ, Schimenti JC, Flesken-Nikitin A, Nikitin AY. Gastric squamous-columnar junction contains a large pool of cancer-prone immature osteopontin responsive Lgr5-CD44+ cells. Nat Commun 2020;11:84. [PMID: 31901081 DOI: 10.1038/s41467-019-13847-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
334 Kagan L, Hoffman A. Systems for region selective drug delivery in the gastrointestinal tract: biopharmaceutical considerations. Expert Opinion on Drug Delivery 2008;5:681-92. [DOI: 10.1517/17425247.5.6.681] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
335 Lentz KA. Current methods for predicting human food effect. AAPS J 2008;10:282-8. [PMID: 18500565 DOI: 10.1208/s12248-008-9025-8] [Cited by in Crossref: 109] [Cited by in F6Publishing: 92] [Article Influence: 8.4] [Reference Citation Analysis]
336 Acevedo-fani A, Singh H. Biopolymer interactions during gastric digestion: Implications for nutrient delivery. Food Hydrocolloids 2021;116:106644. [DOI: 10.1016/j.foodhyd.2021.106644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
337 Shivva V, Tucker IG, Duffull SB. An In Silico Knockout Model for Gastrointestinal Absorption Using a Systems Pharmacology Approach - Development and Application for Ketones. PLoS One 2016;11:e0163795. [PMID: 27685985 DOI: 10.1371/journal.pone.0163795] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
338 Balimane PV, Chong S. Evaluation of Permeability and P-glycoprotein Interactions: Industry Outlook. In: Krishna R, Yu L, editors. Biopharmaceutics Applications in Drug Development. Boston: Springer US; 2008. pp. 101-38. [DOI: 10.1007/978-0-387-72379-2_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
339 Varankovich NV, Nickerson MT, Korber DR. Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases. Front Microbiol 2015;6:685. [PMID: 26236287 DOI: 10.3389/fmicb.2015.00685] [Cited by in Crossref: 73] [Cited by in F6Publishing: 55] [Article Influence: 12.2] [Reference Citation Analysis]
340 Strindberg S, Plum J, Bagger C, Janfelt C, Müllertz A. Visualizing the Journey of Fenofibrate through the Rat Gastrointestinal Tract by Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging. Mol Pharm 2021;18:2189-97. [PMID: 33891424 DOI: 10.1021/acs.molpharmaceut.0c01043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
341 Gorrasi G, Pantani R. Hydrolysis and Biodegradation of Poly(lactic acid). In: Di Lorenzo ML, Androsch R, editors. Synthesis, Structure and Properties of Poly(lactic acid). Cham: Springer International Publishing; 2018. pp. 119-51. [DOI: 10.1007/12_2016_12] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 6.8] [Reference Citation Analysis]
342 Higashiyama H, Sumitomo H, Ozawa A, Igarashi H, Tsunekawa N, Kurohmaru M, Kanai Y. Anatomy of the Murine Hepatobiliary System: A Whole-Organ-Level Analysis Using a Transparency Method. Anat Rec (Hoboken) 2016;299:161-72. [PMID: 26559382 DOI: 10.1002/ar.23287] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
343 Freichel OL, Lippold BC. A new oral erosion controlled drug delivery system with a late burst in the release profile. European Journal of Pharmaceutics and Biopharmaceutics 2000;50:345-51. [DOI: 10.1016/s0939-6411(00)00120-x] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
344 Varum FJ, Veiga F, Sousa JS, Basit AW. Mucus thickness in the gastrointestinal tract of laboratory animals. J Pharm Pharmacol 2012;64:218-27. [PMID: 22221097 DOI: 10.1111/j.2042-7158.2011.01399.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
345 Lee JJ, Jacobsen EA, Ochkur SI, McGarry MP, Condjella RM, Doyle AD, Luo H, Zellner KR, Protheroe CA, Willetts L, Lesuer WE, Colbert DC, Helmers RA, Lacy P, Moqbel R, Lee NA. Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red". J Allergy Clin Immunol 2012;130:572-84. [PMID: 22935586 DOI: 10.1016/j.jaci.2012.07.025] [Cited by in Crossref: 118] [Cited by in F6Publishing: 117] [Article Influence: 13.1] [Reference Citation Analysis]
346 McConnell EL, Basit AW, Murdan S. Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments. J Pharm Pharmacol. 2008;60:63-70. [PMID: 18088506 DOI: 10.1211/jpp.60.1.0008] [Cited by in Crossref: 336] [Cited by in F6Publishing: 310] [Article Influence: 25.8] [Reference Citation Analysis]
347 Sugano K. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population. International Journal of Pharmaceutics 2009;373:55-61. [DOI: 10.1016/j.ijpharm.2009.02.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
348 Patel B, Chen H, Ahuja A, Krieger JF, Noblet J, Chambers S, Kassab GS. Constitutive modeling of the passive inflation-extension behavior of the swine colon. J Mech Behav Biomed Mater 2018;77:176-86. [PMID: 28922650 DOI: 10.1016/j.jmbbm.2017.08.031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
349 Desesso J, Jacobson C. Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. Food and Chemical Toxicology 2001;39:209-28. [DOI: 10.1016/s0278-6915(00)00136-8] [Cited by in Crossref: 334] [Cited by in F6Publishing: 75] [Article Influence: 16.7] [Reference Citation Analysis]
350 Ma Y, Fuchs AV, Boase NR, Rolfe BE, Coombes AG, Thurecht KJ. The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery. Eur J Pharm Biopharm 2015;94:393-403. [PMID: 26117186 DOI: 10.1016/j.ejpb.2015.06.014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
351 Stewart AS, Pratt-Phillips S, Gonzalez LM. Alterations in Intestinal Permeability: The Role of the "Leaky Gut" in Health and Disease. J Equine Vet Sci 2017;52:10-22. [PMID: 31000910 DOI: 10.1016/j.jevs.2017.02.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
352 Liu Y, Li X, Zhang Y, Huang J, Wu Y, Wang L. Considerations for application of biopharmaceutics classification system in chicken: Exemplified by seven drugs classification. J Vet Pharmacol Ther 2020;43:179-88. [PMID: 32039497 DOI: 10.1111/jvp.12842] [Reference Citation Analysis]
353 Mitra A, Wu Y. Challenges and opportunities in achieving bioequivalence for fixed-dose combination products. AAPS J 2012;14:646-55. [PMID: 22684403 DOI: 10.1208/s12248-012-9378-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
354 Lozoya-agullo I, González-álvarez I, González-álvarez M, Merino-sanjuán M, Bermejo M. In Situ Perfusion Model in Rat Colon for Drug Absorption Studies: Comparison with Small Intestine and Caco-2 Cell Model. Journal of Pharmaceutical Sciences 2015;104:3136-45. [DOI: 10.1002/jps.24447] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
355 Schimpel C, Teubl B, Absenger M, Meindl C, Fröhlich E, Leitinger G, Zimmer A, Roblegg E. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles. Mol Pharm 2014;11:808-18. [PMID: 24502507 DOI: 10.1021/mp400507g] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 13.0] [Reference Citation Analysis]
356 Snoeck V, Verfaillie T, Verdonck F, Goddeeris B, Cox E. The jejunal Peyer's patches are the major inductive sites of the F4-specific immune response following intestinal immunisation of pigs with F4 (K88) fimbriae. Vaccine 2006;24:3812-20. [DOI: 10.1016/j.vaccine.2005.07.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
357 Marasanapalle VP, Crison JR, Devarakonda KR, Li X, Jasti BR. Predictive models for drugs exhibiting negative food effects based on their biopharmaceutical characteristics. Drug Dev Ind Pharm 2011;37:1429-38. [PMID: 21615244 DOI: 10.3109/03639045.2011.584193] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
358 Lee HJ. Protein drug oral delivery: The recent progress. Arch Pharm Res 2002;25:572-84. [DOI: 10.1007/bf02976925] [Cited by in Crossref: 89] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
359 Cheat S, Gerez JR, Cognié J, Alassane-Kpembi I, Bracarense AP, Raymond-Letron I, Oswald IP, Kolf-Clauw M. Nivalenol has a greater impact than deoxynivalenol on pig jejunum mucosa in vitro on explants and in vivo on intestinal loops. Toxins (Basel) 2015;7:1945-61. [PMID: 26035490 DOI: 10.3390/toxins7061945] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
360 Nadia J, Bronlund J, Singh RP, Singh H, Bornhorst GM. Structural breakdown of starch-based foods during gastric digestion and its link to glycemic response: In vivo and in vitro considerations. Compr Rev Food Sci Food Saf 2021;20:2660-98. [PMID: 33884751 DOI: 10.1111/1541-4337.12749] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
361 Shelma R, Sharma CP. In vitro and in vivo evaluation of curcumin loaded lauroyl sulphated chitosan for enhancing oral bioavailability. Carbohydrate Polymers 2013;95:441-8. [DOI: 10.1016/j.carbpol.2013.02.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
362 Augustine R, Ashkenazi DL, Arzi RS, Zlobin V, Shofti R, Sosnik A. Nanoparticle-in-microparticle oral drug delivery system of a clinically relevant darunavir/ritonavir antiretroviral combination. Acta Biomater 2018;74:344-59. [PMID: 29723705 DOI: 10.1016/j.actbio.2018.04.045] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 9.7] [Reference Citation Analysis]
363 Lennernäs H, Abrahamsson B. The Biopharmaceutics Classification System. Comprehensive Medicinal Chemistry II. Elsevier; 2007. pp. 971-88. [DOI: 10.1016/b0-08-045044-x/00137-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
364 Fox EA, Phillips RJ, Martinson FA, Baronowsky EA, Powley TL. Vagal afferent innervation of smooth muscle in the stomach and duodenum of the mouse: Morphology and topography. J Comp Neurol 2000;428:558-76. [DOI: 10.1002/1096-9861(20001218)428:3<558::aid-cne11>3.0.co;2-m] [Cited by in Crossref: 89] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
365 He Y, Ho C. Amorphous Solid Dispersions: Utilization and Challenges in Drug Discovery and Development. Journal of Pharmaceutical Sciences 2015;104:3237-58. [DOI: 10.1002/jps.24541] [Cited by in Crossref: 128] [Cited by in F6Publishing: 113] [Article Influence: 21.3] [Reference Citation Analysis]
366 Arenas-Hernández MM, Rojas-López M, Medrano-López A, Nuñez-Reza KJ, Puente JL, Martínez-Laguna Y, Torres AG. Environmental regulation of the long polar fimbriae 2 of enterohemorrhagic Escherichia coli O157:H7. FEMS Microbiol Lett 2014;357:105-14. [PMID: 24966050 DOI: 10.1111/1574-6968.12513] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
367 Fan T, Chen C, Guo H, Xu J, Zhang J, Zhu X, Yang Y, Zhou Z, Li L, Huang Y. Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs. European Journal of Pharmaceutics and Biopharmaceutics 2014;88:518-28. [DOI: 10.1016/j.ejpb.2014.06.011] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 10.6] [Reference Citation Analysis]
368 Mitra A, Li L, Marsac P, Marks B, Liu Z, Brown C. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug. Int J Pharm 2016;505:107-14. [PMID: 27012984 DOI: 10.1016/j.ijpharm.2016.03.036] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
369 Traverso G, Kirtane AR, Schoellhammer CM, Langer R. Convergence for Translation: Drug-Delivery Research in Multidisciplinary Teams. Angew Chem Int Ed 2018;57:4156-63. [DOI: 10.1002/anie.201712512] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
370 Peppas NA, Carr DA. Impact of Absorption and Transport on Intelligent Therapeutics and Nano-scale Delivery of Protein Therapeutic Agents. Chem Eng Sci 2009;64:4553-65. [PMID: 20161384 DOI: 10.1016/j.ces.2009.04.050] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
371 Kohoutová M, Dejmek J, Tůma Z, Kuncová J. Variability of mitochondrial respiration in relation to sepsis-induced multiple organ dysfunction. Physiol Res 2018;67:S577-92. [PMID: 30607965 DOI: 10.33549/physiolres.934050] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
372 Martinez MN, Pedersoli WM, Ravis WR, Jackson JD, Cullison R. Feasibility of interspecies extrapolation in determining the bioequivalence of animal products intended for intramuscular administration. J Vet Pharmacol Ther 2001;24:125-35. [DOI: 10.1046/j.1365-2885.2001.00316.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
373 Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV. Microencapsulation of probiotics for gastrointestinal delivery. J Control Release. 2012;162:56-67. [PMID: 22698940 DOI: 10.1016/j.jconrel.2012.06.003] [Cited by in Crossref: 383] [Cited by in F6Publishing: 292] [Article Influence: 42.6] [Reference Citation Analysis]
374 Hall V. Porcine Embryonic Stem Cells: A Possible Source for Cell Replacement Therapy. Stem Cell Rev 2008;4:275-82. [DOI: 10.1007/s12015-008-9040-2] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
375 Van Speybroeck M, Mellaerts R, Mols R, Thi TD, Martens JA, Van Humbeeck J, Annaert P, Van den Mooter G, Augustijns P. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. European Journal of Pharmaceutical Sciences 2010;41:623-30. [DOI: 10.1016/j.ejps.2010.09.002] [Cited by in Crossref: 140] [Cited by in F6Publishing: 124] [Article Influence: 12.7] [Reference Citation Analysis]
376 Pieper IA, Bertau M. Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage. Expert Opinion on Drug Metabolism & Toxicology 2010;6:747-60. [DOI: 10.1517/17425251003769859] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
377 Omwenga I, Zhao S, Kanja L, Mol H, Rietjens IMCM, Louisse J. Prediction of dose-dependent in vivo acetylcholinesterase inhibition by profenofos in rats and humans using physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry. Arch Toxicol 2021;95:1287-301. [PMID: 33651127 DOI: 10.1007/s00204-021-03004-4] [Reference Citation Analysis]
378 Lambert JM, Weinbreck F, Kleerebezem M. In Vitro Analysis of Protection of the Enzyme Bile Salt Hydrolase against Enteric Conditions by Whey Protein−Gum Arabic Microencapsulation. J Agric Food Chem 2008;56:8360-4. [DOI: 10.1021/jf801068u] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
379 Mercier GT, Nehete PN, Passeri MF, Nehete BN, Weaver EA, Templeton NS, Schluns K, Buchl SS, Sastry KJ, Barry MA. Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules. Vaccine 2007;25:8687-701. [PMID: 18063450 DOI: 10.1016/j.vaccine.2007.10.030] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
380 Zhu AZ, Ho MD, Gemski CK, Chuang BC, Liao M, Xia CQ. Utilizing In Vitro Dissolution-Permeation Chamber for the Quantitative Prediction of pH-Dependent Drug-Drug Interactions with Acid-Reducing Agents: a Comparison with Physiologically Based Pharmacokinetic Modeling. AAPS J 2016;18:1512-23. [PMID: 27600136 DOI: 10.1208/s12248-016-9972-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
381 Solnick JV, Eaton KA, Peek RM. Animal Models of Helicobacter pylori Infection. In: Backert S, Yamaoka Y, editors. Helicobacter pylori Research. Tokyo: Springer Japan; 2016. pp. 273-97. [DOI: 10.1007/978-4-431-55936-8_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
382 Desesso JM, Williams AL. Contrasting the Gastrointestinal Tracts of Mammals: Factors that Influence Absorption. Elsevier; 2008. pp. 353-71. [DOI: 10.1016/s0065-7743(08)00021-3] [Cited by in Crossref: 24] [Article Influence: 1.8] [Reference Citation Analysis]
383 Bergström CA, Holm R, Jørgensen SA, Andersson SB, Artursson P, Beato S, Borde A, Box K, Brewster M, Dressman J, Feng K, Halbert G, Kostewicz E, Mcallister M, Muenster U, Thinnes J, Taylor R, Mullertz A. Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs. European Journal of Pharmaceutical Sciences 2014;57:173-99. [DOI: 10.1016/j.ejps.2013.10.015] [Cited by in Crossref: 175] [Cited by in F6Publishing: 151] [Article Influence: 25.0] [Reference Citation Analysis]
384 Zhang R, Zhang Q, Ma LQ, Cui X. Effects of Food Constituents on Absorption and Bioaccessibility of Dietary Synthetic Phenolic Antioxidant by Caco-2 Cells. J Agric Food Chem 2020;68:4670-7. [DOI: 10.1021/acs.jafc.9b07315] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
385 Clear NJ, Milton A, Humphrey M, Henry BT, Wulff M, Nichols DJ, Anziano RJ, Wilding I. Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon. European Journal of Pharmaceutical Sciences 2001;13:375-84. [DOI: 10.1016/s0928-0987(01)00134-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
386 Mcintyre CM, Monk HM. Medication absorption considerations in patients with postpyloric enteral feeding tubes. American Journal of Health-System Pharmacy 2014;71:549-56. [DOI: 10.2146/ajhp130597] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
387 Croyle MA, Callahan SM, Auricchio A, Schumer G, Linse KD, Wilson JM, Brunner LJ, Kobinger GP. PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum. J Virol 2004;78:912-21. [PMID: 14694122 DOI: 10.1128/jvi.78.2.912-921.2004] [Cited by in Crossref: 115] [Cited by in F6Publishing: 50] [Article Influence: 6.8] [Reference Citation Analysis]
388 Lyons T, Jahns H, Brady J, O'Hara E, Waters SM, Kenny D, Doyle E, Meade KG. Integrated analyses of the microbiological, immunological and ontological transitions in the calf ileum during early life. Sci Rep 2020;10:21264. [PMID: 33277514 DOI: 10.1038/s41598-020-77907-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
389 Kashuba ADM, Dyer JR, Kramer LM, Raasch RH, Eron JJ, Cohen MS. Antiretroviral-Drug Concentrations in Semen: Implications for Sexual Transmission of Human Immunodeficiency Virus Type 1. Antimicrob Agents Chemother 1999;43:1817-26. [DOI: 10.1128/aac.43.8.1817] [Cited by in Crossref: 106] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
390 Petto C, Gäbel G, Pfannkuche H. Architecture and Chemical Coding of the Inner and Outer Submucous Plexus in the Colon of Piglets. PLoS One 2015;10:e0133350. [PMID: 26230272 DOI: 10.1371/journal.pone.0133350] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
391 Neirinckx E, Vervaet C, Michiels J, De Smet S, Van den Broeck W, Remon JP, De Backer P, Croubels S. Feasibility of the Ussing chamber technique for the determination of in vitro jejunal permeability of passively absorbed compounds in different animal species. J Vet Pharmacol Ther 2011;34:290-7. [PMID: 21492193 DOI: 10.1111/j.1365-2885.2010.01218.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
392 Tanno FK, Sakuma S, Masaoka Y, Kataoka M, Kozaki T, Kamaguchi R, Ikeda Y, Kokubo H, Yamashita S. Site-specific drug delivery to the middle-to-lower region of the small intestine reduces food-drug interactions that are responsible for low drug absorption in the fed state. J Pharm Sci 2008;97:5341-53. [PMID: 18386838 DOI: 10.1002/jps.21382] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
393 Tanner SA, Zihler Berner A, Rigozzi E, Grattepanche F, Chassard C, Lacroix C. In vitro continuous fermentation model (PolyFermS) of the swine proximal colon for simultaneous testing on the same gut microbiota. PLoS One 2014;9:e94123. [PMID: 24709947 DOI: 10.1371/journal.pone.0094123] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
394 Lemmens G, Van Camp A, Kourula S, Vanuytsel T, Augustijns P. Drug Disposition in the Lower Gastrointestinal Tract: Targeting and Monitoring. Pharmaceutics 2021;13:161. [PMID: 33530468 DOI: 10.3390/pharmaceutics13020161] [Reference Citation Analysis]
395 Leonard TW, Lynch J, Mckenna MJ, Brayden DJ. Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET™. Expert Opinion on Drug Delivery 2006;3:685-92. [DOI: 10.1517/17425247.3.5.685] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 5.3] [Reference Citation Analysis]
396 Cronkhite RI, Michael JG. Sub-compartmentalization of the gastrointestinal (GI) immune system determined with microbeads that differ in release properties. Vaccine 2004;22:2106-15. [PMID: 15149766 DOI: 10.1016/j.vaccine.2003.12.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
397 Shin BS, Yoo SD, Kim TH, Bulitta JB, Landersdorfer CB, Shin JC, Choi JH, Weon K, Joo SH, Shin S. Quantitative Determination of Absorption and First-Pass Metabolism of Apicidin, a Potent Histone Deacetylase Inhibitor. Drug Metab Dispos 2014;42:974-82. [DOI: 10.1124/dmd.113.056713] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
398 Krook MA, Hagerman AE. Stability of Polyphenols Epigallocatechin Gallate and Pentagalloyl Glucose in a Simulated Digestive System. Food Res Int 2012;49:112-6. [PMID: 23028206 DOI: 10.1016/j.foodres.2012.08.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
399 Faisal W, Ruane-o’hora T, O’driscoll CM, Griffin BT. A novel lipid-based solid dispersion for enhancing oral bioavailability of Lycopene – In vivo evaluation using a pig model. International Journal of Pharmaceutics 2013;453:307-14. [DOI: 10.1016/j.ijpharm.2013.06.027] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
400 Wuelfing WP, Daublain P, Kesisoglou F, Templeton A, Mcgregor C. Preclinical Dose Number and Its Application in Understanding Drug Absorption Risk and Formulation Design for Preclinical Species. Mol Pharmaceutics 2015;12:1031-9. [DOI: 10.1021/mp500504q] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
401 Xiao J, Metzler-Zebeli BU, Zebeli Q. Gut Function-Enhancing Properties and Metabolic Effects of Dietary Indigestible Sugars in Rodents and Rabbits. Nutrients 2015;7:8348-65. [PMID: 26426045 DOI: 10.3390/nu7105397] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
402 Teply BA, Tong R, Jeong SY, Luther G, Sherifi I, Yim CH, Khademhosseini A, Farokhzad OC, Langer RS, Cheng J. The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules. Biomaterials 2008;29:1216-23. [PMID: 18082254 DOI: 10.1016/j.biomaterials.2007.11.018] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
403 Kulkarni R, Yumibe N, Wang Z, Zhang X, Tang CC, Ruterbories K, Cox A, Mccain R, Knipp GT. Comparative Pharmacokinetics Studies of Immediate- and Modified-Release Formulations of Glipizide in Pigs and Dogs. Journal of Pharmaceutical Sciences 2012;101:4327-36. [DOI: 10.1002/jps.23292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
404 Tuleu C, Andrieux C, Boy P, Chaumeil JC. Gastrointestinal transit of pellets in rats: effect of size and density. Int J Pharm 1999;180:123-31. [PMID: 10089299 DOI: 10.1016/s0378-5173(98)00400-1] [Cited by in Crossref: 52] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
405 Martinez MN, Mistry B, Lukacova V, Lentz KA, Polli JE, Hoag SW, Dowling T, Kona R, Fahmy RM. Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs. AAPS J 2017;19:712-26. [PMID: 28265981 DOI: 10.1208/s12248-017-0055-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
406 Zane P, Guo Z, MacGerorge D, Vicat P, Ollier C. Use of the pentagastrin dog model to explore the food effects on formulations in early drug development. Eur J Pharm Sci 2014;57:207-13. [PMID: 24090732 DOI: 10.1016/j.ejps.2013.09.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
407 Abuzarur-aloul R, Gjellan K, Sjölund M, Graffner C. Critical Dissolution Tests of Oral Systems Based on Statistically Designed Experiments. II. In Vitro Optimization of Screened Variables on ER-Coated Spheres for the Establishment of an in Vitro/In Vivo Correlation. Drug Development and Industrial Pharmacy 2008;24:203-12. [DOI: 10.3109/03639049809085611] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
408 Vertzoni M, Valsami G, Reppas C. Plasma profiles of lycopene after single oral and intravenous administrations in dogs. Journal of Pharmacy and Pharmacology 2006;58:1211-7. [DOI: 10.1211/jpp.58.9.0007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
409 Shishoo C, Shah S, Rathod I, Savale S, Vora M. Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation. International Journal of Pharmaceutics 2001;228:53-67. [DOI: 10.1016/s0378-5173(01)00831-6] [Cited by in Crossref: 83] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
410 Sarfarazi A, Lee G, Mirjalili SA, Phillips ARJ, Windsor JA, Trevaskis NL. Therapeutic delivery to the peritoneal lymphatics: Current understanding, potential treatment benefits and future prospects. Int J Pharm 2019;567:118456. [PMID: 31238102 DOI: 10.1016/j.ijpharm.2019.118456] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
411 Sohal IS, O'Fallon KS, Gaines P, Demokritou P, Bello D. Ingested engineered nanomaterials: state of science in nanotoxicity testing and future research needs. Part Fibre Toxicol 2018;15:29. [PMID: 29970114 DOI: 10.1186/s12989-018-0265-1] [Cited by in Crossref: 86] [Cited by in F6Publishing: 75] [Article Influence: 28.7] [Reference Citation Analysis]
412 Green BT, Lyte M, Kulkarni-Narla A, Brown DR. Neuromodulation of enteropathogen internalization in Peyer's patches from porcine jejunum. J Neuroimmunol 2003;141:74-82. [PMID: 12965256 DOI: 10.1016/s0165-5728(03)00225-x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
413 Thompson CL, Hofer MJ, Campbell IL, Holmes AJ. Community dynamics in the mouse gut microbiota: a possible role for IRF9-regulated genes in community homeostasis. PLoS One 2010;5:e10335. [PMID: 20428250 DOI: 10.1371/journal.pone.0010335] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
414 Schepens MAA, ten Bruggencate SJM, Schonewille AJ, Brummer RM, van der Meer R, Bovee-oudenhoven IMJ. The protective effect of supplemental calcium on colonic permeability depends on a calcium phosphate-induced increase in luminal buffering capacity. Br J Nutr 2012;107:950-6. [DOI: 10.1017/s0007114511003977] [Cited by in Crossref: 8] [Article Influence: 0.8] [Reference Citation Analysis]
415 Pereira-fantini PM, Thomas SL, Wilson G, Taylor RG, Sourial M, Bines JE. Short- and long-term effects of small bowel resection: a unique histological study in a piglet model of short bowel syndrome. Histochem Cell Biol 2011;135:195-202. [DOI: 10.1007/s00418-011-0778-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
416 Seeger B. Farm Animal-derived Models of the Intestinal Epithelium: Recent Advances and Future Applications of Intestinal Organoids. Altern Lab Anim 2020;48:215-33. [PMID: 33337913 DOI: 10.1177/0261192920974026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
417 Kambayashi A, Kiyota T, Fujiwara M, Dressman JB. PBPK modeling coupled with biorelevant dissolution to forecast the oral performance of amorphous solid dispersion formulations. European Journal of Pharmaceutical Sciences 2019;135:83-90. [DOI: 10.1016/j.ejps.2019.05.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
418 Liu X, Zhang B, Sohal IS, Bello D, Chen H. Is "nano safe to eat or not"? A review of the state-of-the art in soft engineered nanoparticle (sENP) formulation and delivery in foods. Adv Food Nutr Res 2019;88:299-335. [PMID: 31151727 DOI: 10.1016/bs.afnr.2019.03.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
419 Zanellato I, Bonarrigo I, Colangelo D, Gabano E, Ravera M, Alessio M, Osella D. Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: how long the organic chain should be? J Inorg Biochem 2014;140:219-27. [PMID: 25171667 DOI: 10.1016/j.jinorgbio.2014.07.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
420 Hatley OJD, Jones CR, Galetin A, Rostami-Hodjegan A. Optimization of intestinal microsomal preparation in the rat: A systematic approach to assess the influence of various methodologies on metabolic activity and scaling factors. Biopharm Drug Dispos 2017;38:187-208. [PMID: 28207929 DOI: 10.1002/bdd.2070] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
421 Roshdy MN, Schnaare RL, Sugita ET, Zietz S, Schwartz JB. An Adjusted Pharmacokinetic Equation for Predicting Drug Levels In Vivo Based on In Vitro Square Root of Time Release Kinetics. Pharmaceutical Development and Technology 2002;7:203-13. [DOI: 10.1081/pdt-120003488] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
422 Scillitani G, Mentino D. Comparative glycopattern analysis of mucins in the Brunner's glands of the guinea-pig and the house mouse (Rodentia). Acta Histochemica 2015;117:612-23. [DOI: 10.1016/j.acthis.2015.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
423 Gao W, Thamphiwatana S, Angsantikul P, Zhang L. Nanoparticle approaches against bacterial infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2014;6:532-47. [PMID: 25044325 DOI: 10.1002/wnan.1282] [Cited by in Crossref: 123] [Cited by in F6Publishing: 108] [Article Influence: 17.6] [Reference Citation Analysis]
424 Davitt CJ, Lavelle EC. Delivery strategies to enhance oral vaccination against enteric infections. Adv Drug Deliv Rev 2015;91:52-69. [PMID: 25817337 DOI: 10.1016/j.addr.2015.03.007] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 12.8] [Reference Citation Analysis]
425 Mazzoni M, Caremoli F, Cabanillas L, de Los Santos J, Million M, Larauche M, Clavenzani P, De Giorgio R, Sternini C. Quantitative analysis of enteric neurons containing choline acetyltransferase and nitric oxide synthase immunoreactivities in the submucosal and myenteric plexuses of the porcine colon. Cell Tissue Res 2021;383:645-54. [PMID: 32965550 DOI: 10.1007/s00441-020-03286-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
426 Trevaskis NL, Porter CJH, Charman WN. The Lymph Lipid Precursor Pool Is a Key Determinant of Intestinal Lymphatic Drug Transport. J Pharmacol Exp Ther 2006;316:881-91. [DOI: 10.1124/jpet.105.094094] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
427 Påhlman I, Andersson S, Gunnarsson K, Odell M, Wilén M. Extensive Biliary Excretion of the Sulfasalazine Analogue, Susalimod, but Different Concentrations in the Bile Duct in Various Animal Species Correlating to Species-Specific Hepatobiliary Toxicity. Pharmacology & Toxicology 1999;85:123-9. [DOI: 10.1111/j.1600-0773.1999.tb00078.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
428 Jiang X, Hou X, Tang L, Jiang Y, Ma G, Li Y. A phase trial of the oral Lactobacillus casei vaccine polarizes Th2 cell immunity against transmissible gastroenteritis coronavirus infection. Appl Microbiol Biotechnol 2016;100:7457-69. [PMID: 27020282 DOI: 10.1007/s00253-016-7424-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
429 Ranganathan S, Vasikaran EM, Elumalai A, Moses JA, Anandharamakrishnan C. Gastric emptying pattern and disintegration kinetics of cooked rice in a 3D printed in vitro dynamic digestion model ARK ®. International Journal of Food Engineering 2021;17:385-93. [DOI: 10.1515/ijfe-2020-0159] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
430 Thörn HA, Yasin M, Dickinson PA, Lennernäs H. Extensive intestinal glucuronidation of raloxifene in vivo in pigs and impact for oral drug delivery. Xenobiotica 2012;42:917-28. [DOI: 10.3109/00498254.2012.683497] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
431 Kaye JL. Review of paediatric gastrointestinal physiology data relevant to oral drug delivery. Int J Clin Pharm 2011;33:20-4. [DOI: 10.1007/s11096-010-9455-0] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
432 Waara ER, Iqbal MN, Robert-Nicoud G, Benziane B, Vallhov H, Wasik AM, Lindgren M, Hagman E, Rinde M, Kupferschmidt N, Berlin R, Johnston EV, Danielsson P, Bengtsson T. Entrapping Digestive Enzymes with Engineered Mesoporous Silica Particles Reduces Metabolic Risk Factors in Humans. Adv Healthc Mater 2020;9:e2000057. [PMID: 32352221 DOI: 10.1002/adhm.202000057] [Reference Citation Analysis]
433 Yang L, Chu JS, Fix JA. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm. 2002;235:1-15. [PMID: 11879735 DOI: 10.1016/s0378-5173(02)00004-2] [Cited by in Crossref: 319] [Cited by in F6Publishing: 41] [Article Influence: 16.8] [Reference Citation Analysis]
434 Cheng D, Shami GJ, Morsch M, Chung RS, Braet F. Ultrastructural Mapping of the Zebrafish Gastrointestinal System as a Basis for Experimental Drug Studies. Biomed Res Int 2016;2016:8758460. [PMID: 27340669 DOI: 10.1155/2016/8758460] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
435 De Matteis V. Exposure to Inorganic Nanoparticles: Routes of Entry, Immune Response, Biodistribution and In Vitro/In Vivo Toxicity Evaluation. Toxics 2017;5:E29. [PMID: 29051461 DOI: 10.3390/toxics5040029] [Cited by in Crossref: 97] [Cited by in F6Publishing: 68] [Article Influence: 24.3] [Reference Citation Analysis]
436 Du H, Huang G. Environmental pH adaption and morphological transitions in Candida albicans. Curr Genet 2016;62:283-6. [PMID: 26581628 DOI: 10.1007/s00294-015-0540-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
437 Ruff A, Holm R, Kostewicz ES. Evaluating the predictability of the in vitro transfer model and in vivo rat studies as a surrogate to investigate the supersaturation and precipitation behaviour of different Albendazole formulations for humans. European Journal of Pharmaceutical Sciences 2017;105:108-18. [DOI: 10.1016/j.ejps.2017.04.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
438 Kumar A, Allison A, Henry M, Scales A, Fouladkhah AC. Development of Salmonellosis as Affected by Bioactive Food Compounds. Microorganisms 2019;7:E364. [PMID: 31540475 DOI: 10.3390/microorganisms7090364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
439 Chiang PC, South SA, Wene SP. The impact of dosing interval in a novel tandem oral dosing strategy: enhancing the exposure of low solubility drug candidates in a preclinical setting. J Drug Deliv 2011;2011:528284. [PMID: 21490753 DOI: 10.1155/2011/528284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
440 Taléns‐visconti R, Garrigues TM, Cantón E, Freixas J, Martín‐villodre A, Plá‐delfina JM. Activity–Bioavailability balance in Oral Drug Development for a Selected Group of 6‐Fluoroquinolones. Journal of Pharmaceutical Sciences 2002;91:2452-64. [DOI: 10.1002/jps.10235] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
441 Gao Y, Gesenberg C, Zheng W. Oral Formulations for Preclinical Studies. Developing Solid Oral Dosage Forms. Elsevier; 2017. pp. 455-95. [DOI: 10.1016/b978-0-12-802447-8.00017-0] [Cited by in Crossref: 12] [Article Influence: 3.0] [Reference Citation Analysis]
442 Mousa SA. In vivo models for the evaluation of antithrombotics and thrombolytics. Methods Mol Biol 2010;663:29-107. [PMID: 20617414 DOI: 10.1007/978-1-60761-803-4_2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
443 Tran T, Siqueira SD, Amenitsch H, Müllertz A, Rades T. In vitro and in vivo performance of monoacyl phospholipid-based self-emulsifying drug delivery systems. Journal of Controlled Release 2017;255:45-53. [DOI: 10.1016/j.jconrel.2017.03.393] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
444 Holst B, Williamson G. Methods to Study Bioavailability of Phytochemicals. In: Bao Y, Fenwick R, editors. Phytochemicals in Health and Disease. CRC Press; 2004. pp. 25-56. [DOI: 10.1201/9780203021408.ch2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
445 McNeal CJ, Meininger CJ, Reddy D, Wilborn CD, Wu G. Safety and Effectiveness of Arginine in Adults. J Nutr 2016;146:2587S-93S. [PMID: 27934649 DOI: 10.3945/jn.116.234740] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
446 Lipka E, Amidon G. Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems. Journal of Controlled Release 1999;62:41-9. [DOI: 10.1016/s0168-3659(99)00022-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
447 Grignard E, Taylor R, McAllister M, Box K, Fotaki N. Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies. Eur J Pharm Sci 2017;99:193-201. [PMID: 27940084 DOI: 10.1016/j.ejps.2016.12.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
448 Helke KL, Swindle MM. Animal models of toxicology testing: the role of pigs. Expert Opin Drug Metab Toxicol. 2013;9:127-139. [PMID: 23216131 DOI: 10.1517/17425255.2013.739607] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 8.3] [Reference Citation Analysis]
449 O'Connor C, Steichen S, Peppas NA. Student Award for Outstanding Research Winner in the Undergraduate Category for the 2017 Society for Biomaterials Annual Meeting and Exposition, April 5-8, 2017, Minneapolis, Minnesota: Development and characterization of stimuli-responsive hydrogel microcarriers for oral protein delivery. J Biomed Mater Res A 2017;105:1243-51. [PMID: 28177593 DOI: 10.1002/jbm.a.36030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
450 Arafat B, Qinna N, Cieszynska M, Forbes RT, Alhnan MA. Tailored on demand anti-coagulant dosing: An in vitro and in vivo evaluation of 3D printed purpose-designed oral dosage forms. Eur J Pharm Biopharm 2018;128:282-9. [PMID: 29673871 DOI: 10.1016/j.ejpb.2018.04.010] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 16.0] [Reference Citation Analysis]
451 Xie W, Song L, Wang X, Xu Y, Liu Z, Zhao D, Wang S, Fan X, Wang Z, Gao C, Wang X, Wang L, Qiao X, Zhou H, Cui W, Jiang Y, Li Y, Tang L. A bovine lactoferricin-lactoferrampin-encoding Lactobacillus reuteri CO21 regulates the intestinal mucosal immunity and enhances the protection of piglets against enterotoxigenic Escherichia coli K88 challenge. Gut Microbes 2021;13:1956281. [PMID: 34369287 DOI: 10.1080/19490976.2021.1956281] [Reference Citation Analysis]
452 Agarwal T, Onesto V, Lamboni L, Ansari A, Maiti TK, Makvandi P, Vosough M, Yang G. Engineering biomimetic intestinal topological features in 3D tissue models: retrospects and prospects. Bio-des Manuf 2021;4:568-95. [DOI: 10.1007/s42242-020-00120-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
453 Tanner SA, Chassard C, Zihler Berner A, Lacroix C. Synergistic effects of Bifidobacterium thermophilum RBL67 and selected prebiotics on inhibition of Salmonella colonization in the swine proximal colon PolyFermS model. Gut Pathog 2014;6:44. [PMID: 25364390 DOI: 10.1186/s13099-014-0044-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
454 Bures J, Kvetina J, Radochova V, Tacheci I, Peterova E, Herman D, Dolezal R, Kopacova M, Rejchrt S, Douda T, Sestak V, Douda L, Karasova JZ. The pharmacokinetic parameters and the effect of a single and repeated doses of memantine on gastric myoelectric activity in experimental pigs. PLoS One 2020;15:e0227781. [PMID: 31978146 DOI: 10.1371/journal.pone.0227781] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
455 Tibbitts J. Issues Related to the Use of Canines in Toxicologic Pathology—Issues With Pharmacokinetics and Metabolism. Toxicol Pathol 2003;31:17-24. [DOI: 10.1080/01926230390174896] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
456 Roussel C, Sivignon A, de Wiele TV, Blanquet-Diot S. Foodborne enterotoxigenic Escherichia coli: from gut pathogenesis to new preventive strategies involving probiotics. Future Microbiol 2017;12:73-93. [PMID: 27983878 DOI: 10.2217/fmb-2016-0101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
457 Haid DC, Jordan-Biegger C, Widmayer P, Breer H. Receptors responsive to protein breakdown products in g-cells and d-cells of mouse, swine and human. Front Physiol 2012;3:65. [PMID: 22514536 DOI: 10.3389/fphys.2012.00065] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
458 Fagerholm U, Lindahl A, Lennernäs H. Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms. J Pharm Pharmacol 1997;49:687-90. [PMID: 9255712 DOI: 10.1111/j.2042-7158.1997.tb06093.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 3.0] [Reference Citation Analysis]
459 Haines RA, Urbiztondo RA, Haynes RA 2nd, Simpson E, Niewiesk S, Lairmore MD. Characterization of New Zealand White Rabbit Gut-Associated Lymphoid Tissues and Use as Viral Oncology Animal Model. ILAR J 2016;57:34-43. [PMID: 27034393 DOI: 10.1093/ilar/ilw004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
460 Lapthorne S, Pereira-Fantini PM, Fouhy F, Wilson G, Thomas SL, Dellios NL, Scurr M, O’Sullivan O, Ross RP, Stanton C. Gut microbial diversity is reduced and is associated with colonic inflammation in a piglet model of short bowel syndrome. Gut Microbes. 2013;4:212-221. [PMID: 23549027 DOI: 10.4161/gmic.24372] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 8.0] [Reference Citation Analysis]
461 Sjögren E, Abrahamsson B, Augustijns P, Becker D, Bolger MB, Brewster M, Brouwers J, Flanagan T, Harwood M, Heinen C, Holm R, Juretschke H, Kubbinga M, Lindahl A, Lukacova V, Münster U, Neuhoff S, Nguyen MA, Peer AV, Reppas C, Hodjegan AR, Tannergren C, Weitschies W, Wilson C, Zane P, Lennernäs H, Langguth P. In vivo methods for drug absorption – Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects. European Journal of Pharmaceutical Sciences 2014;57:99-151. [DOI: 10.1016/j.ejps.2014.02.010] [Cited by in Crossref: 166] [Cited by in F6Publishing: 156] [Article Influence: 23.7] [Reference Citation Analysis]
462 Anderson RC, MacGibbon AKH, Haggarty N, Armstrong KM, Roy NC. Bovine dairy complex lipids improve in vitro measures of small intestinal epithelial barrier integrity. PLoS One 2018;13:e0190839. [PMID: 29304106 DOI: 10.1371/journal.pone.0190839] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
463 Schmühl C, Beckstette M, Heroven AK, Bunk B, Spröer C, McNally A, Overmann J, Dersch P. Comparative Transcriptomic Profiling of Yersinia enterocolitica O:3 and O:8 Reveals Major Expression Differences of Fitness- and Virulence-Relevant Genes Indicating Ecological Separation. mSystems 2019;4:e00239-18. [PMID: 31020044 DOI: 10.1128/mSystems.00239-18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
464 Chuluunbaatar T, Ichii O, Nakamura T, Irie T, Namba T, Islam MR, Otani Y, Masum MA, Okamatsu-Ogura Y, Elewa YHA, Kon Y. Unique Running Pattern and Mucosal Morphology Found in the Colon of Cotton Rats. Front Physiol 2020;11:587214. [PMID: 33192600 DOI: 10.3389/fphys.2020.587214] [Reference Citation Analysis]
465 Grassi M, Bonora GM, Drioli S, Cateni F, Zacchigna M. Pharmacokinetic analysis of multi PEG–theophylline conjugates. Computational Biology and Chemistry 2012;40:7-14. [DOI: 10.1016/j.compbiolchem.2012.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
466 Jeong Y, Yv̄ RP, Ohno T, Yoshikawa Y, Shibata N, Kato S, Takeuchi K, Takada K. Application of Eudragit P-4135F for the delivery of ellagic acid to the rat lower small intestine. Journal of Pharmacy and Pharmacology 2001;53:1079-85. [DOI: 10.1211/0022357011776469] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
467 Chiang P, Liu J, Fan P, Wong H. Exploring a Kinetic Model Approach in Biopharmaceutics: Estimating the Fraction Absorbed of Orally Administered Drugs in Humans. Journal of Pharmaceutical Sciences 2018;107:1798-805. [DOI: 10.1016/j.xphs.2018.03.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
468 Risovic V, Rosland M, Sivak O, Wasan KM, Bartlett K. Assessing the Antifungal Activity of a New Oral Lipid-Based Amphotericin B Formulation Following Administration to Rats Infected with Aspergillus Fumigatus. Drug Development and Industrial Pharmacy 2008;33:703-7. [DOI: 10.1080/03639040601077349] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
469 van der Zande M, Jemec Kokalj A, Spurgeon DJ, Loureiro S, Silva PV, Khodaparast Z, Drobne D, Clark NJ, van den Brink NW, Baccaro M, van Gestel CAM, Bouwmeester H, Handy RD. The gut barrier and the fate of engineered nanomaterials: a view from comparative physiology. Environ Sci : Nano 2020;7:1874-98. [DOI: 10.1039/d0en00174k] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 9.0] [Reference Citation Analysis]
470 Brown DR, Price LD. Catecholamines and sympathomimetic drugs decrease early Salmonella Typhimurium uptake into porcine Peyer's patches. FEMS Immunol Med Microbiol 2008;52:29-35. [PMID: 18031537 DOI: 10.1111/j.1574-695X.2007.00348.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
471 Gu CH, Li H, Levons J, Lentz K, Gandhi RB, Raghavan K, Smith RL. Predicting effect of food on extent of drug absorption based on physicochemical properties. Pharm Res 2007;24:1118-30. [PMID: 17385020 DOI: 10.1007/s11095-007-9236-1] [Cited by in Crossref: 105] [Cited by in F6Publishing: 83] [Article Influence: 7.5] [Reference Citation Analysis]
472 Kanasty R, Low S, Bhise N, Yang J, Peeke E, Schwarz M, Wright J, Carter B, Moorthy S, Grant T, DeBenedictis B, Bishoff M, Simses C, Bellinger AM. A pharmaceutical answer to nonadherence: Once weekly oral memantine for Alzheimer's disease. J Control Release 2019;303:34-41. [PMID: 30928488 DOI: 10.1016/j.jconrel.2019.03.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
473 Regazzi M, Alessiani M, Reggiani P, Gatti S, Spada M, Iacona I, Rossi G, Tzakis A. Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation. Transplantation Proceedings 1997;29:1857-60. [DOI: 10.1016/s0041-1345(97)00098-5] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
474 Kosa RE, Lazzaro S, Bi YA, Tierney B, Gates D, Modi S, Costales C, Rodrigues AD, Tremaine LM, Varma MV. Simultaneous Assessment of Transporter-Mediated Drug-Drug Interactions Using a Probe Drug Cocktail in Cynomolgus Monkey. Drug Metab Dispos 2018;46:1179-89. [PMID: 29880631 DOI: 10.1124/dmd.118.081794] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
475 Hua S. Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors. Front Pharmacol 2020;11:524. [PMID: 32425781 DOI: 10.3389/fphar.2020.00524] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
476 Christiansen ML, Müllertz A, Garmer M, Kristensen J, Jacobsen J, Abrahamsson B, Holm R. Evaluation of the Use of Göttingen Minipigs to Predict Food Effects on the Oral Absorption of Drugs in Humans. Journal of Pharmaceutical Sciences 2015;104:135-43. [DOI: 10.1002/jps.24270] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
477 Li Z, Vachharajani NN, Krishna R. On the assessment of effects of food on the pharmacokinetics of drugs in early development. Biopharm Drug Dispos 2002;23:165-71. [DOI: 10.1002/bdd.309] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
478 Gershanik T, Benzeno S, Benita S. Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge. Pharm Res 1998;15:863-9. [PMID: 9647351 DOI: 10.1023/a:1011968313933] [Cited by in Crossref: 73] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
479 Stoll BR, Batycky RP, Leipold HR, Milstein S, Edwards DA. A theory of molecular absorption from the small intestine. Chemical Engineering Science 2000;55:473-89. [DOI: 10.1016/s0009-2509(99)00308-5] [Cited by in Crossref: 26] [Article Influence: 1.2] [Reference Citation Analysis]
480 Oki J, Watanabe D, Uekusa T, Sugano K. Mechanism of Supersaturation Suppression in Dissolution Process of Acidic Drug Salt. Mol Pharmaceutics 2019;16:1669-77. [DOI: 10.1021/acs.molpharmaceut.9b00006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
481 Adhikari C, Mishra A, Nayak D, Chakraborty A. Metal organic frameworks modified mesoporous silica nanoparticles (MSN): A nano-composite system to inhibit uncontrolled chemotherapeutic drug delivery from Bare-MSN. Journal of Drug Delivery Science and Technology 2018;47:1-11. [DOI: 10.1016/j.jddst.2018.06.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
482 Thiesen A, Drozdowski L, Iordache C, Neo CC, Woudstra TD, Xenodemetropoulos T, Keelan M, Clandinin MT, Thomson AB, Wild G. Adaptation following intestinal resection: mechanisms and signals. Best Pract Res Clin Gastroenterol. 2003;17:981-995. [PMID: 14642861 DOI: 10.1016/s1521-6918(03)00097-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
483 Sharma Ghimire P, Ouyang H, Wang Q, Luo Y, Shi B, Yang J, Lü Y, Jin C. Insight into Enzymatic Degradation of Corn, Wheat, and Soybean Cell Wall Cellulose Using Quantitative Secretome Analysis of Aspergillus fumigatus. J Proteome Res 2016;15:4387-402. [DOI: 10.1021/acs.jproteome.6b00465] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
484 Gu C, Gandhi RB, Tay LK, Zhou S, Raghavan K. Importance of using physiologically relevant volume of dissolution medium to correlate the oral exposure of formulations of BMS-480188 mesylate. International Journal of Pharmaceutics 2004;269:195-202. [DOI: 10.1016/j.ijpharm.2003.09.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
485 Bradham K, Diamond G, Juhasz A, Nelson C, Thomas D. Comparison of mouse and swine bioassays for determination of soil arsenic relative bioavailability. Applied Geochemistry 2018;88:221-5. [DOI: 10.1016/j.apgeochem.2017.05.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
486 Chiang PC, South SA, Foster KA, Daniels JS, Wene SP, Albin LA, Thompson DC. Utilizing a novel tandem oral dosing strategy to enhance exposure of low-solubility drug candidates in a preclinical setting. J Pharm Sci 2010;99:3132-40. [PMID: 20229600 DOI: 10.1002/jps.22092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
487 Furfine ES, Baker CT, Hale MR, Reynolds DJ, Salisbury JA, Searle AD, Studenberg SD, Todd D, Tung RD, Spaltenstein A. Preclinical pharmacology and pharmacokinetics of GW433908, a water-soluble prodrug of the human immunodeficiency virus protease inhibitor amprenavir. Antimicrob Agents Chemother 2004;48:791-8. [PMID: 14982766 DOI: 10.1128/AAC.48.3.791-798.2004] [Cited by in Crossref: 76] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
488 Niu X, de Graaf IA, Langelaar-Makkinje M, Horvatovich P, Groothuis GM. Diclofenac toxicity in human intestine ex vivo is not related to the formation of intestinal metabolites. Arch Toxicol 2015;89:107-19. [PMID: 24770551 DOI: 10.1007/s00204-014-1242-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
489 Parrott N, Lukacova V, Fraczkiewicz G, Bolger MB. Predicting pharmacokinetics of drugs using physiologically based modeling--application to food effects. AAPS J 2009;11:45-53. [PMID: 19184451 DOI: 10.1208/s12248-008-9079-7] [Cited by in Crossref: 107] [Cited by in F6Publishing: 95] [Article Influence: 8.9] [Reference Citation Analysis]
490 Chen S, Guo F, Deng T, Zhu S, Liu W, Zhong H, Yu H, Luo R, Deng Z. Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced Oral Colon Absorption of Insulin. AAPS PharmSciTech 2017;18:1277-87. [DOI: 10.1208/s12249-016-0594-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
491 Reynaud Y, Buffière C, David J, Cohade B, Vauris M, Lopez M, Souchon I, Dupont D, Rémond D. Temporal changes in postprandial intragastric pH: Comparing measurement methods, food structure effects, and kinetic modelling. Food Research International 2020;128:108784. [DOI: 10.1016/j.foodres.2019.108784] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
492 Palus K, Całka J. Influence of Acrylamide Administration on the Neurochemical Characteristics of Enteric Nervous System (ENS) Neurons in the Porcine Duodenum. Int J Mol Sci 2019;21:E15. [PMID: 31861419 DOI: 10.3390/ijms21010015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
493 Medarević D, Cvijić S, Dobričić V, Mitrić M, Djuriš J, Ibrić S. Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: In vitro-in silico approach. European Journal of Pharmaceutical Sciences 2018;124:188-98. [DOI: 10.1016/j.ejps.2018.08.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
494 Proctor DM, Suh M, Aylward LL, Kirman CR, Harris MA, Thompson CM, Gürleyük H, Gerads R, Haws LC, Hays SM. Hexavalent chromium reduction kinetics in rodent stomach contents. Chemosphere 2012;89:487-93. [PMID: 22682893 DOI: 10.1016/j.chemosphere.2012.04.065] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
495 Musende AG, Eberding A, Wood CA, Adomat H, Fazli L, Hurtado-Coll A, Jia W, Bally MB, Tomlinson Guns ES. A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer. Anticancer Drugs 2012;23:543-52. [PMID: 22481061 DOI: 10.1097/CAD.0b013e32835006f5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
496 Sjödin E, Fritsch H, Eriksson UG, Logren U, Nordgren A, Forsell P, Knutson L, Lennernäs H. Intestinal and Hepatobiliary Transport of Ximelagatran and Its Metabolites in Pigs. Drug Metab Dispos 2008;36:1519-28. [DOI: 10.1124/dmd.108.020412] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
497 Larhed AW, Artursson P, Gråsjö J, Björk E. Diffusion of drugs in native and purified gastrointestinal mucus. J Pharm Sci 1997;86:660-5. [PMID: 9188047 DOI: 10.1021/js960503w] [Cited by in Crossref: 118] [Cited by in F6Publishing: 114] [Article Influence: 4.9] [Reference Citation Analysis]
498 Thelen K, Coboeken K, Willmann S, Burghaus R, Dressman JB, Lippert J. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, Part 1: Oral solutions. Journal of Pharmaceutical Sciences 2011;100:5324-45. [DOI: 10.1002/jps.22726] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
499 Alqahtani S, Roberts CJ, Stolnik S, Bosquillon C. Development of an In Vitro System to Study the Interactions of Aerosolized Drugs with Pulmonary Mucus. Pharmaceutics 2020;12:E145. [PMID: 32053877 DOI: 10.3390/pharmaceutics12020145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
500 Laomongkholchaisri P, Teanpaisan R, Wonglapsuwan M, Piwat S. Impact of Potential Probiotic Lactobacillus Strains on Host Growth and Development in a Drosophila melanogaster Model. Probiotics Antimicrob Proteins 2021;13:390-7. [PMID: 32875521 DOI: 10.1007/s12602-020-09705-z] [Reference Citation Analysis]
501 Edwards GL, Azain MJ, Parks A. Agricultural Animals as Biomedical Models: Occupational Health and Safety Considerations. ILAR J 2018;59:161-7. [PMID: 30476116 DOI: 10.1093/ilar/ily013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
502 Ruiz-garcı́a A, Bermejo M, Merino V, Sánchez-castaño G, Freixas J, Garrigues TM. Pharmacokinetics, bioavailability and absorption of flumequine in the rat. European Journal of Pharmaceutics and Biopharmaceutics 1999;48:253-8. [DOI: 10.1016/s0939-6411(99)00057-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
503 Gardner N, Haresign W, Spiller R, Farraj N, Wiseman J, Norbury H, Illum L. Development and Validation of a Pig Model for Colon-specific Drug Delivery. Journal of Pharmacy and Pharmacology 1996;48:689-93. [DOI: 10.1111/j.2042-7158.1996.tb03952.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
504 Oetzmann von Sochaczewski C, Tagkalos E, Lindner A, Baumgart N, Gruber G, Baumgart J, Lang H, Heimann A, Muensterer OJ. Bodyweight, not age, determines oesophageal length and breaking strength in rats. J Pediatr Surg 2019;54:297-302. [PMID: 30503022 DOI: 10.1016/j.jpedsurg.2018.10.085] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
505 Pridgen EM, Alexis F, Farokhzad OC. Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opin Drug Deliv 2015;12:1459-73. [PMID: 25813361 DOI: 10.1517/17425247.2015.1018175] [Cited by in Crossref: 127] [Cited by in F6Publishing: 105] [Article Influence: 21.2] [Reference Citation Analysis]
506 Gopirajah R, Anandharamakrishnan C. Advancement of Imaging and Modeling Techniques for Understanding Gastric Physical Forces on Food. Food Eng Rev 2016;8:323-35. [DOI: 10.1007/s12393-016-9140-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
507 Song B, Bransford P, Peresypkin A, Medek A, Mudunuri P, Randles EG, Dworakowski W, Kumar S, Snyder PW. Overcoming the Bile Salt-Mediated Formation of Nanocolloids That Inhibit Oral Absorption of VX-985. J Pharm Sci 2019;108:821-31. [PMID: 30385281 DOI: 10.1016/j.xphs.2018.10.036] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
508 Hu Z, Shimokawa T, Ohno T, Kimura G, Mawatari S, Kamitsuna M, Yoshikawa Y, Masuda S, Takada K. Characterization of Norfloxacine Release from Tablet Coated with a New pH-Sensitive Polymer, P-4135F. Journal of Drug Targeting 2009;7:223-32. [DOI: 10.3109/10611869909085505] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
509 Karasov WH, Hume ID. Vertebrate Gastrointestinal System. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 409-80. [DOI: 10.1002/cphy.cp130107] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
510 Mittal R, Jhaveri VM, Kay SS, Greer A, Sutherland KJ, Mcmurry HS, Lin N, Mittal J, Malhotra AK, Patel AP. Recent Advances in Understanding the Pathogenesis of Cardiovascular Diseases and Development of Treatment Modalities. CHDDT 2019;19:19-32. [DOI: 10.2174/1871529x18666180508111353] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
511 Pearson W, Orth MW, Lindinger MI. Differential anti-inflammatory and chondroprotective effects of simulated digests of indomethacin and an herbal composite (Mobility TM ) in a cartilage explant model of articular inflammation. J Vet Pharmacol Ther 2007;30:523-33. [DOI: 10.1111/j.1365-2885.2007.00905.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
512 Tachecí I, Květina J, Kuneš M, Pavlík M, Kopáčová M, Černý V, Rejchrt S, Edakkanambeth Varayil J, Bureš J. The effect of general anaesthesia on gastric myoelectric activity in experimental pigs. BMC Gastroenterol 2013;13:48. [PMID: 23496859 DOI: 10.1186/1471-230X-13-48] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
513 Sulaiman S, Marciani L. MRI of the Colon in the Pharmaceutical Field: The Future before us. Pharmaceutics 2019;11:E146. [PMID: 30934716 DOI: 10.3390/pharmaceutics11040146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
514 Arévalo-pérez R, Maderuelo C, Lanao JM. Recent advances in colon drug delivery systems. Journal of Controlled Release 2020;327:703-24. [DOI: 10.1016/j.jconrel.2020.09.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
515 Martínez-Romero E, Aguirre-Noyola JL, Bustamante-Brito R, González-Román P, Hernández-Oaxaca D, Higareda-Alvear V, Montes-Carreto LM, Martínez-Romero JC, Rosenblueth M, Servín-Garcidueñas LE. We and herbivores eat endophytes. Microb Biotechnol 2021;14:1282-99. [PMID: 33320440 DOI: 10.1111/1751-7915.13688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
516 Liu F, Zhuang X, Yang C, Li Z, Xiong S, Zhang Z, Li J, Lu C, Zhang Z. Characterization of preclinical in vitro and in vivo ADME properties and prediction of human PK using a physiologically based pharmacokinetic model for YQA-14, a new dopamine D 3 receptor antagonist candidate for treatment of drug addiction: PRECLINICAL PK AND PBPK SIMULATION OF YQA-14. Biopharm Drug Dispos 2014;35:296-307. [DOI: 10.1002/bdd.1897] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
517 Takano R, Furumoto K, Shiraki K, Takata N, Hayashi Y, Aso Y, Yamashita S. Rate-Limiting Steps of Oral Absorption for Poorly Water-Soluble Drugs in Dogs; Prediction from a Miniscale Dissolution Test and a Physiologically-Based Computer Simulation. Pharm Res 2008;25:2334-44. [DOI: 10.1007/s11095-008-9637-9] [Cited by in Crossref: 103] [Cited by in F6Publishing: 82] [Article Influence: 7.9] [Reference Citation Analysis]
518 Cundy KC, Sue IL, Visor GC, Marshburn J, Nakamura C, Lee WA, Shaw JP. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs. J Pharm Sci 1997;86:1334-8. [PMID: 9423141 DOI: 10.1021/js970264s] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
519 Vidal E, Jun B, Gordon WC, Maire MA, Martine L, Grégoire S, Khoury S, Cabaret S, Berdeaux O, Acar N, Bretillon L, Bazan NG. Bioavailability and spatial distribution of fatty acids in the rat retina after dietary omega-3 supplementation. J Lipid Res 2020;61:1733-46. [PMID: 33127836 DOI: 10.1194/jlr.RA120001057] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
520 Steger J, Patzke I, Berlet M, Ficht S, Eblenkamp M, Mela P, Wilhelm D. Design of a force-measuring setup for colorectal compression anastomosis and first ex-vivo results. Int J Comput Assist Radiol Surg 2021;16:1335-45. [PMID: 33891254 DOI: 10.1007/s11548-021-02371-8] [Reference Citation Analysis]
521 Palus K, Bulc M, Całka J. Effect of Acrylamide Supplementation on the CART-, VAChT-, and nNOS-Immunoreactive Nervous Structures in the Porcine Stomach. Animals (Basel) 2020;10:E555. [PMID: 32225044 DOI: 10.3390/ani10040555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
522 Mahler GJ, Esch MB, Tako E, Southard TL, Archer SD, Glahn RP, Shuler ML. Oral exposure to polystyrene nanoparticles affects iron absorption. Nature Nanotech 2012;7:264-71. [DOI: 10.1038/nnano.2012.3] [Cited by in Crossref: 191] [Cited by in F6Publishing: 175] [Article Influence: 21.2] [Reference Citation Analysis]
523 Hubálek F, Refsgaard HHF, Gram-Nielsen S, Madsen P, Nishimura E, Münzel M, Brand CL, Stidsen CE, Claussen CH, Wulff EM, Pridal L, Ribel U, Kildegaard J, Porsgaard T, Johansson E, Steensgaard DB, Hovgaard L, Glendorf T, Hansen BF, Jensen MK, Nielsen PK, Ludvigsen S, Rugh S, Garibay PW, Moore MC, Cherrington AD, Kjeldsen T. Molecular engineering of safe and efficacious oral basal insulin. Nat Commun 2020;11:3746. [PMID: 32719315 DOI: 10.1038/s41467-020-17487-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
524 Schreiber KL, Brown DR. Adrenocorticotrophic hormone modulates Escherichia coli O157:H7 adherence to porcine colonic mucosa. Stress 2009;8:185-90. [DOI: 10.1080/10253890500188732] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
525 Yuan Y, Duranceau A, Ferraro P, Martin J, Liberman M. Vascular conditioning of the stomach before esophageal reconstruction by gastric interposition: Gastric vascular conditioning. Diseases of the Esophagus 2012;25:740-9. [DOI: 10.1111/j.1442-2050.2011.01311.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
526 Deng Y, Zhang Y, Qiao R, Bonilla MM, Yang X, Ren H, Lemos B. Evidence that microplastics aggravate the toxicity of organophosphorus flame retardants in mice (Mus musculus). J Hazard Mater 2018;357:348-54. [PMID: 29908513 DOI: 10.1016/j.jhazmat.2018.06.017] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 19.7] [Reference Citation Analysis]
527 Gonzalez LM, Moeser AJ, Blikslager AT. Animal models of ischemia-reperfusion-induced intestinal injury: progress and promise for translational research. Am J Physiol Gastrointest Liver Physiol. 2015;308:G63-G75. [PMID: 25414098 DOI: 10.1152/ajpgi.00112.2013] [Cited by in Crossref: 92] [Cited by in F6Publishing: 90] [Article Influence: 13.1] [Reference Citation Analysis]
528 Klausner EA, Lavy E, Stepensky D, Friedman M, Hoffman A. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm Res 2002;19:1516-23. [PMID: 12425470 DOI: 10.1023/a:1020412817716] [Cited by in Crossref: 48] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
529 Neal-kluever A, Fisher J, Grylack L, Kakiuchi-kiyota S, Halpern W. Physiology of the Neonatal Gastrointestinal System Relevant to the Disposition of Orally Administered Medications. Drug Metab Dispos 2019;47:296-313. [DOI: 10.1124/dmd.118.084418] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
530 Sholukh AM, Watkins JD, Vyas HK, Gupta S, Lakhashe SK, Thorat S, Zhou M, Hemashettar G, Bachler BC, Forthal DN, Villinger F, Sattentau QJ, Weiss RA, Agatic G, Corti D, Lanzavecchia A, Heeney JL, Ruprecht RM. Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge. Vaccine 2015;33:2086-95. [PMID: 25769884 DOI: 10.1016/j.vaccine.2015.02.020] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 9.8] [Reference Citation Analysis]
531 Janssen P, Prins NH, Peeters PJ, Zuideveld KP, Lefebvre RA. 5-HT7 receptor efficacy distribution throughout the canine stomach. Br J Pharmacol 2004;143:331-42. [PMID: 15339857 DOI: 10.1038/sj.bjp.0705922] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
532 Schmidt S. Acknowledging Receipts? New Evidence for Dermal Absorption of Bisphenols. Environ Health Perspect 2020;128:34003. [PMID: 32159379 DOI: 10.1289/EHP6249] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
533 Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art. J Control Release 2016;240:504-26. [PMID: 27292178 DOI: 10.1016/j.jconrel.2016.06.016] [Cited by in Crossref: 184] [Cited by in F6Publishing: 152] [Article Influence: 36.8] [Reference Citation Analysis]
534 Voortman T, Hendriks HF, Witkamp RF, Wortelboer HM. Effects of long- and short-chain fatty acids on the release of gastrointestinal hormones using an ex vivo porcine intestinal tissue model. J Agric Food Chem 2012;60:9035-42. [PMID: 22757966 DOI: 10.1021/jf2045697] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
535 von Erlach T, Saxton S, Shi Y, Minahan D, Reker D, Javid F, Lee YL, Schoellhammer C, Esfandiary T, Cleveland C, Booth L, Lin J, Levy H, Blackburn S, Hayward A, Langer R, Traverso G. Robotically handled whole-tissue culture system for the screening of oral drug formulations. Nat Biomed Eng 2020;4:544-59. [PMID: 32341538 DOI: 10.1038/s41551-020-0545-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
536 Snoeck V, Huyghebaert N, Cox E, Vermeire A, Saunders J, Remon JP, Verschooten F, Goddeeris BM. Gastrointestinal transit time of nondisintegrating radio-opaque pellets in suckling and recently weaned piglets. J Control Release 2004;94:143-53. [PMID: 14684278 DOI: 10.1016/j.jconrel.2003.09.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
537 Macheras P, Chryssafidis P. Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts. Pharm Res 2020;37:187. [PMID: 32888087 DOI: 10.1007/s11095-020-02894-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
538 Nehoff H, Parayath NN, Domanovitch L, Taurin S, Greish K. Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect. Int J Nanomedicine 2014;9:2539-55. [PMID: 24904213 DOI: 10.2147/IJN.S47129] [Cited by in Crossref: 38] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
539 Květina J, Edakkanambeth Varayil J, Ali SM, Kuneš M, Bureš J, Tachecí I, Rejchrt S, Kopáčová M. Preclinical electrogastrography in experimental pigs. Interdiscip Toxicol 2010;3:53-8. [PMID: 21217873 DOI: 10.2478/v10102-010-0011-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
540 Guo F, Zhang M, Gao Y, Zhu S, Chen S, Liu W, Zhong H, Liu J. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation. Drug Delivery 2015;23:2003-14. [DOI: 10.3109/10717544.2015.1048489] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
541 Cheat S, Pinton P, Cossalter A, Cognie J, Vilariño M, Callu P, Raymond-letron I, Oswald IP, Kolf-clauw M. The mycotoxins deoxynivalenol and nivalenol show in vivo synergism on jejunum enterocytes apoptosis. Food and Chemical Toxicology 2016;87:45-54. [DOI: 10.1016/j.fct.2015.11.019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
542 Barillaro V, Evrard B, Delattre L, Piell G. Oral bioavailability in pigs of a miconazole/hydroxypropyl-gamma-cyclodextrin/L-tartaric acid inclusion complex produced by supercritical carbon dioxide processing. AAPS J 2005;7:E149-55. [PMID: 16146337 DOI: 10.1208/aapsj070116] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
543 Leigh SC, Papastamatiou Y, German DP. The nutritional physiology of sharks. Rev Fish Biol Fisheries 2017;27:561-85. [DOI: 10.1007/s11160-017-9481-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 4.8] [Reference Citation Analysis]
544 Miyake M, Minami T, Toguchi H, Odomi M, Ogawara K, Higaki K, Kimura T. Importance of bile acids for novel oral absorption system containing polyamines to improve intestinal absorption. Journal of Controlled Release 2006;115:130-3. [DOI: 10.1016/j.jconrel.2006.07.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
545 Zane P, Gieschen H, Kersten E, Mathias N, Ollier C, Johansson P, Van den Bergh A, Van Hemelryck S, Reichel A, Rotgeri A, Schäfer K, Müllertz A, Langguth P. In vivo models and decision trees for formulation development in early drug development: A review of current practices and recommendations for biopharmaceutical development. Eur J Pharm Biopharm 2019;142:222-31. [PMID: 31233862 DOI: 10.1016/j.ejpb.2019.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
546 Moss DM, Curley P, Kinvig H, Hoskins C, Owen A. The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery. Expert Rev Gastroenterol Hepatol 2018;12:223-36. [PMID: 29088978 DOI: 10.1080/17474124.2018.1399794] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
547 Raoof AA, Ramtoola Z, McKenna B, Yu RZ, Hardee G, Geary RS. Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs. Eur J Pharm Sci 2002;17:131-8. [PMID: 12393140 DOI: 10.1016/s0928-0987(02)00162-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
548 Nofsinger R, Clas SD, Sanchez RI, Walji A, Manser K, Nissley B, Balsells J, Nair A, Dang Q, Bennett DJ, Hafey M, Wang J, Higgins J, Templeton A, Coleman P, Grobler J, Smith R, Wu Y. Design of prodrugs to enhance colonic absorption by increasing lipophilicity and blocking ionization. Pharmaceuticals (Basel) 2014;7:207-19. [PMID: 24566521 DOI: 10.3390/ph7020207] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
549 Paran TS, Rolle U, Puri P. Postnatal development of the mucosal plexus in the porcine small and large intestine. Pediatr Surg Int 2006;22:997-1001. [DOI: 10.1007/s00383-006-1786-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
550 Hua Z, Kimura G, Ito Y, Mawatari S, Shimokawa T, Yoshikawa H, Yoshikawa Y, Takada K. Technology to Obtain Sustained Release Characteristics of Drugs after Delivered to the Colon. Journal of Drug Targeting 2009;6:439-48. [DOI: 10.3109/10611869908996850] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
551 Pohl CS, Medland JE, Moeser AJ. Early-life stress origins of gastrointestinal disease: animal models, intestinal pathophysiology, and translational implications. Am J Physiol Gastrointest Liver Physiol 2015;309:G927-41. [PMID: 26451004 DOI: 10.1152/ajpgi.00206.2015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
552 Rubbens J, Mols R, Brouwers J, Augustijns P. Exploring gastric drug absorption in fasted and fed state rats. Int J Pharm 2018;548:636-41. [PMID: 29981414 DOI: 10.1016/j.ijpharm.2018.07.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
553 Tyagi P, Pechenov S, Anand Subramony J. Oral peptide delivery: Translational challenges due to physiological effects. Journal of Controlled Release 2018;287:167-76. [DOI: 10.1016/j.jconrel.2018.08.032] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 15.7] [Reference Citation Analysis]
554 Ball RL, Bajaj P, Whitehead KA. Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract. Sci Rep 2018;8:2178. [PMID: 29391566 DOI: 10.1038/s41598-018-20632-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
555 Shah R, Kolanos R, Dinovi MJ, Mattia A, Kaneko KJ. Dietary exposures for the safety assessment of seven emulsifiers commonly added to foods in the United States and implications for safety. Food Additives & Contaminants: Part A 2017;34:905-17. [DOI: 10.1080/19440049.2017.1311420] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
556 Christfort JF, Strindberg S, Plum J, Hall-andersen J, Janfelt C, Nielsen LH, Müllertz A. Developing a predictive in vitro dissolution model based on gastrointestinal fluid characterisation in rats. European Journal of Pharmaceutics and Biopharmaceutics 2019;142:307-14. [DOI: 10.1016/j.ejpb.2019.07.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
557 McCullough RW. Barrier therapies supporting the biology of the mucosal barrier-medical devices for common clinical mucosal disorders. Transl Gastroenterol Hepatol 2021;6:15. [PMID: 33409409 DOI: 10.21037/tgh.2020.02.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
558 Ban H, Muraoka M, Ioriya K, Ohashi N. Synthesis and biological activity of novel 4-phenyl-1,8-naphthyridin-2(1H)-on-3-yl ureas: Potent acyl-CoA:cholesterol acyltransferase inhibitor with improved aqueous solubility. Bioorganic & Medicinal Chemistry Letters 2006;16:44-8. [DOI: 10.1016/j.bmcl.2005.09.056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
559 Benshitrit RC, Levi CS, Tal SL, Shimoni E, Lesmes U. Development of oral food-grade delivery systems: Current knowledge and future challenges. Food Funct 2012;3:10-21. [DOI: 10.1039/c1fo10068h] [Cited by in Crossref: 80] [Cited by in F6Publishing: 6] [Article Influence: 8.9] [Reference Citation Analysis]
560 Helander HF, Fändriks L. Surface area of the digestive tract - revisited. Scand J Gastroenterol 2014;49:681-9. [PMID: 24694282 DOI: 10.3109/00365521.2014.898326] [Cited by in Crossref: 370] [Cited by in F6Publishing: 306] [Article Influence: 52.9] [Reference Citation Analysis]
561 Bélteky P, Rónavári A, Igaz N, Szerencsés B, Tóth IY, Pfeiffer I, Kiricsi M, Kónya Z. Silver nanoparticles: aggregation behavior in biorelevant conditions and its impact on biological activity. Int J Nanomedicine 2019;14:667-87. [PMID: 30705586 DOI: 10.2147/IJN.S185965] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 16.5] [Reference Citation Analysis]
562 Suenderhauf C, Hammann F, Maunz A, Helma C, Huwyler J. Combinatorial QSAR Modeling of Human Intestinal Absorption. Mol Pharmaceutics 2011;8:213-24. [DOI: 10.1021/mp100279d] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
563 Lin Y, Shatkin JA, Kong F. Evaluating mucoadhesion properties of three types of nanocellulose in the gastrointestinal tract in vitro and ex vivo. Carbohydrate Polymers 2019;210:157-66. [DOI: 10.1016/j.carbpol.2019.01.029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
564 Mavroudis PD, Hermes HE, Teutonico D, Preuss TG, Schneckener S. Development and validation of a physiology-based model for the prediction of pharmacokinetics/toxicokinetics in rabbits. PLoS One 2018;13:e0194294. [PMID: 29561908 DOI: 10.1371/journal.pone.0194294] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
565 Harwood MD, Neuhoff S, Carlson GL, Warhurst G, Rostami-hodjegan A. Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption: PROTEIN ABUNDANCE FOR INTESTINAL TRANSPORTERS WITHIN A PBPK FRAMEWORK. Biopharm Drug Dispos 2013;34:2-28. [DOI: 10.1002/bdd.1810] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 8.4] [Reference Citation Analysis]
566 Morrison J, Nophsker M, Elzinga P, Donoso M, Park H, Haskell R. A polychromatic turbidity microplate assay to distinguish discovery stage drug molecules with beneficial precipitation properties. International Journal of Pharmaceutics 2017;531:24-34. [DOI: 10.1016/j.ijpharm.2017.07.086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
567 Muenster U, Mueck W, van der Mey D, Schlemmer K, Greschat-schade S, Haerter M, Pelzetter C, Pruemper C, Verlage J, Göller AH, Ohm A. Predicting biopharmaceutical performance of oral drug candidates – Extending the volume to dissolve applied dose concept. European Journal of Pharmaceutics and Biopharmaceutics 2016;102:191-201. [DOI: 10.1016/j.ejpb.2016.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
568 Kong Y, Olejar KJ, On SLW, Chelikani V. The Potential of Lactobacillus spp. for Modulating Oxidative Stress in the Gastrointestinal Tract. Antioxidants (Basel) 2020;9:E610. [PMID: 32664392 DOI: 10.3390/antiox9070610] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
569 Philip A, Ferro VA, Tate RJ. Determination of the potential bioavailability of plant microRNAs using a simulated human digestion process. Mol Nutr Food Res 2015;59:1962-72. [DOI: 10.1002/mnfr.201500137] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 9.2] [Reference Citation Analysis]
570 Bures J, Smajs D, Kvetina J, Förstl M, Smarda J, Kohoutova D, Kunes M, Cyrany J, Tacheci I, Rejchrt S, Lesna J, Vorisek V, Kopacova M. Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli NissleWorld J Gastroenterol 2011; 17(5): 609-617 [PMID: 21350709 DOI: 10.3748/wjg.v17.i5.609] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
571 Lewis MC, Patel DV, Fowler J, Duncker S, Zuercher AW, Mercenier A, Bailey M. Dietary supplementation with Bifidobacterium lactis NCC2818 from weaning reduces local immunoglobulin production in lymphoid-associated tissues but increases systemic antibodies in healthy neonates. Br J Nutr 2013;110:1243-52. [PMID: 23473077 DOI: 10.1017/S0007114513000251] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
572 Chen EP, Mahar Doan KM, Portelli S, Coatney R, Vaden V, Shi W. Gastric pH and gastric residence time in fasted and fed conscious cynomolgus monkeys using the Bravo pH system. Pharm Res 2008;25:123-34. [PMID: 17612796 DOI: 10.1007/s11095-007-9358-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
573 Polster CS, Wu S, Gueorguieva I, Sperry DC. Mechanism for Enhanced Absorption of a Solid Dispersion Formulation of LY2300559 Using the Artificial Stomach Duodenum Model. Mol Pharmaceutics 2015;12:1131-40. [DOI: 10.1021/mp5006036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
574 Brehmer A, Schrödl F, Neuhuber W, Tooyama I, Kimura H. Co-expression pattern of neuronal nitric oxide synthase and two variants of choline acetyltransferase in myenteric neurons of porcine ileum. Journal of Chemical Neuroanatomy 2004;27:33-41. [DOI: 10.1016/j.jchemneu.2003.09.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
575 Thanou M, Verhoef J, Junginger H. Chitosan and its derivatives as intestinal absorption enhancers. Advanced Drug Delivery Reviews 2001;50:S91-S101. [DOI: 10.1016/s0169-409x(01)00180-6] [Cited by in Crossref: 280] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
576 Hamada T, Watanabe Y, Iida K, Sano N, Amano N. Microminipig: A suitable animal model to estimate oral absorption of sustained-release formulation in humans. Int J Pharm 2020;584:119457. [PMID: 32464228 DOI: 10.1016/j.ijpharm.2020.119457] [Reference Citation Analysis]
577 Desseaux V, Stocker P, Brouant P, Ajandouz EH. The Mechanisms of Alpha-Amylase Inhibition by Flavan-3-Ols and the Possible Impacts of Drinking Green Tea on Starch Digestion: Alpha-amylase inhibition by flavanols. . . Journal of Food Science 2018;83:2858-65. [DOI: 10.1111/1750-3841.14353] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
578 Lee C, Kim H, Bardwell JCA. Electrostatic interactions are important for chaperone-client interaction in vivo. Microbiology (Reading) 2018;164:992-7. [PMID: 29870331 DOI: 10.1099/mic.0.000676] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
579 Nielsen TS, Jørgensen H, Knudsen KEB, Lærke HN. The microbial fermentation characteristics depend on both carbohydrate source and heat processing: a model experiment with ileo-cannulated pigs. Int J Food Sci Nutr 2017;68:811-20. [PMID: 28367709 DOI: 10.1080/09637486.2017.1307947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
580 Kosugi Y, Yamamoto S, Sano N, Furuta A, Igari T, Fujioka Y, Amano N. Evaluation of Acid Tolerance of Drugs Using Rats and Dogs Controlled for Gastric Acid Secretion. J Pharm Sci 2015;104:2887-93. [PMID: 25720462 DOI: 10.1002/jps.24401] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
581 Varum FJ, Veiga F, Sousa JS, Basit AW. An investigation into the role of mucus thickness on mucoadhesion in the gastrointestinal tract of pig. European Journal of Pharmaceutical Sciences 2010;40:335-41. [DOI: 10.1016/j.ejps.2010.04.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
582 Renner S, Dobenecker B, Blutke A, Zöls S, Wanke R, Ritzmann M, Wolf E. Comparative aspects of rodent and nonrodent animal models for mechanistic and translational diabetes research. Theriogenology 2016;86:406-21. [PMID: 27180329 DOI: 10.1016/j.theriogenology.2016.04.055] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
583 Kohl KD, Stengel A, Samuni-Blank M, Dearing MD. Effects of anatomy and diet on gastrointestinal pH in rodents. J Exp Zool A Ecol Genet Physiol 2013;319:225-9. [PMID: 23460608 DOI: 10.1002/jez.1786] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
584 Bures J, Tacheci I, Kvetina J, Radochova V, Kohoutova D, Valis M, Rejchrt S, Knoblochova V, Zdarova Karasova J. Dextran Sodium Sulphate-Induced Gastrointestinal Injury Further Aggravates the Impact of Galantamine on the Gastric Myoelectric Activity in Experimental Pigs. Pharmaceuticals (Basel) 2021;14:590. [PMID: 34207410 DOI: 10.3390/ph14060590] [Reference Citation Analysis]
585 Lee C, Luner PE, Locke K, Briggs K. Application of an Artificial Stomach-Duodenum Reduced Gastric pH Dog Model for Formulation Principle Assessment and Mechanistic Performance Understanding. Journal of Pharmaceutical Sciences 2017;106:1987-97. [DOI: 10.1016/j.xphs.2017.02.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
586 Parmentier J, Thomas N, Müllertz A, Fricker G, Rades T. Exploring the fate of liposomes in the intestine by dynamic in vitro lipolysis. Int J Pharm 2012;437:253-63. [PMID: 22939968 DOI: 10.1016/j.ijpharm.2012.08.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
587 Matteucci ME, Paguio JC, Miller MA, Williams Iii RO, Johnston KP. Highly Supersaturated Solutions from Dissolution of Amorphous Itraconazole Microparticles at pH 6.8. Mol Pharmaceutics 2009;6:375-85. [DOI: 10.1021/mp800106a] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
588 Varum FJ, Veiga F, Sousa JS, Basit AW. Mucoadhesive platforms for targeted delivery to the colon. International Journal of Pharmaceutics 2011;420:11-9. [DOI: 10.1016/j.ijpharm.2011.08.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
589 Trevaskis NL, Lo CM, Ma LY, Tso P, Irving HR, Porter CJH, Charman WN. An Acute and Coincident Increase in FABP Expression and Lymphatic Lipid and Drug Transport Occurs During Intestinal Infusion of Lipid-Based Drug Formulations to Rats. Pharm Res 2006;23:1786-96. [DOI: 10.1007/s11095-006-9021-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
590 van der Meulen J, Hulst MM, Smits MA, Schuurman T. Small intestinal segment perfusion test in piglets: future applications in studying probiotics-gut crosstalk in infectious diarrhoea? Benef Microbes 2010;1:439-45. [PMID: 21831782 DOI: 10.3920/BM2010.0025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
591 Fillmann HS, Llessuy S, Marroni CA, Fillmann LS, Marroni NP. Diabetes Mellitus and Anal Sphincter Pressures: An Experimental Model in Rats. Diseases of the Colon & Rectum 2007;50:517-22. [DOI: 10.1007/s10350-006-0838-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
592 Hamed E, Gerson MC, Millard RW, Sakr A. A study of the pharmacodynamic differences between immediate and extended release bumetanide formulations. International Journal of Pharmaceutics 2003;267:129-40. [DOI: 10.1016/j.ijpharm.2003.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
593 Kovacs-Nolan J, Mine Y. Microencapsulation for the gastric passage and controlled intestinal release of immunoglobulin Y. J Immunol Methods 2005;296:199-209. [PMID: 15680164 DOI: 10.1016/j.jim.2004.11.017] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
594 Kim HM, Yang S, Kim J, Park S, Cho JH, Park JY, Kim TS, Yoon ES, Song SY, Bang S. Active locomotion of a paddling-based capsule endoscope in an in vitro and in vivo experiment (with videos). Gastrointest Endosc. 2010;72:381-387. [PMID: 20497903 DOI: 10.1016/j.gie.2009.12.058] [Cited by in Crossref: 94] [Cited by in F6Publishing: 52] [Article Influence: 8.5] [Reference Citation Analysis]
595 Stamatopoulos K, O'Farrell C, Simmons M, Batchelor H. In vivo models to evaluate ingestible devices: Present status and current trends. Adv Drug Deliv Rev 2021;177:113915. [PMID: 34371085 DOI: 10.1016/j.addr.2021.113915] [Reference Citation Analysis]
596 Brayden D, Creed E, O'Connell A, Leipold H, Agarwal R, Leone-Bay A. Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers. Pharm Res 1997;14:1772-9. [PMID: 9453067 DOI: 10.1023/a:1012192115828] [Cited by in Crossref: 49] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
597 del Castillo JR, Laroute V, Pommier P, Zémirline C, Keïta A, Concordet D, Toutain PL. Interindividual variability in plasma concentrations after systemic exposure of swine to dietary doxycycline supplied with and without paracetamol: a population pharmacokinetic approach. J Anim Sci 2006;84:3155-66. [PMID: 17032811 DOI: 10.2527/jas.2005-561] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
598 Youhanna S, Lauschke VM. The Past, Present and Future of Intestinal In Vitro Cell Systems for Drug Absorption Studies. J Pharm Sci 2021;110:50-65. [PMID: 32628951 DOI: 10.1016/j.xphs.2020.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
599 Li J, Li C, Sun H, Juhasz AL, Luo J, Li H, Ma LQ. Arsenic Relative Bioavailability in Contaminated Soils: Comparison of Animal Models, Dosing Schemes, and Biological End Points. Environ Sci Technol 2016;50:453-61. [DOI: 10.1021/acs.est.5b04552] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
600 Mendez-Catala DM, Spenkelink A, Rietjens IMCM, Beekmann K. An in vitromodel to quantify interspecies differences in kinetics for intestinal microbial bioactivation and detoxification of zearalenone. Toxicol Rep 2020;7:938-46. [PMID: 32793423 DOI: 10.1016/j.toxrep.2020.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
601 Kopácová M, Tachecí I, Kvetina J, Bures J, Kunes M, Spelda S, Tycová V, Svoboda Z, Rejchrt S. Wireless video capsule enteroscopy in preclinical studies: methodical design of its applicability in experimental pigs. Dig Dis Sci 2010;55:626-30. [PMID: 19294508 DOI: 10.1007/s10620-009-0779-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
602 Poinard B, Kamaluddin S, Tan AQQ, Neoh KG, Kah JCY. Polydopamine Coating Enhances Mucopenetration and Cell Uptake of Nanoparticles. ACS Appl Mater Interfaces 2019;11:4777-89. [DOI: 10.1021/acsami.8b18107] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
603 Gujral N, Löbenberg R, Suresh M, Sunwoo H. In-vitro and in-vivo binding activity of chicken egg yolk immunoglobulin Y (IgY) against gliadin in food matrix. J Agric Food Chem. 2012;60:3166-3172. [PMID: 22400905 DOI: 10.1021/jf205319s] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
604 Corá LA, Américo MF, Oliveira RB, Serra CHR, Baffa O, Evangelista RC, Oliveira GF, Miranda JRA. Biomagnetic Methods: Technologies Applied to Pharmaceutical Research. Pharm Res 2011;28:438-55. [DOI: 10.1007/s11095-010-0285-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
605 Prasanna P, Kumar P, Kumar S, Rajana VK, Kant V, Prasad SR, Mohan U, Ravichandiran V, Mandal D. Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis - A review. Biomed Pharmacother 2021;141:111920. [PMID: 34328115 DOI: 10.1016/j.biopha.2021.111920] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
606 Freire C, Podczeck F, Ferreira D, Veiga F, Sousa J, Pena A. Assessment of the in-vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery. Journal of Pharmacy and Pharmacology 2010;62:55-61. [DOI: 10.1211/jpp.62.01.0005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
607 Billat PA, Roger E, Faure S, Lagarce F. Models for drug absorption from the small intestine: where are we and where are we going? Drug Discov Today 2017;22:761-75. [PMID: 28115264 DOI: 10.1016/j.drudis.2017.01.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 12.3] [Reference Citation Analysis]
608 Trevaskis NL, Porter CJH, Charman WN. Bile Increases Intestinal Lymphatic Drug Transport in the Fasted Rat. Pharm Res 2005;22:1863-70. [DOI: 10.1007/s11095-005-6808-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
609 Stark D, Barratt J, Chan D, Ellis JT. Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel. Clin Microbiol Rev 2016;29:553-80. [PMID: 27170141 DOI: 10.1128/CMR.00076-15] [Cited by in Crossref: 52] [Cited by in F6Publishing: 19] [Article Influence: 10.4] [Reference Citation Analysis]
610 Meunier J, Cardot J, Gauthier P, Beyssac E, Alric M. Use of rotary fluidized-bed technology for development of sustained-release plant extracts pellets: Potential application for feed additive delivery1. Journal of Animal Science 2006;84:1850-9. [DOI: 10.2527/jas.2005-361] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
611 Saal W, Wyttenbach N, Alsenz J, Kuentz M. Interactions of dimethylaminoethyl methacrylate copolymer with non-acidic drugs demonstrated high solubilization in vitro and pronounced sustained release in vivo. European Journal of Pharmaceutics and Biopharmaceutics 2018;125:68-75. [DOI: 10.1016/j.ejpb.2018.01.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
612 O'driscoll C, Griffin B. Biopharmaceutical challenges associated with drugs with low aqueous solubility—The potential impact of lipid-based formulations. Advanced Drug Delivery Reviews 2008;60:617-24. [DOI: 10.1016/j.addr.2007.10.012] [Cited by in Crossref: 180] [Cited by in F6Publishing: 165] [Article Influence: 13.8] [Reference Citation Analysis]
613 Yuan C, Zhang P, Jin Y, Ullah Shah A, Zhang E, Yang Q. Single-Blinded Study Highlighting the Differences between the Small Intestines of Neonatal and Weaned Piglets. Animals (Basel) 2021;11:271. [PMID: 33494523 DOI: 10.3390/ani11020271] [Reference Citation Analysis]
614 Elfers K, Armbrecht Y, Mazzuoli-Weber G. Good to Know: Baseline Data on Feed Intake, Fecal Pellet Output and Intestinal Transit Time in Guinea Pig as a Frequently Used Model in Gastrointestinal Research. Animals (Basel) 2021;11:1593. [PMID: 34071498 DOI: 10.3390/ani11061593] [Reference Citation Analysis]
615 Gao W, Chan JM, Farokhzad OC. pH-Responsive nanoparticles for drug delivery. Mol Pharm 2010;7:1913-20. [PMID: 20836539 DOI: 10.1021/mp100253e] [Cited by in Crossref: 650] [Cited by in F6Publishing: 569] [Article Influence: 59.1] [Reference Citation Analysis]
616 Yao M, Xie J, Du H, Mcclements DJ, Xiao H, Li L. Progress in microencapsulation of probiotics: A review. Comprehensive Reviews in Food Science and Food Safety 2020;19:857-74. [DOI: 10.1111/1541-4337.12532] [Cited by in Crossref: 47] [Cited by in F6Publishing: 22] [Article Influence: 47.0] [Reference Citation Analysis]
617 Marks SL, Kook PH, Papich MG, Tolbert MK, Willard MD. ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats. J Vet Intern Med 2018;32:1823-40. [PMID: 30378711 DOI: 10.1111/jvim.15337] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
618 Wu P, Chen XD. On designing biomimic in vitro human and animal digestion track models: ideas, current and future devices. Current Opinion in Food Science 2020;35:10-9. [DOI: 10.1016/j.cofs.2019.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
619 Schittny A, Philipp-Bauer S, Detampel P, Huwyler J, Puchkov M. Mechanistic insights into effect of surfactants on oral bioavailability of amorphous solid dispersions. J Control Release 2020;320:214-25. [PMID: 31978445 DOI: 10.1016/j.jconrel.2020.01.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
620 Yang I, Nell S, Suerbaum S. Survival in hostile territory: the microbiota of the stomach. FEMS Microbiol Rev 2013;37:736-61. [DOI: 10.1111/1574-6976.12027] [Cited by in Crossref: 90] [Cited by in F6Publishing: 69] [Article Influence: 11.3] [Reference Citation Analysis]
621 El-kattan A, Hurst S, Brodfuehrer J, Loi C. Anatomical and Physiological Factors Affecting Oral Drug Bioavailability in Rats, Dogs, and Humans. In: Hu M, Li X, editors. Oral Bioavailability. Hoboken: John Wiley & Sons, Inc.; 2011. pp. 253-65. [DOI: 10.1002/9781118067598.ch16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
622 Muenster U, Pelzetter C, Backensfeld T, Ohm A, Kuhlmann T, Mueller H, Lustig K, Keldenich J, Greschat S, Göller AH, Gnoth MJ. Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): Tools to predict in vivo bioavailability from orally applied drug suspensions. European Journal of Pharmaceutics and Biopharmaceutics 2011;78:522-30. [DOI: 10.1016/j.ejpb.2011.01.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
623 Brayden DJ, Walsh E. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative. AAPS J 2014;16:1064-76. [PMID: 24961919 DOI: 10.1208/s12248-014-9634-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
624 Hubbard D, Enda M, Bond T, Moghaddam SP, Conarton J, Scaife C, Volckmann E, Ghandehari H. Transepithelial Transport of PAMAM Dendrimers Across Isolated Human Intestinal Tissue. Mol Pharm 2015;12:4099-107. [PMID: 26414679 DOI: 10.1021/acs.molpharmaceut.5b00541] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
625 Lowinger MB, Maier EY, Williams RO 3rd, Zhang F. Hydrophilic Poly(urethanes) Are an Effective Tool for Gastric Retention Independent of Drug Release Rate. J Pharm Sci 2020;109:1967-77. [PMID: 32087181 DOI: 10.1016/j.xphs.2020.02.011] [Reference Citation Analysis]
626 Mudie DM, Stewart AM, Rosales JA, Biswas N, Adam MS, Smith A, Craig CD, Morgen MM, Vodak DT. Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs. Pharmaceutics 2021;13:557. [PMID: 33921109 DOI: 10.3390/pharmaceutics13040557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
627 Weitschies W, Müller L, Grimm M, Koziolek M. Ingestible devices for studying the gastrointestinal physiology and their application in oral biopharmaceutics. Adv Drug Deliv Rev 2021;176:113853. [PMID: 34192551 DOI: 10.1016/j.addr.2021.113853] [Reference Citation Analysis]
628 Medland JE, Pohl CS, Edwards LL, Frandsen S, Bagley K, Li Y, Moeser AJ. Early life adversity in piglets induces long-term upregulation of the enteric cholinergic nervous system and heightened, sex-specific secretomotor neuron responses. Neurogastroenterol Motil 2016;28:1317-29. [PMID: 27134125 DOI: 10.1111/nmo.12828] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
629 Johannessen H, Kodama Y, Zhao C, Sousa MML, Slupphaug G, Kulseng B, Chen D. Eating Behavior and Glucagon-Like Peptide-1-Producing Cells in Interposed Ileum and Pancreatic Islets in Rats Subjected to Ileal Interposition Associated with Sleeve Gastrectomy. OBES SURG 2013;23:39-49. [DOI: 10.1007/s11695-012-0750-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
630 Roth WJ, Kissinger CB, McCain RR, Cooper BR, Marchant-Forde JN, Vreeman RC, Hannou S, Knipp GT. Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing. AAPS J 2013;15:763-74. [PMID: 23595360 DOI: 10.1208/s12248-013-9482-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
631 Gradauer K, Barthelmes J, Vonach C, Almer G, Mangge H, Teubl B, Roblegg E, Dünnhaupt S, Fröhlich E, Bernkop-Schnürch A, Prassl R. Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats. J Control Release 2013;172:872-8. [PMID: 24140721 DOI: 10.1016/j.jconrel.2013.10.011] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 10.3] [Reference Citation Analysis]
632 Sagawa K, Li F, Liese R, Sutton SC. Fed and fasted gastric pH and gastric residence time in conscious beagle dogs. J Pharm Sci 2009;98:2494-500. [PMID: 19177514 DOI: 10.1002/jps.21602] [Cited by in Crossref: 76] [Cited by in F6Publishing: 56] [Article Influence: 6.3] [Reference Citation Analysis]
633 Bergin IL, Witzmann FA. Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int J Biomed Nanosci Nanotechnol 2013;3. [PMID: 24228068 DOI: 10.1504/IJBNN.2013.054515] [Cited by in Crossref: 176] [Cited by in F6Publishing: 55] [Article Influence: 22.0] [Reference Citation Analysis]
634 Hubbard D, Bond T, Ghandehari H. Regional Morphology and Transport of PAMAM Dendrimers Across Isolated Rat Intestinal Tissue. Macromol Biosci 2015;15:1735-43. [PMID: 26332343 DOI: 10.1002/mabi.201500225] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
635 Brenneman KE, Willingham C, Kilbourne JA, Curtiss R 3rd, Roland KL. A low gastric pH mouse model to evaluate live attenuated bacterial vaccines. PLoS One 2014;9:e87411. [PMID: 24489912 DOI: 10.1371/journal.pone.0087411] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
636 Deng P, Beloshapka AN, Vester Boler BM, Swanson KS. Dietary fibre fermentability but not viscosity elicited the ‘second-meal effect’ in healthy adult dogs. Br J Nutr 2013;110:960-8. [DOI: 10.1017/s0007114513000020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
637 Koopmans SJ, Schuurman T. Considerations on pig models for appetite, metabolic syndrome and obese type 2 diabetes: From food intake to metabolic disease. Eur J Pharmacol 2015;759:231-9. [PMID: 25814261 DOI: 10.1016/j.ejphar.2015.03.044] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 8.3] [Reference Citation Analysis]
638 Rideout TC, Harding SV, Raslawsky A, Rempel CB. Dietary Resistant Starch Supplementation Increases High-Density Lipoprotein Particle Number in Pigs Fed a Western Diet. J Diet Suppl 2017;14:334-45. [PMID: 27653386 DOI: 10.1080/19390211.2016.1229371] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
639 Connor A. Location, location, location: gastrointestinal delivery site and its impact on absorption. Therapeutic Delivery 2012;3:575-8. [DOI: 10.4155/tde.12.34] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
640 Le Ferrec E, Chesne C, Artusson P, Brayden D, Fabre G, Gires P, Guillou F, Rousset M, Rubas W, Scarino M. In Vitro Models of the Intestinal Barrier: The Report and Recommendations of ECVAM Workshop 46 ,. Altern Lab Anim 2001;29:649-68. [DOI: 10.1177/026119290102900604] [Cited by in Crossref: 128] [Cited by in F6Publishing: 118] [Article Influence: 64.0] [Reference Citation Analysis]
641 Richards KL, Suter SE. Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma? Immunol Rev 2015;263:173-91. [PMID: 25510277 DOI: 10.1111/imr.12238] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
642 Suh M, Casteel S, Dunsmore M, Ring C, Verwiel A, Proctor DM. Bioaccessibility and relative oral bioavailability of cobalt and nickel in residential soil and dust affected by metal grinding operations. Science of The Total Environment 2019;660:677-89. [DOI: 10.1016/j.scitotenv.2018.12.317] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
643 Radloff J, Cornelius V, Markov AG, Amasheh S. Caprate Modulates Intestinal Barrier Function in Porcine Peyer's Patch Follicle-Associated Epithelium. Int J Mol Sci 2019;20:E1418. [PMID: 30897851 DOI: 10.3390/ijms20061418] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
644 Venkatesan N, Uchino K, Amagase K, Ito Y, Shibata N, Takada K. Gastro-intestinal patch system for the delivery of erythropoietin. Journal of Controlled Release 2006;111:19-26. [DOI: 10.1016/j.jconrel.2005.11.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
645 Fernandes TM, Gomes BB, Lanfer-marquez UM. Apparent absorption of chlorophyll from spinach in an assay with dogs. Innovative Food Science & Emerging Technologies 2007;8:426-32. [DOI: 10.1016/j.ifset.2007.03.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
646 Mathes CM, Bueter M, Smith KR, Lutz TA, le Roux CW, Spector AC. Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation. Am J Physiol Regul Integr Comp Physiol 2012;302:R751-67. [PMID: 22170618 DOI: 10.1152/ajpregu.00214.2011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
647 Vila L, García-rodríguez A, Cortés C, Marcos R, Hernández A. Assessing the effects of silver nanoparticles on monolayers of differentiated Caco-2 cells, as a model of intestinal barrier. Food and Chemical Toxicology 2018;116:1-10. [DOI: 10.1016/j.fct.2018.04.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
648 Akazawa T, Uchida Y, Miyauchi E, Tachikawa M, Ohtsuki S, Terasaki T. High Expression of UGT1A1/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human. Mol Pharmaceutics 2018;15:127-40. [DOI: 10.1021/acs.molpharmaceut.7b00772] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
649 Suys EJA, Brundel DHS, Chalmers DK, Pouton CW, Porter CJH. Interaction with biliary and pancreatic fluids drives supersaturation and drug absorption from lipid-based formulations of low (saquinavir) and high (fenofibrate) permeability poorly soluble drugs. J Control Release 2021;331:45-61. [PMID: 33450318 DOI: 10.1016/j.jconrel.2021.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
650 Müllertz A. Biorelevant Dissolution Media. In: Augustijns P, Brewster ME, editors. Solvent Systems and Their Selection in Pharmaceutics and Biopharmaceutics. New York: Springer; 2007. pp. 151-77. [DOI: 10.1007/978-0-387-69154-1_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
651 Guo H, Wang C, Liu Z, Gu H, Li Y, Zhao L, Hou R, Zhu J, Ho H, Hao Z. Quantification of in vivo gastric fluid volume in Bama miniature pigs in fasted state. Biopharm Drug Dispos 2018;39:403-7. [DOI: 10.1002/bdd.2155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
652 Paustenbach D, Finley B, Mowat F, Kerger B. Human Health Risk and Exposure Assessment of Chromium (VI) in Tap Water. Journal of Toxicology and Environmental Health, Part A 2003;66:1295-339. [DOI: 10.1080/15287390306388] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
653 Krogdahl Å, Sundby A, Holm H. Characteristics of digestive processes in Atlantic salmon (Salmo salar). Enzyme pH optima, chyme pH, and enzyme activities. Aquaculture 2015;449:27-36. [DOI: 10.1016/j.aquaculture.2015.02.032] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
654 Newman A, Knipp G, Zografi G. Assessing the performance of amorphous solid dispersions. Journal of Pharmaceutical Sciences 2012;101:1355-77. [DOI: 10.1002/jps.23031] [Cited by in Crossref: 241] [Cited by in F6Publishing: 209] [Article Influence: 26.8] [Reference Citation Analysis]
655 Pedron T, Freire BM, Castro CE, Ribal LF, Batista BL. Availability of arsenic in rice grains by in vitro and in vivo (humans) assays. Journal of Trace Elements in Medicine and Biology 2019;56:184-91. [DOI: 10.1016/j.jtemb.2019.08.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
656 Imai T, Sakai M, Ohtake H, Azuma H, Otagiri M. In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs. Pharm Res 1999;16:80-6. [PMID: 9950283 DOI: 10.1023/a:1018822829302] [Cited by in Crossref: 30] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
657 Coleman SA, Tapia-Siles SC, Pakleppa M, Vorstius JB, Keatch RP, Tang B, Cuschieri A. A hydraulically driven colonoscope. Surg Endosc 2016;30:4515-24. [PMID: 27450210 DOI: 10.1007/s00464-016-4784-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
658 Hatton GB, Yadav V, Basit AW, Merchant HA. Animal Farm: Considerations in Animal Gastrointestinal Physiology and Relevance to Drug Delivery in Humans. Journal of Pharmaceutical Sciences 2015;104:2747-76. [DOI: 10.1002/jps.24365] [Cited by in Crossref: 96] [Cited by in F6Publishing: 88] [Article Influence: 16.0] [Reference Citation Analysis]
659 Walsh PL, Bothe JR, Bhardwaj S, Hu M, Nofsinger R, Xia B, Persak S, Pennington J, Bak A. A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets. Drug Development and Industrial Pharmacy 2016;42:836-44. [DOI: 10.3109/03639045.2015.1082583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
660 Jang SF, Goins BA, Phillips WT, Santoyo C, Rice-Ficht A, McConville JT. Size discrimination in rat and mouse gastric emptying. Biopharm Drug Dispos 2013;34:107-24. [PMID: 23143681 DOI: 10.1002/bdd.1828] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
661 Moon C, Oh E. Rationale and strategies for formulation development of oral fixed dose combination drug products. Journal of Pharmaceutical Investigation 2016;46:615-31. [DOI: 10.1007/s40005-016-0286-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
662 Tajiri S, Kanamaru T, Kamada M, Konno T, Nakagami H. Dosage form design and in vitro/in vivo evaluation of cevimeline extended-release tablet formulations. Int J Pharm 2010;383:99-105. [PMID: 19747964 DOI: 10.1016/j.ijpharm.2009.09.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
663 Chanyi RM, Craven L, Harvey B, Reid G, Silverman MJ, Burton JP. Faecal microbiota transplantation: Where did it start? What have studies taught us? Where is it going? SAGE Open Med 2017;5:2050312117708712. [PMID: 28540051 DOI: 10.1177/2050312117708712] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
664 Salphati L, Childers K, Pan L, Tsutsui K, Takahashi L. Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man. Journal of Pharmacy and Pharmacology 2001;53:1007-13. [DOI: 10.1211/0022357011776252] [Cited by in Crossref: 87] [Cited by in F6Publishing: 74] [Article Influence: 7.9] [Reference Citation Analysis]
665 Willmann S, Thelen K, Becker C, Dressman JB, Lippert J. Mechanism-based prediction of particle size-dependent dissolution and absorption: Cilostazol pharmacokinetics in dogs. European Journal of Pharmaceutics and Biopharmaceutics 2010;76:83-94. [DOI: 10.1016/j.ejpb.2010.06.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
666 Kambayashi A, Dressman JB. Forecasting gastrointestinal precipitation and oral pharmacokinetics of dantrolene in dogs using an in vitro precipitation testing coupled with in silico modeling and simulation. European Journal of Pharmaceutics and Biopharmaceutics 2017;119:107-13. [DOI: 10.1016/j.ejpb.2017.06.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
667 Louisse J, Bosgra S, Blaauboer BJ, Rietjens IMCM, Verwei M. Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling. Arch Toxicol 2015;89:1135-48. [DOI: 10.1007/s00204-014-1289-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
668 Lazzari S, Codari F, Storti G, Morbidelli M, Moscatelli D. Modeling the pH-dependent PLA oligomer degradation kinetics. Polymer Degradation and Stability 2014;110:80-90. [DOI: 10.1016/j.polymdegradstab.2014.08.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
669 Mckim JM. Food additive carrageenan: Part I: A critical review of carrageenan in vitro studies, potential pitfalls, and implications for human health and safety. Critical Reviews in Toxicology 2014;44:211-43. [DOI: 10.3109/10408444.2013.861797] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 8.6] [Reference Citation Analysis]
670 Gulzar A, Gai S, Yang P, Li C, Ansari MB, Lin J. Stimuli responsive drug delivery application of polymer and silica in biomedicine. J Mater Chem B 2015;3:8599-622. [DOI: 10.1039/c5tb00757g] [Cited by in Crossref: 73] [Cited by in F6Publishing: 6] [Article Influence: 12.2] [Reference Citation Analysis]
671 Koziolek M, Grimm M, Bollmann T, Schäfer KJ, Blattner SM, Lotz R, Boeck G, Weitschies W. Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule. European Journal of Pharmaceutics and Biopharmaceutics 2019;136:221-30. [DOI: 10.1016/j.ejpb.2019.01.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
672 Wasan KM, Holtorf L, Subramanian R, Cassidy SM, Pritchard PH, Stewart DJ, Novak E, Moghadasian MH. Assessing plasma pharmacokinetics of cholesterol following oral coadministration with a novel vegetable stanol mixture to fasting rats. J Pharm Sci 2001;90:23-8. [PMID: 11064375 DOI: 10.1002/1520-6017(200101)90:1<23::aid-jps3>3.0.co;2-p] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
673 Nagy K, Fébel H, Bazar G, Grosz G, Gáspár R, Ferenc Szűcs K, Tóth T. Non-invasive smooth muscle electromyography (SMEMG) as a novel monitoring technology of the gastrointestinal tract of awake, free-moving pigs-A pilot study. PLoS One 2021;16:e0257311. [PMID: 34516588 DOI: 10.1371/journal.pone.0257311] [Reference Citation Analysis]
674 New R. Oral Delivery of Biologics via the Intestine. Pharmaceutics 2020;13:E18. [PMID: 33374222 DOI: 10.3390/pharmaceutics13010018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
675 Wasan KM, Zamfir C, Pritchard P, Pederson RA. Influence of Phytostanol Phosphoryl Ascorbate (FM-VP4) on Insulin Resistance, Hyperglycemia, Plasma Lipid Levels, and Gastrointestinal Absorption of Exogenous Cholesterol in Zucker (fa/fa) Fatty and Lean Rats. Journal of Pharmaceutical Sciences 2003;92:281-8. [DOI: 10.1002/jps.10297] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
676 Lentle RG. Deconstructing the physical processes of digestion: reductionist approaches may provide greater understanding. Food Funct 2018;9:4069-84. [PMID: 30011345 DOI: 10.1039/c8fo00722e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
677 Stull F, Hipp H, Stockbridge RB, Bardwell JCA. In vivo chloride concentrations surge to proteotoxic levels during acid stress. Nat Chem Biol 2018;14:1051-8. [PMID: 30323217 DOI: 10.1038/s41589-018-0143-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
678 Fröhlich E, Roblegg E. Models for oral uptake of nanoparticles in consumer products. Toxicology 2012;291:10-7. [PMID: 22120540 DOI: 10.1016/j.tox.2011.11.004] [Cited by in Crossref: 208] [Cited by in F6Publishing: 169] [Article Influence: 20.8] [Reference Citation Analysis]
679 Liu Y, Ji P. Dietary Factors in Prevention of Pediatric Escherichia coli Infection: A Model Using Domestic Piglets. ILAR J 2018;59:338-51. [PMID: 31095688 DOI: 10.1093/ilar/ilz005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
680 Schlosser PM, Sasso AF. A revised model of ex-vivo reduction of hexavalent chromium in human and rodent gastric juices. Toxicology and Applied Pharmacology 2014;280:352-61. [DOI: 10.1016/j.taap.2014.08.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
681 Tanno FK, Sakuma S, Masaoka Y, Kataoka M, Kozaki T, Kamaguchi R, Ikeda Y, Kokubo H, Yamashita S. Site‐Specific Drug Delivery to the Middle Region of the Small Intestine by Application of Enteric Coating with Hypromellose Acetate Succinate (HPMCAS). Journal of Pharmaceutical Sciences 2008;97:2665-79. [DOI: 10.1002/jps.21172] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
682 Liu Y, Hou W, Li L, Cheng W. Hepatobiliary physiological changes after Roux-en-Y cholecysto-colonic diversion. Journal of Pediatric Surgery 2014;49:1104-8. [DOI: 10.1016/j.jpedsurg.2014.02.041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
683 Scharek-Tedin L, Zentek J. A porcine animal model to mimic the restart of enteral nutrition (refeeding-model). Arch Anim Nutr 2019;73:52-66. [PMID: 31274344 DOI: 10.1080/1745039X.2018.1557919] [Reference Citation Analysis]
684 Hofmann M, Thieringer F, Nguyen MA, Månsson W, Galle PR, Langguth P. A novel technique for intraduodenal administration of drug suspensions/solutions with concurrent pH monitoring applied to ibuprofen formulations. Eur J Pharm Biopharm 2019;136:192-202. [PMID: 30659894 DOI: 10.1016/j.ejpb.2019.01.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
685 Nam KY, Cho SM, Choi YW, Park C, Meghani NM, Park JB, Lee BJ. Double controlled release of highly insoluble cilostazol using surfactant-driven pH dependent and pH-independent polymeric blends and in vivo bioavailability in beagle dogs. Int J Pharm 2019;558:284-90. [PMID: 30641181 DOI: 10.1016/j.ijpharm.2019.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
686 Mitchell DY, Eusebio RA, Dunlap LE, Pallone KA, Nesbitt JD, Russell DA, Clay ME, Bekker PJ. Risedronate gastrointestinal absorption is independent of site and rate of administration. Pharm Res 1998;15:228-32. [PMID: 9523308 DOI: 10.1023/a:1011910517200] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
687 Walthall K, Cappon GD, Hurtt ME, Zoetis T. Postnatal development of the gastrointestinal system: a species comparison. Birth Defects Res B Dev Reprod Toxicol. 2005;74:132-156. [PMID: 15834902 DOI: 10.1002/bdrb.20040] [Cited by in Crossref: 98] [Cited by in F6Publishing: 83] [Article Influence: 6.1] [Reference Citation Analysis]
688 Bines JE, Taylor RG, Justice F, Paris MC, Sourial M, Nagy E, Emselle S, Catto-Smith AG, Fuller PJ. Influence of diet complexity on intestinal adaptation following massive small bowel resection in a preclinical model. J Gastroenterol Hepatol. 2002;17:1170-1179. [PMID: 12453276 DOI: 10.1046/j.1440-1746.2002.02872.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
689 Sohlenius-Sternbeck AK, Orzechowski A. Characterization of the rates of testosterone metabolism to various products and of glutathione transferase and sulfotransferase activities in rat intestine and comparison to the corresponding hepatic and renal drug-metabolizing enzymes. Chem Biol Interact 2004;148:49-56. [PMID: 15223356 DOI: 10.1016/j.cbi.2004.05.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
690 Zhong C, Langrish T. A comparison of different physical stomach models and an analysis of shear stresses and strains in these system. Food Research International 2020;135:109296. [DOI: 10.1016/j.foodres.2020.109296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
691 Liu M, Wu L, Zhu X, Shan W, Li L, Cui Y, Huang Y. Core–shell stability of nanoparticles plays an important role for overcoming the intestinal mucus and epithelium barrier. J Mater Chem B 2016;4:5831-41. [DOI: 10.1039/c6tb01199c] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
692 Wright ND, Kong F, Williams BS, Fortner L. A human duodenum model (HDM) to study transport and digestion of intestinal contents. Journal of Food Engineering 2016;171:129-36. [DOI: 10.1016/j.jfoodeng.2015.10.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
693 Dai WG, Dong LC, Shi X, Nguyen J, Evans J, Xu Y, Creasey AA. Evaluation of drug precipitation of solubility-enhancing liquid formulations using milligram quantities of a new molecular entity (NME). J Pharm Sci 2007;96:2957-69. [PMID: 17705287 DOI: 10.1002/jps.20886] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
694 Trevaskis NL, Shackleford DM, Charman WN, Edwards GA, Gardin A, Appel-Dingemanse S, Kretz O, Galli B, Porter CJ. Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism. Pharm Res 2009;26:1486-95. [PMID: 19280324 DOI: 10.1007/s11095-009-9860-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
695 Boegh M, Nielsen HM. Mucus as a Barrier to Drug Delivery - Understanding and Mimicking the Barrier Properties. Basic Clin Pharmacol Toxicol 2015;116:179-86. [DOI: 10.1111/bcpt.12342] [Cited by in Crossref: 140] [Cited by in F6Publishing: 124] [Article Influence: 20.0] [Reference Citation Analysis]
696 Liu J, Leng P, Liu Y. Oral drug delivery with nanoparticles into the gastrointestinal mucosa. Fundam Clin Pharmacol 2021;35:86-96. [PMID: 32749731 DOI: 10.1111/fcp.12594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
697 Collado-Romero M, Aguilar C, Arce C, Lucena C, Codrea MC, Morera L, Bendixen E, Moreno Á, Garrido JJ. Quantitative proteomics and bioinformatic analysis provide new insight into the dynamic response of porcine intestine to Salmonella Typhimurium. Front Cell Infect Microbiol 2015;5:64. [PMID: 26389078 DOI: 10.3389/fcimb.2015.00064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article